Document
false--12-31Q120192019-03-310000059440falseLarge Accelerated Filerfalse0.380.400.100.102500000002500000001409146421408990651409146421408990652946500033590002430000000.0900.0800.0850.0850.0750.0800.1840.0520.4850.1500.5000.1500.4950.03150000005462800054202000111000000010000000P2YP12MP90D0P1Y0
0000059440
2019-01-01
2019-03-31
0000059440
2019-05-07
0000059440
2018-12-31
0000059440
2019-03-31
0000059440
2018-01-01
2018-03-31
0000059440
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TobaccoSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TobaccoSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-03-31
0000059440
us-gaap:RetainedEarningsMember
2018-01-01
2018-03-31
0000059440
2017-12-31
0000059440
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0000059440
2018-03-31
0000059440
us-gaap:CommonStockMember
2017-12-31
0000059440
us-gaap:RetainedEarningsMember
2018-03-31
0000059440
us-gaap:CommonStockMember
2018-03-31
0000059440
us-gaap:NoncontrollingInterestMember
2018-01-01
2018-03-31
0000059440
us-gaap:RetainedEarningsMember
2017-12-31
0000059440
us-gaap:AdditionalPaidInCapitalMember
2018-01-01
2018-03-31
0000059440
us-gaap:NoncontrollingInterestMember
2017-12-31
0000059440
us-gaap:CommonStockMember
2018-01-01
2018-03-31
0000059440
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-12-31
0000059440
us-gaap:AdditionalPaidInCapitalMember
2018-03-31
0000059440
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0000059440
us-gaap:NoncontrollingInterestMember
2018-03-31
0000059440
us-gaap:CommonStockMember
2019-03-31
0000059440
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0000059440
us-gaap:RetainedEarningsMember
2018-12-31
0000059440
us-gaap:CommonStockMember
2018-12-31
0000059440
us-gaap:NoncontrollingInterestMember
2018-12-31
0000059440
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0000059440
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0000059440
us-gaap:NoncontrollingInterestMember
2019-03-31
0000059440
us-gaap:RetainedEarningsMember
2019-03-31
0000059440
us-gaap:NoncontrollingInterestMember
2019-01-01
2019-03-31
0000059440
us-gaap:CommonStockMember
2019-01-01
2019-03-31
0000059440
us-gaap:RetainedEarningsMember
2019-01-01
2019-03-31
0000059440
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0000059440
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-03-31
0000059440
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0000059440
us-gaap:TrademarksMember
2018-12-31
0000059440
vgr:MasterSettlementAgreementIntangibleAssetMember
2019-03-31
0000059440
us-gaap:TrademarksMember
2019-03-31
0000059440
vgr:MasterSettlementAgreementIntangibleAssetMember
2018-12-31
0000059440
srt:MaximumMember
2018-12-31
0000059440
2018-09-27
0000059440
vgr:AccountingStandardsUpdate201802Member
2019-01-01
0000059440
srt:MaximumMember
2019-03-31
0000059440
srt:MinimumMember
2018-12-31
0000059440
srt:MinimumMember
2019-03-31
0000059440
us-gaap:RestrictedStockMember
2019-01-01
2019-03-31
0000059440
us-gaap:RestrictedStockMember
2018-01-01
2018-03-31
0000059440
us-gaap:ConvertibleDebtSecuritiesMember
2019-01-01
2019-03-31
0000059440
us-gaap:ConvertibleDebtSecuritiesMember
2018-01-01
2018-03-31
0000059440
vgr:TobaccoMember
2018-01-01
2018-03-31
0000059440
vgr:OtherBrandsMember
vgr:TobaccoMember
2019-01-01
2019-03-31
0000059440
vgr:OtherBrandsMember
vgr:TobaccoMember
2018-01-01
2018-03-31
0000059440
vgr:CoreDiscountBrandsPyramidGrandPrixLiggettSelectEveandEAGLE20sMember
vgr:TobaccoMember
2019-01-01
2019-03-31
0000059440
vgr:TobaccoMember
2019-01-01
2019-03-31
0000059440
vgr:CoreDiscountBrandsPyramidGrandPrixLiggettSelectEveandEAGLE20sMember
vgr:TobaccoMember
2018-01-01
2018-03-31
0000059440
2019-01-01
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:WestMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TitleFeesMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:WestMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:NortheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:WestMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:WestMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:WestMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TitleFeesMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TitleFeesMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TitleFeesMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TitleFeesMember
vgr:WestMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:WestMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
vgr:TitleFeesMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:WestMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:NortheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TitleFeesMember
vgr:WestMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TitleFeesMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:WestMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:WestMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TitleFeesMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TitleFeesMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:NortheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:WestMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:PropertyManagementIncomeMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:DevelopmentMarketingMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:CommissionandOtherBrokerageIncomeMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:OtherRealEstateRevenuesMember
vgr:WestMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:TotalDouglasEllimanRealityRevenueMember
vgr:SoutheastMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
vgr:WestMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
us-gaap:TransferredOverTimeMember
2019-01-01
2019-03-31
0000059440
2023-04-01
2019-03-31
0000059440
us-gaap:EquipmentMember
2019-03-31
0000059440
us-gaap:AccountingStandardsUpdate201602Member
2019-01-01
0000059440
vgr:OneLeaseLessorAffiliateofSignificantInvestorMember
2019-01-01
2019-03-31
0000059440
vgr:OneLeaseLessorAffiliateofSignificantInvestorMember
2019-03-31
0000059440
srt:MaximumMember
2019-01-01
2019-03-31
0000059440
srt:MinimumMember
2019-01-01
2019-03-31
0000059440
us-gaap:InventoriesMember
2018-12-31
0000059440
vgr:FinishedGoodsMember
2018-12-31
0000059440
vgr:FinishedGoodsMember
2019-03-31
0000059440
vgr:WorkinProcessMember
2018-12-31
0000059440
vgr:LeafTobaccoMember
2018-12-31
0000059440
us-gaap:InventoriesMember
2019-03-31
0000059440
vgr:LiggettMember
us-gaap:InventoriesMember
2019-01-01
2019-03-31
0000059440
vgr:OtherRawMaterialsMember
2019-03-31
0000059440
vgr:OtherRawMaterialsMember
2018-12-31
0000059440
vgr:WorkinProcessMember
2019-03-31
0000059440
vgr:LeafTobaccoMember
2019-03-31
0000059440
vgr:MarketableDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:DebtSecuritiesMember
2019-03-31
0000059440
vgr:CorporateSecuritiesandU.S.GovernmentSecuritiesMember
2019-01-01
2019-03-31
0000059440
us-gaap:OtherLongTermInvestmentsMember
2019-01-01
2019-03-31
0000059440
vgr:CorporateSecuritiesandU.S.GovernmentSecuritiesMember
2018-01-01
2018-03-31
0000059440
us-gaap:DebtSecuritiesMember
2018-12-31
0000059440
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2019-03-31
0000059440
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0000059440
vgr:ForeignFixedIncomeSecuritiesMember
2019-03-31
0000059440
us-gaap:CorporateDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:USTreasurySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
vgr:MarketableEquitySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
vgr:MarketableEquitySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FixedIncomeFundsMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FixedIncomeFundsMember
2018-12-31
0000059440
vgr:LadenburgThalmannFinancialServicesInc.Member
2018-12-31
0000059440
vgr:IndianCreekInvestorsLPMember
2018-12-31
0000059440
vgr:LadenburgThalmannFinancialServicesInc.Member
2019-03-31
0000059440
vgr:IndianCreekInvestorsLPMember
2019-03-31
0000059440
vgr:BoyarValueFundMember
2018-12-31
0000059440
vgr:BoyarValueFundMember
2019-03-31
0000059440
vgr:CastleBrandsMember
2018-12-31
0000059440
vgr:CastleBrandsMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
vgr:SagaponackMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2019-03-31
0000059440
vgr:DouglasEllimanRealtyLlcMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
vgr:A3526thAvenueLLCMember
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2019-03-31
0000059440
vgr:DouglasEllimanRealtyLlcMember
2019-01-01
2019-03-31
0000059440
srt:MultifamilyMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
vgr:A3526thAvenueLLCMember
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2019-02-28
0000059440
vgr:NewValleyLlcMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
vgr:EscenaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
vgr:EscenaMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
vgr:SagaponackMember
2015-04-01
2015-04-30
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:OtherPropertyMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:OtherPropertyMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:ApartmentBuildingMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:ApartmentBuildingMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:ApartmentBuildingMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:ApartmentBuildingMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
us-gaap:NonUsMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
us-gaap:NonUsMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-01-01
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
2018-01-01
2018-03-31
0000059440
vgr:NewValleyLlcMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
vgr:SagaponackMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
vgr:EscenaMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
vgr:EscenaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
us-gaap:NonUsMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
us-gaap:NonUsMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:OtherPropertyMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:OtherPropertyMember
2018-12-31
0000059440
vgr:NewValleyLlcMember
srt:RetailSiteMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:OtherPropertyMember
srt:MaximumMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
srt:MaximumMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
srt:MaximumMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:MultifamilyMember
srt:MinimumMember
vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:MinimumMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:MaximumMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:HotelMember
srt:MinimumMember
vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember
2019-03-31
0000059440
vgr:NewValleyLlcMember
srt:OtherPropertyMember
srt:MinimumMember
2019-03-31
0000059440
us-gaap:ConvertibleDebtMember
2019-03-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:OtherDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:ConvertibleDebtMember
2019-03-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-12-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SeniorNotesMember
2018-12-31
0000059440
us-gaap:SeniorNotesMember
2019-03-31
0000059440
us-gaap:SeniorNotesMember
2018-12-31
0000059440
us-gaap:ConvertibleDebtMember
2018-12-31
0000059440
us-gaap:OtherDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SeniorNotesMember
2019-03-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-03-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:OtherDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:OtherDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:ConvertibleDebtMember
2018-12-31
0000059440
vgr:A5.5VariableInterestSeniorConvertibleDebenturesdue2020Member
us-gaap:ConvertibleDebtMember
2018-12-31
0000059440
vgr:LiggettMember
us-gaap:SecuredDebtMember
2019-03-31
0000059440
vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member
us-gaap:ConvertibleDebtMember
2018-12-31
0000059440
vgr:LiggettMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2018-12-31
0000059440
vgr:LiggettMember
vgr:TermLoanUnderCreditFacilityMember
us-gaap:LineOfCreditMember
2019-03-31
0000059440
vgr:LiggettMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:TermLoanUnderCreditFacilityMember
us-gaap:LineOfCreditMember
2018-12-31
0000059440
vgr:LiggettMember
us-gaap:SecuredDebtMember
2018-12-31
0000059440
vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member
us-gaap:ConvertibleDebtMember
2019-03-31
0000059440
us-gaap:NotesPayableOtherPayablesMember
2018-12-31
0000059440
vgr:A10.5SeniorNotesdue2026Member
us-gaap:ConvertibleDebtMember
2019-03-31
0000059440
vgr:A10.5SeniorNotesdue2026Member
us-gaap:ConvertibleDebtMember
2018-12-31
0000059440
us-gaap:NotesPayableOtherPayablesMember
2019-03-31
0000059440
vgr:A6.125SeniorSecuredNotesdue2025Member
us-gaap:SeniorNotesMember
2018-12-31
0000059440
vgr:A6.125SeniorSecuredNotesdue2025Member
us-gaap:SeniorNotesMember
2019-03-31
0000059440
vgr:A5.5VariableInterestSeniorConvertibleDebenturesdue2020Member
us-gaap:ConvertibleDebtMember
2019-03-31
0000059440
vgr:A10.5SeniorNotesdue2026Member
us-gaap:SeniorNotesMember
2018-11-02
0000059440
vgr:LiggettMember
us-gaap:LineOfCreditMember
2019-03-31
0000059440
vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member
us-gaap:ConvertibleDebtMember
2019-01-01
2019-01-31
0000059440
vgr:A10.5SeniorNotesdue2026Member
us-gaap:SeniorNotesMember
2018-11-02
2018-11-02
0000059440
vgr:A10.5SeniorNotesdue2026Member
us-gaap:SeniorNotesMember
2019-03-31
0000059440
vgr:DouglasEllimanRealtyLlcMember
vgr:A10.5SeniorNotesdue2026Member
us-gaap:SeniorNotesMember
2018-11-02
0000059440
vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member
us-gaap:ConvertibleDebtMember
2019-01-31
0000059440
vgr:LiggettMember
vgr:IndividualActionsCasesMember
stpr:OH
2019-03-31
0000059440
vgr:LiggettMember
vgr:IndividualActionsCasesMember
stpr:NY
2019-03-31
0000059440
vgr:LiggettMember
vgr:IndividualActionsCasesMember
stpr:LA
2019-03-31
0000059440
vgr:LiggettMember
vgr:IndividualActionsCasesMember
stpr:FL
2019-03-31
0000059440
vgr:LiggettMember
vgr:IndividualActionsCasesMember
stpr:IL
2019-03-31
0000059440
vgr:LiggettMember
vgr:IndividualActionsCasesMember
stpr:WV
2019-03-31
0000059440
vgr:IndividualActionsCasesMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:HealthCareCostRecoveryActions20112015NPMAdjustmentMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:HealthCareCostRecoveryActionsMember
1996-03-01
1998-03-31
0000059440
vgr:LiggettAndVectorTobaccoMember
us-gaap:SalesRevenueNetMember
us-gaap:ProductConcentrationRiskMember
2019-01-01
2019-03-31
0000059440
vgr:LiggettMember
vgr:HealthCareCostRecoveryActionsMember
stpr:FL
2010-01-01
2010-12-31
0000059440
vgr:TobaccoLitigationPersonalInjuryCasesMember
stpr:WV
2013-10-01
2013-10-31
0000059440
vgr:VectorTobaccoMember
vgr:HealthCareCostRecoveryActionsMember
2019-03-31
0000059440
vgr:TobaccoLitigationPersonalInjuryCasesMember
stpr:WV
2013-05-01
2013-05-31
0000059440
vgr:LiggettAndVectorTobaccoMember
vgr:HealthCareCostRecoveryActionsNPMAdjustmentMember
us-gaap:CostOfSalesMember
2013-01-01
2017-12-31
0000059440
vgr:LiggettMember
vgr:TobaccoLitigationPersonalInjuryCasesMember
stpr:WV
2019-03-31
0000059440
vgr:EngleProgenyCasesMember
2019-03-31
0000059440
vgr:LiggettAndVectorTobaccoMember
vgr:EngleProgenyCasesMember
2019-01-01
2019-03-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2017-09-01
2017-09-30
0000059440
vgr:LiggettMember
1996-03-01
1998-03-31
0000059440
vgr:HealthCareCostRecoveryActionsMember
1996-03-01
1998-03-31
0000059440
vgr:LiggettMember
vgr:HealthCareCostRecoveryActionsMember
stpr:MS
2019-03-21
0000059440
vgr:LiggettMember
vgr:HealthCareCostRecoveryActionsMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2019-03-31
0000059440
vgr:LiggettMember
2019-01-01
2019-03-31
0000059440
vgr:LiggettAndVectorTobaccoMember
vgr:EngleProgenyCasesMember
2019-03-31
0000059440
vgr:LiggettAndVectorTobaccoMember
vgr:HealthCareCostRecoveryActionsMember
2017-12-28
2017-12-28
0000059440
vgr:LiggettMember
vgr:Santorov.R.J.ReynoldsMember
us-gaap:SuretyBondMember
2018-12-31
0000059440
1996-11-21
1996-11-21
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2016-12-01
2016-12-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2013-10-01
2013-10-31
0000059440
vgr:LiggettMember
2018-01-01
2018-03-31
0000059440
vgr:HealthCareCostRecoveryActions2003NPMAdjustmentMember
2019-01-01
2019-03-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2017-06-01
2017-06-30
0000059440
vgr:ParsonsVAcSIncMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2015-02-01
2015-02-28
0000059440
vgr:LiggettMember
vgr:ClassActionsMember
2019-03-31
0000059440
vgr:LiggettAndVectorTobaccoMember
vgr:HealthCareCostRecoveryActions20042010NPMAdjustmentMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2013-10-31
0000059440
vgr:HealthCareCostRecoveryActionsMember
2019-01-01
2019-03-31
0000059440
vgr:LiggettMember
vgr:CrowCreekSiouxTribev.AmericanTobaccoCompanyMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
2016-10-01
2016-12-31
0000059440
vgr:LiggettMember
vgr:EngleProgenyCasesMember
stpr:FL
2009-06-30
0000059440
vgr:LiggettMember
vgr:HealthCareCostRecoveryActionsMember
stpr:MS
2016-01-12
2016-01-12
0000059440
vgr:LiggettMember
vgr:Santorov.R.J.ReynoldsMember
2019-01-01
2019-03-31
0000059440
vgr:TobaccoLitigationPersonalInjuryCasesMember
stpr:WV
2001-12-31
0000059440
vgr:LiggettMember
vgr:LukacsCampbellDouglasClayTulloWardRizzutoLambertandBuchananMember
2019-01-01
2019-03-31
0000059440
vgr:HealthCareCostRecoveryActions2003NPMAdjustmentMember
2019-03-31
0000059440
vgr:LiggettMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:TobaccoLitigationPersonalInjuryCasesMember
stpr:WV
2017-04-30
0000059440
vgr:LiggettMember
1996-11-21
1996-11-21
0000059440
vgr:LiggettAndVectorTobaccoMember
vgr:HealthCareCostRecoveryActionsMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:HealthCareCostRecoveryActionsMember
stpr:MN
2003-01-01
2003-12-31
0000059440
vgr:LiggettAndVectorTobaccoMember
srt:MaximumMember
us-gaap:SuretyBondMember
2019-03-31
0000059440
vgr:LiggettMember
vgr:IndividualActionsCasesMember
stpr:MD
2019-03-31
0000059440
us-gaap:SettledLitigationMember
2018-01-01
2018-03-31
0000059440
us-gaap:PendingLitigationMember
2018-03-31
0000059440
us-gaap:SettledLitigationMember
2018-03-31
0000059440
us-gaap:PendingLitigationMember
2018-01-01
2018-03-31
0000059440
us-gaap:PendingLitigationMember
2017-12-31
0000059440
us-gaap:SettledLitigationMember
2017-12-31
0000059440
us-gaap:PendingLitigationMember
2019-01-01
2019-03-31
0000059440
us-gaap:SettledLitigationMember
2018-12-31
0000059440
us-gaap:SettledLitigationMember
2019-01-01
2019-03-31
0000059440
us-gaap:SettledLitigationMember
2019-03-31
0000059440
us-gaap:PendingLitigationMember
2018-12-31
0000059440
us-gaap:PendingLitigationMember
2019-03-31
0000059440
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2019-01-01
2019-03-31
0000059440
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2018-01-01
2018-03-31
0000059440
us-gaap:PensionPlansDefinedBenefitMember
2018-01-01
2018-03-31
0000059440
us-gaap:PensionPlansDefinedBenefitMember
2019-01-01
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
vgr:MeasurementInputLeverageAdjustedEquityandVolatilityofPeerFirmsMember
vgr:MonteCarloSimulationModelMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedDividendPaymentMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputConversionPriceMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputSharePriceMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputRiskFreeInterestRateMember
vgr:MonteCarloSimulationModelMember
2019-03-31
0000059440
vgr:RestrictedAssetsMember
us-gaap:CommercialPaperMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000059440
vgr:CurrentRestrictedAssetsMember
us-gaap:CommercialPaperMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
vgr:RestrictedAssetsMember
us-gaap:CommercialPaperMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
vgr:DouglasEllimanMember
2019-03-31
0000059440
vgr:CurrentRestrictedAssetsMember
us-gaap:CommercialPaperMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
vgr:MeasurementInputLeverageAdjustedEquityandVolatilityofPeerFirmsMember
vgr:MonteCarloSimulationModelMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputSharePriceMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedDividendPaymentMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputRiskFreeInterestRateMember
vgr:MonteCarloSimulationModelMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputConversionPriceMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000059440
us-gaap:SuretyBondMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
vgr:ForeignFixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
vgr:MarketableEquitySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:SuretyBondMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FixedIncomeFundsMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:SuretyBondMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:EquitySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
vgr:ForeignFixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
vgr:ForeignFixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2018-12-31
0000059440
us-gaap:CommercialPaperMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasurySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasurySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
vgr:ForeignFixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasurySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasurySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000059440
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
vgr:MarketableEquitySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2018-12-31
0000059440
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2018-12-31
0000059440
us-gaap:EquitySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FixedIncomeFundsMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000059440
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:EquitySecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:SuretyBondMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FixedIncomeSecuritiesMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000059440
us-gaap:FixedIncomeFundsMember
2018-12-31
0000059440
us-gaap:FairValueInputsLevel3Member
vgr:MarketableEquitySecuritiesMember
2018-12-31
0000059440
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
vgr:ForeignFixedIncomeSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
2019-03-31
0000059440
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel3Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
vgr:MarketableEquitySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2019-03-31
0000059440
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel1Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:USTreasurySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FixedIncomeSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
vgr:MarketableEquitySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:SuretyBondMember
us-gaap:FairValueInputsLevel2Member
2019-03-31
0000059440
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel2Member
2019-03-31
0000059440
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:EquitySecuritiesMember
2019-03-31
0000059440
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel3Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:USTreasurySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:FixedIncomeSecuritiesMember
2019-03-31
0000059440
vgr:MarketableEquitySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:CorporateDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:MoneyMarketFundsMember
2019-03-31
0000059440
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
2019-03-31
0000059440
us-gaap:FixedIncomeSecuritiesMember
2019-03-31
0000059440
us-gaap:SuretyBondMember
us-gaap:FairValueInputsLevel1Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:CommercialPaperMember
2019-03-31
0000059440
us-gaap:EquitySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:USTreasurySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FixedIncomeSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:FixedIncomeFundsMember
2019-03-31
0000059440
us-gaap:CertificatesOfDepositMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:CorporateDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:SuretyBondMember
us-gaap:FairValueInputsLevel3Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
vgr:ForeignFixedIncomeSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
vgr:ForeignFixedIncomeSecuritiesMember
2019-03-31
0000059440
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel1Member
2019-03-31
0000059440
us-gaap:FixedIncomeFundsMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel1Member
us-gaap:EquitySecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel2Member
us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember
2019-03-31
0000059440
us-gaap:SuretyBondMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:FixedIncomeFundsMember
2019-03-31
0000059440
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel2Member
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputCreditSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputCreditSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputCreditSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputCreditSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-03-31
0000059440
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputCreditSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputCreditSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000059440
us-gaap:OperatingSegmentsMember
vgr:TobaccoSegmentMember
2018-01-01
2018-03-31
0000059440
us-gaap:OperatingSegmentsMember
vgr:TobaccoSegmentMember
2019-01-01
2019-03-31
0000059440
us-gaap:OperatingSegmentsMember
vgr:RealEstateSegmentMember
2019-01-01
2019-03-31
0000059440
us-gaap:CorporateNonSegmentMember
2019-01-01
2019-03-31
0000059440
us-gaap:CorporateNonSegmentMember
2018-01-01
2018-03-31
0000059440
us-gaap:OperatingSegmentsMember
vgr:RealEstateSegmentMember
2018-01-01
2018-03-31
0000059440
srt:GuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2019-03-31
0000059440
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
2019-03-31
0000059440
srt:ConsolidationEliminationsMember
2019-03-31
0000059440
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2019-03-31
0000059440
srt:GuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2018-12-31
0000059440
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2018-12-31
0000059440
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
2018-12-31
0000059440
srt:ConsolidationEliminationsMember
2018-12-31
0000059440
srt:GuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2019-01-01
2019-03-31
0000059440
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
2019-01-01
2019-03-31
0000059440
srt:ConsolidationEliminationsMember
2019-01-01
2019-03-31
0000059440
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2019-01-01
2019-03-31
0000059440
srt:GuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2018-01-01
2018-03-31
0000059440
srt:ConsolidationEliminationsMember
2018-01-01
2018-03-31
0000059440
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2018-01-01
2018-03-31
0000059440
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
2018-01-01
2018-03-31
0000059440
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2018-03-31
0000059440
srt:GuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2017-12-31
0000059440
srt:ConsolidationEliminationsMember
2017-12-31
0000059440
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
2018-03-31
0000059440
srt:GuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2018-03-31
0000059440
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
2017-12-31
0000059440
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
2017-12-31
0000059440
srt:ConsolidationEliminationsMember
2018-03-31
vgr:venture
iso4217:USD
xbrli:pure
xbrli:shares
iso4217:USD
xbrli:shares
vgr:investment
vgr:state
vgr:defendant
vgr:case
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For The Quarterly Period Ended March 31, 2019
VECTOR GROUP LTD.
(Exact name of registrant as specified in its charter)
|
| | |
Delaware | 1-5759 | 65-0949535 |
(State or other jurisdiction of incorporation | Commission File Number | (I.R.S. Employer Identification No.) |
incorporation or organization) | | |
4400 Biscayne Boulevard
Miami, Florida 33137
305-579-8000
(Address, including zip code and telephone number, including area code,
of the principal executive offices)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
x Yes o No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
x Yes o No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
| | | | |
x Large accelerated filer | o Accelerated filer | o Non-accelerated filer | o Smaller reporting company | o Emerging Growth Company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the Registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
o Yes x No
Securities Registered Pursuant to 12(b) of the Act:
|
| | |
Title of each class: | Trading | Name of each exchange |
| Symbol(s) | on which registered: |
Common stock, par value $0.10 per share | VGR | New York Stock Exchange |
At May 7, 2019, Vector Group Ltd. had 140,959,065 shares of common stock outstanding.
VECTOR GROUP LTD.
FORM 10-Q
TABLE OF CONTENTS
|
| |
| Page |
PART I. FINANCIAL INFORMATION | |
| |
Item 1. Vector Group Ltd. Condensed Consolidated Financial Statements (Unaudited): | |
| |
Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018 | |
| |
Condensed Consolidated Statements of Operations for the three months ended March 31, 2019 and 2018 | |
| |
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2019 and 2018 | |
| |
Condensed Consolidated Statements of Stockholders' Deficiency for the three months ended March 31, 2019 and 2018 | |
| |
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2019 and 2018 | |
| |
Notes to Condensed Consolidated Financial Statements | |
| |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
| |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | |
| |
Item 4. Controls and Procedures | |
| |
PART II. OTHER INFORMATION | |
| |
Item 1. Legal Proceedings | |
| |
Item 1A. Risk Factors | |
| |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | |
| |
Item 6. Exhibits | |
| |
SIGNATURE | |
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
ASSETS: | | | |
Current assets: | | | |
Cash and cash equivalents | $ | 312,638 |
| | $ | 584,581 |
|
Investment securities at fair value | 134,652 |
| | 131,569 |
|
Accounts receivable - trade, net | 36,440 |
| | 34,246 |
|
Inventories | 101,977 |
| | 90,997 |
|
Restricted assets | 5,412 |
| | 4,477 |
|
Other current assets | 36,242 |
| | 26,351 |
|
Total current assets | 627,361 |
| | 872,221 |
|
Property, plant and equipment, net | 85,641 |
| | 86,736 |
|
Investments in real estate, net | 26,777 |
| | 26,220 |
|
Long-term investments (of which $54,202 and $54,628 were carried at fair value) | 66,768 |
| | 66,259 |
|
Investments in real estate ventures | 138,393 |
| | 141,105 |
|
Operating lease right of use assets | 124,723 |
| | — |
|
Restricted assets | 6,316 |
| | 6,306 |
|
Goodwill and other intangible assets, net | 266,065 |
| | 266,611 |
|
Prepaid pension costs | 24,179 |
| | 23,869 |
|
Other assets | 62,933 |
| | 60,177 |
|
Total assets | $ | 1,429,156 |
| | $ | 1,549,504 |
|
LIABILITIES AND STOCKHOLDERS' DEFICIENCY: | | | |
Current liabilities: | | | |
Current portion of notes payable and long-term debt | $ | 41,080 |
| | $ | 256,134 |
|
Current portion of fair value of derivatives embedded within convertible debt | — |
| | 6,635 |
|
Current payments due under the Master Settlement Agreement | 73,809 |
| | 36,561 |
|
Current portion of employee benefits | 875 |
| | 875 |
|
Income taxes payable, net | 9,701 |
| | 5,252 |
|
Litigation accruals | 3,404 |
| | 310 |
|
Current operating lease liability | 20,414 |
| | — |
|
Other current liabilities | 153,334 |
| | 179,153 |
|
Total current liabilities | 302,617 |
| | 484,920 |
|
Notes payable, long-term debt and other obligations, less current portion | 1,387,945 |
| | 1,386,697 |
|
Fair value of derivatives embedded within convertible debt | 21,075 |
| | 24,789 |
|
Non-current employee benefits | 61,684 |
| | 61,288 |
|
Deferred income taxes, net | 39,823 |
| | 37,411 |
|
Non-current operating lease liability | 128,999 |
| | — |
|
Payments due under the Master Settlement Agreement | 16,383 |
| | 16,383 |
|
Litigation accruals | 19,027 |
| | 21,794 |
|
Other liabilities | 41,704 |
| | 63,588 |
|
Total liabilities | 2,019,257 |
| | 2,096,870 |
|
Commitments and contingencies (Note 9) |
| |
|
Stockholders' deficiency: | | | |
Preferred stock, par value $1.00 per share, 10,000,000 shares authorized | — |
| | — |
|
Common stock, par value $0.10 per share, 250,000,000 shares authorized,140,899,065 and 140,914,642 shares issued and outstanding | 14,090 |
| | 14,092 |
|
Accumulated deficit | (580,581 | ) | | (542,169 | ) |
Accumulated other comprehensive loss | (24,098 | ) | | (19,982 | ) |
Total Vector Group Ltd. stockholders' deficiency | (590,589 | ) | | (548,059 | ) |
Non-controlling interest | 488 |
| | 693 |
|
Total stockholders' deficiency | (590,101 | ) | | (547,366 | ) |
Total liabilities and stockholders' deficiency | $ | 1,429,156 |
| | $ | 1,549,504 |
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Revenues: | | | |
Tobacco* | $ | 256,756 |
| | $ | 267,116 |
|
Real estate | 164,168 |
| | 161,850 |
|
Total revenues | 420,924 |
| | 428,966 |
|
| | | |
Expenses: | | | |
Cost of sales: | | | |
Tobacco* | 177,303 |
| | 184,962 |
|
Real estate | 108,717 |
| | 109,313 |
|
Total cost of sales | 286,020 |
| | 294,275 |
|
| | | |
Operating, selling, administrative and general expenses | 92,314 |
| | 89,076 |
|
Litigation settlement and judgment income | — |
| | (2,469 | ) |
Operating income | 42,590 |
| | 48,084 |
|
| | | |
Other income (expenses): | | | |
Interest expense | (37,520 | ) | | (45,947 | ) |
Change in fair value of derivatives embedded within convertible debt | 10,349 |
| | 10,567 |
|
Equity in losses from real estate ventures | (2,439 | ) | | (6,560 | ) |
Equity in earnings from investments | 1,362 |
| | 1,162 |
|
Net gains (losses) recognized on investment securities | 4,773 |
| | (3,340 | ) |
Other, net | 2,667 |
| | 1,646 |
|
Income before provision for income taxes | 21,782 |
| | 5,612 |
|
Income tax expense | 6,749 |
| | 1,948 |
|
| | | |
Net income | 15,033 |
| | 3,664 |
|
| | | |
Net (income) loss attributed to non-controlling interest | (80 | ) | | 3,547 |
|
| | | |
Net income attributed to Vector Group Ltd. | $ | 14,953 |
| | $ | 7,211 |
|
| | | |
Per basic common share: | | | |
| | | |
Net income applicable to common shares attributed to Vector Group Ltd. | $ | 0.09 |
| | $ | 0.04 |
|
| | | |
Per diluted common share: | | | |
| | | |
Net income applicable to common shares attributed to Vector Group Ltd. | $ | 0.08 |
| | $ | 0.04 |
|
* $104,633 and $112,801, respectively.
The accompanying notes are an integral part of the condensed consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in Thousands)
Unaudited
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
| |
Net income | $ | 15,033 |
| | $ | 3,664 |
|
| | | |
Net unrealized gains (losses) on investment securities available for sale: | | | |
Change in net unrealized gains (losses) | 377 |
| | (692 | ) |
Net unrealized (gains) losses reclassified into net income | (33 | ) | | 595 |
|
Net unrealized gains (losses) on investment securities available for sale | 344 |
| | (97 | ) |
|
|
| | |
Net change in pension-related amounts | | | |
Amortization of loss | 457 |
| | 442 |
|
Net change in pension-related amounts | 457 |
| | 442 |
|
| | | |
Other comprehensive income | 801 |
| | 345 |
|
| | | |
Income tax effect on: | | | |
Change in net unrealized gains (losses) on investment securities | (104 | ) | | 189 |
|
Net unrealized (gains) losses reclassified into net income on investment securities | 9 |
| | (163 | ) |
Pension-related amounts | (125 | ) | | (121 | ) |
Income tax provision on other comprehensive income | (220 | ) | | (95 | ) |
| | | |
Other comprehensive income, net of tax | 581 |
| | 250 |
|
| | | |
Comprehensive income | 15,614 |
| | 3,914 |
|
| | | |
Comprehensive (income) loss attributed to non-controlling interest | (80 | ) | | 3,547 |
|
Comprehensive income attributed to Vector Group Ltd. | $ | 15,534 |
| | $ | 7,461 |
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY
(Dollars in Thousands, Except Share Amounts)
Unaudited
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Vector Group Ltd. Stockholders' Deficiency | | | |
| | | Additional Paid-In | | | | Accumulated Other Comprehensive | | Non-controlling | | |
| Common Stock | | | Accumulated | | | | |
| Shares | | Amount | | Capital | | Deficit | | Loss | | Interest | | Total |
Balance as of January 1, 2019 | 140,914,642 |
| | $ | 14,092 |
| | $ | — |
| | $ | (542,169 | ) | | $ | (19,982 | ) | | $ | 693 |
| | $ | (547,366 | ) |
Impact of adoption of new accounting standards | — |
| | — |
| | — |
| | 3,147 |
| | (4,697 | ) | | — |
| | (1,550 | ) |
Net income | — |
| | — |
| | — |
| | 14,953 |
| | — |
| | 80 |
| | 15,033 |
|
Total other comprehensive income | — |
| | — |
| | — |
| | — |
| | 581 |
| | — |
| | 581 |
|
Distributions and dividends on common stock ($0.40 per share) | — |
| | — |
| | (2,264 | ) | | (56,512 | ) | | — |
| | — |
| | (58,776 | ) |
Surrender of shares in connection with restricted stock vesting | (15,577 | ) | | (2 | ) | | (172 | ) | | — |
| | — |
| | — |
| | (174 | ) |
Stock-based compensation | — |
| | — |
| | 2,436 |
| | — |
| | — |
| | — |
| | 2,436 |
|
Distributions to non-controlling interest | — |
| | — |
| | — |
| | — |
| | — |
| | (285 | ) | | (285 | ) |
Balance as of March 31, 2019 | 140,899,065 |
| | $ | 14,090 |
| | $ | — |
| | $ | (580,581 | ) | | $ | (24,098 | ) | | $ | 488 |
| | $ | (590,101 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Vector Group Ltd. Stockholders' Deficiency | | | |
| | | Additional Paid-In | | | | Accumulated Other Comprehensive | | Non-controlling | | |
| Common Stock | | | Accumulated | | | | |
| Shares | | Amount | | Capital | | Deficit | | Loss | | Interest | | Total |
Balance as of January 1, 2018 | 134,365,424 |
| | $ | 13,437 |
| | $ | — |
| | $ | (414,785 | ) | | $ | (12,571 | ) | | $ | 82,159 |
| | $ | (331,760 | ) |
Impact of adoption of new accounting standards | — |
| | — |
| | — |
| | 1,094 |
| | (6,036 | ) | | (7,915 | ) | | (12,857 | ) |
Net income | — |
| | — |
| | — |
| | 7,211 |
| | — |
| | (3,547 | ) | | 3,664 |
|
Total other comprehensive income | — |
| | — |
| | — |
| | — |
| | 250 |
| | — |
| | 250 |
|
Distributions and dividends on common stock ($0.38 per share) | — |
| | — |
| | (2,384 | ) | | (53,516 | ) | | — |
| | — |
| | (55,900 | ) |
Effect of stock dividend* | 6,718,271 |
| | 672 |
| | — |
| | (672 | ) | | — |
| | — |
| | — |
|
Stock-based compensation | — |
| | — |
| | 2,384 |
| | — |
| | — |
| | — |
| | 2,384 |
|
Balance as of March 31, 2018 | 141,083,695 |
| | $ | 14,109 |
| | $ | — |
| | $ | (460,668 | ) | | $ | (18,357 | ) | | $ | 70,697 |
| | $ | (394,219 | ) |
* Represents the effect of the September 27, 2018 stock dividend on the first quarter 2018 common-stock activity.
The accompanying notes are an integral part of the condensed consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)
Unaudited
|
| | | | | | | |
| Three Months Ended | | Three Months Ended |
| March 31, 2019 | | March 31, 2018 |
Net cash provided by operating activities | $ | 19,726 |
| | $ | 40,714 |
|
Cash flows from investing activities: | | | |
Sale of investment securities | 7,759 |
| | 2,357 |
|
Maturities of investment securities | 11,308 |
| | 8,112 |
|
Purchase of investment securities | (20,623 | ) | | (4,364 | ) |
Investments in real estate ventures | (871 | ) | | (533 | ) |
Distributions from investments in real estate ventures | 1,134 |
| | 219 |
|
Increase in cash surrender value of life insurance policies | (238 | ) | | (36 | ) |
Increase in restricted assets | (7 | ) | | (4 | ) |
Capital expenditures | (3,825 | ) | | (3,987 | ) |
Repayments of notes receivable | — |
| | 32 |
|
Purchase of subsidiaries | (668 | ) | | — |
|
Pay downs of investment securities | 258 |
| | 446 |
|
Investments in real estate, net | (641 | ) | | (355 | ) |
Net cash (used in) provided by investing activities | (6,414 | ) | | 1,887 |
|
Cash flows from financing activities: | | | |
Repayments of debt | (230,466 | ) | | (490 | ) |
Borrowings under revolver | 94,400 |
| | 55,170 |
|
Repayments on revolver | (87,420 | ) | | (61,728 | ) |
Dividends and distributions on common stock | (60,459 | ) | | (57,187 | ) |
Distributions to non-controlling interest | (285 | ) | | — |
|
Net cash used in financing activities | (284,230 | ) | | (64,235 | ) |
Net decrease in cash, cash equivalents and restricted cash | (270,918 | ) | | (21,634 | ) |
Cash, cash equivalents and restricted cash, beginning of period | 591,729 |
| | 310,937 |
|
Cash, cash equivalents and restricted cash, end of period | $ | 320,811 |
| | $ | 289,303 |
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
| |
1. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
| |
(a) | Basis of Presentation: |
The condensed consolidated financial statements of Vector Group Ltd. (the “Company” or “Vector”) include the accounts of Liggett Group LLC (“Liggett”), Vector Tobacco Inc. (“Vector Tobacco”), Liggett Vector Brands LLC (“Liggett Vector Brands”), New Valley LLC (“New Valley”) and other less significant subsidiaries. New Valley includes the accounts of Douglas Elliman Realty, LLC (“Douglas Elliman”) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated.
Liggett and Vector Tobacco are engaged in the manufacture and sale of cigarettes in the United States. Liggett Vector Brands coordinates Liggett and Vector Tobacco’s sales and marketing efforts. Certain references to “Liggett” refer to the Company’s tobacco operations, including the business of Liggett and Vector Tobacco, unless otherwise specified. New Valley is engaged in the real estate business.
The unaudited, interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and, in management’s opinion, contain all adjustments, consisting only of normal recurring items, necessary for a fair statement of the results for the periods presented. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission (“SEC”). The consolidated results of operations for interim periods should not be regarded as necessarily indicative of the results that may be expected for the entire year.
| |
(b) | Distributions and Dividends on Common Stock: |
The Company records distributions on its common stock as dividends in its condensed consolidated statement of stockholders’ deficiency to the extent of retained earnings. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in capital to the extent paid-in-capital is available and then to accumulated deficit. The Company’s stock dividends are recorded as stock splits and given retroactive effect to earnings per share for all periods presented.
| |
(c) | Earnings Per Share (“EPS”): |
Information concerning the Company’s common stock has been adjusted to give retroactive effect to the 5% stock dividend distributed to Company stockholders on September 27, 2018. All per share amounts and references to share amounts have been updated to reflect the retrospective effect of the stock dividend.
Net income for purposes of determining basic EPS was as follows:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Net income attributed to Vector Group Ltd. | $ | 14,953 |
| | $ | 7,211 |
|
Income attributed to participating securities | (2,003 | ) | | (1,772 | ) |
Net income applicable to common shares attributed to Vector Group Ltd. | $ | 12,950 |
| | $ | 5,439 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Net income for purposes of determining diluted EPS was as follows:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Net income attributed to Vector Group Ltd. | $ | 14,953 |
| | $ | 7,211 |
|
Income attributable to 7.5% Variable Interest Senior Convertible Notes | (1,246 | ) | | — |
|
Income attributed to participating securities | (2,003 | ) | | (1,772 | ) |
Net income applicable to common shares attributed to Vector Group Ltd. | $ | 11,704 |
| | $ | 5,439 |
|
Basic and diluted EPS were calculated using the following common shares:
|
| | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Weighted-average shares for basic EPS | 139,493,555 |
| | 139,288,460 |
|
Plus incremental shares related to convertible debt | 2,776,775 |
| | — |
|
Plus incremental shares related to stock options and non-vested restricted stock | 14,670 |
| | 338,591 |
|
Weighted-average shares for diluted EPS | 142,285,000 |
| | 139,627,051 |
|
The following non-vested restricted stock and shares issuable upon the conversion of convertible debt were outstanding during the three months ended March 31, 2019 and 2018, but were not included in the computation of diluted EPS because the impact of the per share expense associated with the restricted stock were greater than the average market price of the common shares during the respective periods and the common shares issuable under the convertible debt were anti-dilutive to EPS.
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Weighted-average shares of non-vested restricted stock | 1,340,781 |
| | — |
|
Weighted-average expense per share | $ | 18.82 |
| | $ | — |
|
Weighted-average number of shares issuable upon conversion of debt | 10,901,963 |
| | 28,819,626 |
|
Weighted-average conversion price | $ | 21.28 |
| | $ | 16.96 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
| |
(d) | Fair Value of Derivatives Embedded within Convertible Debt: |
The Company has estimated the fair value of the embedded derivatives based principally on the results of a valuation model. A readily determinable fair value of the embedded derivatives is not available. The estimated fair value of the derivatives embedded within the convertible debt is based principally on the present value of future dividend payments expected to be received by the convertible debt holders over the term of the debt. The discount rate applied to the future cash flows is estimated based on a spread in the yield of the Company’s debt when compared to risk-free securities with the same duration. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads for secured to unsecured debt, unsecured to subordinated debt and subordinated debt to preferred stock to determine the fair value of the derivatives embedded within the convertible debt. The valuation also considers other items, including current and future dividends and the volatility of Vector’s stock price. At March 31, 2019, the range of estimated fair values of the Company’s embedded derivatives was between $21,022 and $21,125. The Company recorded the fair value of its embedded derivatives at the approximate midpoint of the range at $21,075 as of March 31, 2019. At December 31, 2018, the range of estimated fair values of the Company’s embedded derivatives was between $31,371 and $31,519. The Company recorded the fair value of its embedded derivatives at the midpoint of the range at $31,424 as of December 31, 2018. The estimated fair value of the Company’s embedded derivatives could change significantly based on future market conditions. (See Note 8.)
| |
(e) | Investments in Real Estate Ventures: |
In accounting for its investments in real estate ventures, the Company identified its participation in Variable Interest Entities (“VIE”), which are defined as (a) entities in which the equity investment at risk is not sufficient to finance its activities without additional subordinated financial support; (b) as a group, the equity investors at risk lack (1) the power to direct the activities of a legal entity that most significantly impact the entity’s economic performance, (2) the obligation to absorb the expected losses of the entity, or (3) the right to receive the expected residual returns of the entity; or (c) as a group, the equity investors have voting rights that are not proportionate to their economic interests and the entity’s activities involve or are conducted on behalf of an investor with a disproportionately small voting interest.
The Company’s interest in VIEs is primarily in the form of equity ownership. The Company examines specific criteria and uses judgment when determining if the Company is the primary beneficiary of a VIE. Factors considered include risk and reward sharing, experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE’s executive committee, existence of unilateral kick-out rights exclusive of protective rights or voting rights and level of economic disproportionality between the Company and its other partner(s).
Accounting guidance requires the consolidation of VIEs in which the Company is the primary beneficiary. The guidance requires consolidation of VIEs that an enterprise has a controlling financial interest. A controlling financial interest will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.
The Company’s maximum exposure to loss in its investments in unconsolidated VIEs is limited to its investment in the VIE, any unfunded capital commitments to the VIE, and, in some cases, guarantees in connection with debt on the specific project. The Company’s maximum exposure to loss in its investment in consolidated VIEs is limited to its investment, which is the carrying value of the investment net of the non-controlling interest. Creditors of the consolidated VIEs have no recourse to the general credit of the primary beneficiary.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Other, net consisted of:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Interest and dividend income | $ | 3,208 |
| | $ | 1,922 |
|
Net periodic benefit cost other than the service costs | (541 | ) | | (253 | ) |
Other expense | — |
| | (23 | ) |
Other, net | $ | 2,667 |
| | $ | 1,646 |
|
| |
(g) | Other Current Liabilities: |
Other current liabilities consisted of:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Accounts payable | $ | 11,704 |
| | $ | 13,144 |
|
Accrued promotional expenses | 30,909 |
| | 37,940 |
|
Accrued excise and payroll taxes payable, net | 12,710 |
| | 14,612 |
|
Accrued interest | 27,571 |
| | 38,673 |
|
Commissions payable | 18,199 |
| | 12,975 |
|
Accrued salary and benefits | 13,352 |
| | 30,228 |
|
Contract liabilities | 7,824 |
| | — |
|
Allowance for sales returns | 7,318 |
| | 6,935 |
|
Other current liabilities | 23,747 |
| | 24,646 |
|
Total other current liabilities | $ | 153,334 |
| | $ | 179,153 |
|
| |
(h) | Goodwill and Other Intangible Assets, Net: |
The components of “Goodwill and other intangible assets, net” were as follows:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Goodwill | $ | 78,008 |
| | $ | 77,568 |
|
| | | |
Indefinite life intangibles: | | | |
Intangible asset associated with benefit under the MSA | 107,511 |
| | 107,511 |
|
Trademark - Douglas Elliman | 80,000 |
| | 80,000 |
|
| | | |
Intangibles with a finite life, net | 546 |
| | 1,532 |
|
| | | |
Total goodwill and other intangible assets, net | $ | 266,065 |
| | $ | 266,611 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
| |
(i) | Reconciliation of Cash, Cash Equivalents and Restricted Cash: |
The components of “Cash, cash equivalents and restricted cash” in the Statement of Cash Flows were as follows:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Cash and cash equivalents | $ | 312,638 |
| | $ | 584,581 |
|
Restricted cash and cash equivalents included in current restricted assets | 3,719 |
| | 2,697 |
|
Restricted cash and cash equivalents included in non-current restricted assets | 4,454 |
| | 4,451 |
|
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows | $ | 320,811 |
| | $ | 591,729 |
|
Amounts included in current restricted assets and non-current restricted assets represent cash and cash equivalents required to be deposited into escrow for bonds required to appeal adverse product liability judgments, amounts required for letters of credit related to office leases, and certain deposit requirements for banking arrangements. The restrictions related to the appellate bonds will remain in place until the appeal process has been completed. The restrictions related to the letters of credit will remain in place for the duration of the respective lease. The restrictions related to the banking arrangements will remain in place for the duration of the arrangement.
(j) New Accounting Pronouncements:
Accounting Standards Updates (“ASU”) adopted in 2019:
In July 2018, the FASB issued ASU No. 2018-09, Codification Improvements (“ASU 2018-09”). This standard does not prescribe any new accounting guidance, but instead makes minor improvements and clarifications of several different FASB Accounting Standards Codification areas based on comments and suggestions made by various stakeholders. Certain updates were applicable immediately while others were effective for the Company’s fiscal year beginning January 1, 2019. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.
In February 2018, the FASB issued ASU No. 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU 2018-02”), which allows for stranded tax effects in accumulated other comprehensive income resulting from the Tax Act to be reclassified to retained earnings. The Company adopted ASU 2018-02 effective January 1, 2019. The reclassification from the adoption of this standard resulted in a decrease of $4,697 to accumulated deficit and an increase of $4,697 to accumulated other comprehensive loss.
In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which provides guidance for accounting for leases. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight-line basis over the term of the lease. Accounting for lessors remains largely unchanged from current U.S. GAAP. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11 “Leases (Topic 842): Targeted Improvements” (ASU 2018-11). ASU 2018-10 clarifies certain areas within ASU 2016-02. Prior to ASU 2018-11, a modified retrospective transition was required for financing or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements. ASU 2018-11 allows entities an additional transition method to the existing requirements whereby an entity could adopt the provisions of ASU 2016-02 by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption without adjustment to the financial statements for periods prior to adoption. ASU 2018-11 also allows a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are present. In December 2018, the FASB also issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors, which requires lessors to exclude lessor costs paid directly to a third party by lessees from lease revenues and expenses, provides an election for lessors to exclude sales taxes and other similar taxes collected from lessees from consideration in the contract, and clarifies lessors accounting for variable payments related to lease and nonlease components. ASU 2016-02, ASU 2018-10, ASU 2018-11 and ASU 2018-20 was effective for the Company’s fiscal year beginning January 1, 2019 and subsequent interim periods.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
On January 1, 2019, the Company adopted ASU No. 2016-02- Leases (Topic 842) applying the modified retrospective method and the option presented under ASU 2018-11 to transition only active leases as of January 1, 2019 with a cumulative effect adjustment as of that date. See Note 3 - Leases, for additional accounting policy and transition disclosures.
ASUs to be adopted in future periods:
In October 2018, the FASB issued ASU No. 2018-17, Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities. The guidance requires indirect interests held through related parties under common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company is currently evaluating the impact of the new guidance on our condensed consolidated financial statements.
In October 2018, the FASB issued ASU No. 2018-16, Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes (“ASU 2018-16”), which amends ASC 815, Derivatives and Hedging. This ASU adds the OIS rate based on SOFR to the list of permissible benchmark rates for hedge accounting purposes. The amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Adoption of ASU 2018-16 will be on a prospective basis for qualifying new or redesignated hedging relationships entered into on or after the date of adoption. The Company is currently assessing the impact the adoption of ASU 2018-16 will have on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other Internal Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact the adoption of ASU 2018-15 will have on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans (“ASU 2018-14”). ASU 2018-14 eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. ASU 2018-14 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. The adoption of ASU 2018-14 will impact financial statement disclosure with no impact on operating results.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is designed to improve the effectiveness of disclosures by removing, modifying and adding disclosures related to fair value measurements. The ASU eliminates disclosures such as the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy. The ASU also adds new disclosure requirements for Level 3 measurements. ASU No. 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of ASU 2018-13 will impact financial statement disclosure with no impact on operating results.
Revenue Recognition Accounting Pronouncement Adoption
On January 1, 2018, the Company adopted Topic 606 applying the modified retrospective method. The following practical expedients and optional disclosure exemptions available under Topic 606 have been applied:
| |
1. | The Company applied the optional exemption in paragraph 606-10-50-14 of Topic 606, and has not disclosed the amount of the transaction price allocated to the remaining performance obligations for the Real Estate property management business because the contracts to provide property management services are typically annual contracts. |
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
| |
2. | The Company applied the optional exemption in paragraph 606-10-50-14A of Topic 606, and has not disclosed the amount of the transaction price allocated to the remaining performance obligations for the Real Estate development marketing business because the transaction prices in these contracts are comprised entirely of variable consideration based on the ultimate selling price of each unit in the subject property. |
Revenue Recognition Policies
Revenue is measured based on a consideration specified in a contract with a customer less any sales incentives. Revenue is recognized when (a) an enforceable contract with a customer exists, that has commercial substance, and collection of substantially all consideration for services is probable; and (b) the performance obligations to the customer are satisfied either over time or at a point in time.
Tobacco sales: Revenue from cigarette sales, which include federal excise taxes billed to customers, are recognized upon shipment of cigarettes when control has passed to the customer. Average collection terms for Tobacco sales range between three and twelve days from the time that the cigarettes are shipped to the customer. The Company records a liability for goods estimated to be returned in other current liabilities and the associated receivable for anticipated federal excise tax refunds in other current assets on the condensed consolidated balance sheet. The liability for returned goods is based principally on sales volumes and historical return rates. The estimated costs of sales incentives, including customer incentives and trade promotion activities, are based principally on historical experience and are accounted for as reductions in Tobacco revenue. Expected payments for sales incentives are included in other current liabilities on the Company’s condensed consolidated balance sheet. The Company accounts for shipping and handling costs as fulfillment costs as part of cost of sales.
Real estate sales: Real estate commissions and other payments earned by the Company’s real estate brokerage businesses are recognized as revenue when the real estate sale is completed or lease agreement is executed, which is the point in time that the performance obligation is satisfied. Any commission and other payments received in advance are deferred until the satisfaction of the performance obligation. Corresponding agent commission expenses, including any advance commission or other direct expense payments, are deferred and recognized as cost of sales concurrently with related revenues.
The Company’s Real Estate revenue contracts with customers do not have multiple material performance obligations to customers under Topic 606, except for contracts in the Company’s development marketing business. Contracts in the development marketing business provide the Company with the exclusive right to sell units in a subject property for a commission fee per unit sold calculated as a percentage of the sales price of each unit. Accordingly, a performance obligation exists for each unit in the development marketing property under contract, and a portion of the total contract transaction price is allocated to and recognized at the time each unit is sold.
The total contract transaction price is allocated to each unit in the subject property and recognized when the performance obligation, i.e. the sale of each unit, is satisfied. Accordingly, the transaction price allocated to the remaining performance obligations for the development marketing business represents variable consideration allocated entirely to wholly unsatisfied performance obligations.
Under development marketing service arrangements, dedicated staff are required for a subject property and these costs are typically reimbursed from the customer through advance payments that are recoupable from future commission earnings. Advance payments received and associated direct costs paid are deferred, allocated to each unit in the subject property, and recognized at the time of the completed sale of each unit.
Development marketing service arrangements also include direct fulfillment costs incurred in advance of the satisfaction of the performance obligation. The Company capitalizes costs incurred in fulfilling a contract with a customer if the fulfillment costs 1) relate directly to an existing contract or anticipated contract, 2) generate or enhance resources that will be used to satisfy performance obligations in the future, and 3) are expected to be recovered. These costs are amortized over the estimated customer relationship period which is the contract term. The Company uses an amortization method that is consistent with the pattern of transfer of goods or services to its customers by allocating these costs to each unit in the subject property and expensing these costs as each unit sold is closed over the contract.
Commission revenue is recognized at the time the performance obligation is met for commercial leasing contracts, which is when the lease agreement is executed, as there are no further performance obligations, including any amounts of future payments under extended payment terms.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Property management revenue arrangements consist of providing operational and administrative services to manage a subject property. Fees for these services are typically billed and collected monthly. Property management service fees are recognized as revenue over time using the output method as the performance obligations under the customer arrangement are satisfied each month.
Title insurance commission fee revenue is earned when the sale of the title insurance policy is completed, which corresponds to the point in time when the underlying real estate sale is completed, which is when the performance obligation is satisfied.
Disaggregation of Revenue
In the following table, revenue is disaggregated by major product line for the Tobacco segment:
|
| | | | | | | | |
| | Three Months Ended |
| | March 31, |
| | 2019 | | 2018 |
Tobacco Segment Revenues: | | | | |
Core Discount Brands - PYRAMID, GRAND PRIX, LIGGETT SELECT, EVE and EAGLE 20’s | | $ | 233,106 |
| | $ | 241,531 |
|
Other Brands | | 23,650 |
| | 25,585 |
|
Total tobacco revenues | | $ | 256,756 |
| | $ | 267,116 |
|
In the following table, revenue is disaggregated by major services line and primary geographical market for the Real Estate segment:
|
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, 2019 |
| | New York City | | Northeast | | Southeast | | West | | Total |
Real Estate Segment Revenues: | | | | | | | | | | |
Commission brokerage income | | $ | 65,679 |
| | $ | 31,111 |
| | $ | 22,971 |
| | $ | 18,529 |
| | $ | 138,290 |
|
Development marketing | | 11,386 |
| | — |
| | 2,630 |
| | 7 |
| | 14,023 |
|
Property management revenue | | 8,167 |
| | 184 |
| | — |
| | — |
| | 8,351 |
|
Title fees | | — |
| | 1,233 |
| | — |
| | — |
| | 1,233 |
|
Total Douglas Elliman Realty revenue | | 85,232 |
| | 32,528 |
| | 25,601 |
| | 18,536 |
| | 161,897 |
|
Other real estate revenues | | — |
| | — |
| | — |
| | 2,271 |
| | 2,271 |
|
Total real estate revenues | | $ | 85,232 |
| | $ | 32,528 |
| | $ | 25,601 |
| | $ | 20,807 |
| | $ | 164,168 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
|
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, 2018 |
| | New York City | | Northeast | | Southeast | | West | | Total |
Real Estate Segment Revenues: | | | | | | | | | | |
Commission brokerage income | | $ | 60,408 |
| | $ | 32,678 |
| | $ | 24,398 |
| | $ | 21,412 |
| | $ | 138,896 |
|
Development marketing | | 10,610 |
| | 123 |
| | 293 |
| | 194 |
| | 11,220 |
|
Property management revenue | | 8,138 |
| | 200 |
| | — |
| | — |
| | 8,338 |
|
Title fees | | — |
| | 989 |
| | — |
| | — |
| | 989 |
|
Total Douglas Elliman Realty revenue | | 79,156 |
| | 33,990 |
| | 24,691 |
| | 21,606 |
| | 159,443 |
|
Other real estate revenues | | — |
| | — |
| | — |
| | 2,407 |
| | 2,407 |
|
Total real estate revenues | | $ | 79,156 |
| | $ | 33,990 |
| | $ | 24,691 |
| | $ | 24,013 |
| | $ | 161,850 |
|
Contract Balances
The following table provides information about contracts assets and contract liabilities from development marketing and commercial leasing contracts with customers:
|
| | | | | | | |
| | | |
| March 31, 2019 | | January 1, 2019 |
Receivables, which are included in accounts receivable - trade, net | $ | 3,175 |
| | $ | 2,050 |
|
Contract assets, net, which are included in other current assets | 9,329 |
| | 9,264 |
|
Payables, which are included in other current liabilities | 1,921 |
| | 1,082 |
|
Contract liabilities, which are included in other current liabilities | 7,824 |
| | 7,071 |
|
Contract assets, net, which are included in other assets | 18,024 |
| | 15,794 |
|
Contract liabilities, which are included in other liabilities | 32,376 |
| | 30,445 |
|
Receivables and payables relate to commission receivables and commissions payable from the Real Estate commercial leasing contracts for which the performance obligation has been satisfied, have extended payment terms and are expected to be received and paid in the next twelve months. Receivables decreased $1,125 for the three-month period ended March 31, 2019 primarily due to revenue accrued as performance obligations are satisfied of $1,551, offset by cash collections. Correspondingly, payables increased $839 primarily due to additional expense accruals as performance obligations are satisfied of $1,119, offset by cash payments.
Contract assets increased by $2,295 during the three months ended March 31, 2019 due to $3,794 of payments made for direct fulfillment costs incurred in advance of the satisfaction of the performance obligations for Real Estate development marketing contracts, offset by costs recognized for units closed during the quarter.
Contract liabilities relate to payments received in advance of the performance obligations being satisfied under the contract for the Real Estate development marketing and are recognized as revenue at the points in time when the Company performs under the contract. Performance obligations related to the Real Estate development marketing contracts are considered satisfied when each unit is closed. Development marketing projects tend to span 4 to 6 years from the time the Company enters into the contract with the developer to the time that all of the sales of the units in a subject property are closed. The timing for sales closings are dependent upon several external factors outside the Company’s control, including but not limited to, economic factors, seller and buyer actions, construction timing and other real estate market factors. Accordingly, all contract liabilities and contract costs associated with development marketing are considered long-term until closing dates for unit sales are scheduled. As of March 31, 2019, the Company estimates approximately $7,824 of contract liabilities will be recognized as revenue within the next twelve months.
Contract liabilities increased by $2,684 during the three months ended March 31, 2019 due to $5,219 of advance payments received from customer prior to the satisfaction of performance obligations for Real Estate development marketing contracts,
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
offset by revenue recognized for units sold during the quarter. The Company recognized revenue of $1,514 and $951 for the three months ended March 31, 2019 and 2018, respectively, that were included in the contract liabilities balances at January 1, 2019 and January 1, 2018, respectively.
Topic 606 requires an entity to disclose the revenue recognized in the reporting period from performance obligations satisfied (or partially satisfied) in previous periods (for example, due to changes in transaction price). There was no revenue recognized relating to performance obligations satisfied or partially satisfied in prior periods for the three months ended March 31, 2019 and 2018, respectively.
Leasing Accounting Pronouncement Adoption
On January 1, 2019, the Company adopted ASU No. 2016-02- Leases (Topic 842) applying the modified retrospective method and the option presented under ASU 2018-11 to transition only active leases as of January 1, 2019 with a cumulative effect adjustment as of that date. All comparative periods prior to January 1, 2019 retain the financial reporting and disclosure requirements of ASC 840. The Company elected the package of practical expedients permitted under the transition guidance within the new standard. The package of three expedients includes: 1) the ability to carry forward the historical lease classification, 2) the elimination of the requirement to reassess whether existing or expired agreements contain leases, and 3) the elimination of the requirement to reassess initial direct costs. The Company also elected the practical expedient related to short-term leases without purchase options reasonably certain to exercise, allowing it to exclude leases with terms of less than twelve (12) months from capitalization for all asset classes. The Company did not elect the hindsight practical expedient when determining the lease terms. The adoption of the new standard resulted in the recording of right-of-use (“ROU”) assets and lease liabilities of $128,890 and $153,676, respectively, as of January 1, 2019. The difference between the ROU assets and lease liabilities reflects the reclassification of historical deferred rent balances of approximately $22,881, and tenant improvement receivable of $355 as adjustments to the ROU asset balances, and an adjustment that increased accumulated deficit by $1,550 to recognize the impairment in ROU assets for asset groups previously identified as being impaired. The standard did not materially impact the Company’s consolidated net earnings and had no impact on cash flows. The new standard had no material impact on liquidity and had no impact on the Company’s debt-covenant compliance under its current debt agreements.
Leasing Policies
The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease ROU assets and lease liabilities on the Company’s balance sheets. Finance leases are included in investments in real estate, net, property, plant and equipment and current and long-term portions of notes payable and long-term debt on the Company’s balance sheets.
ROU assets represent the Company’s right to use an underlying asset for the duration of the lease term. Lease liabilities represent the Company’s obligation to make lease payments as determined by the lease agreement. Lease liabilities are recorded at commencement for the net present value of future lease payments over the lease term. The discount rate used is generally the Company’s estimated incremental borrowing rate unless the lessor’s implicit rate is readily determinable. Discount rates are calculated periodically to estimate the rate the Company would pay to borrow the funds necessary to obtain an asset of similar value, over a similar term, with a similar security. ROU assets are recorded and recognized at commencement for the lease liability amount, initial direct costs incurred and is reduced for lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. Finance lease cost is recognized on a straight line basis over the shorter of the useful life of the asset and the lease term.
The Company has lease agreements with lease and non-lease components; the Company has elected the accounting policy to combine lease and non-lease components for all underlying asset classes.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Leases
The Company has operating and finance leases for corporate and sales offices, and certain vehicles and equipment. The leases have remaining lease terms of one year to 15 years, some of which include options to extend for up to 5 years, and some of which include options to terminate the leases within one year. However, the Company in general is not reasonably certain to exercise options to renew or terminate, and therefore renewal and termination options are not considered in the lease term or the ROU asset and lease liability balances. The Company’s lease population includes purchase options on equipment leases that are included in the lease payments when reasonably certain to be exercised. The Company’s lease population does not include any residual value guarantees. The Company’s lease population does not contain any material restrictive covenants.
The Company has leases with variable payments, most commonly in the form of Common Area Maintenance (“CAM”) and tax charges which are based on actual costs incurred. These variable payments were excluded from the ROU asset and lease liability balances since they are not fixed or in-substance fixed payments. Variable payments are expensed as incurred.
The components of lease expense were as follows:
|
| | | |
| Three Months Ended |
| March 31, |
| 2019 |
Operating lease cost | $ | 8,875 |
|
Short-term lease cost | 234 |
|
Variable lease cost | 792 |
|
| |
Finance lease cost: | |
Amortization of right-of-use assets | 56 |
|
Interest on lease liabilities | 3 |
|
Total lease cost | $ | 9,960 |
|
Supplemental cash flow information related to leases was as follows:
|
| | | |
| Three Months Ended |
| March 31, |
| 2019 |
Cash paid for amounts included in measurement of lease liabilities: | |
Operating cash flows from operating leases | $ | 9,001 |
|
Operating cash flows from finance leases | 3 |
|
Financing cash flows from finance leases | 54 |
|
| |
Right-of-use assets obtained in exchange for lease obligations: | |
Operating leases | 356 |
|
Finance leases | — |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Supplemental balance sheet information related to leases was as follows:
|
| | | | |
| March 31, | |
| 2019 | |
Operating leases: | | |
Operating lease right-of-use assets | $ | 124,723 |
| |
| | |
Current operating lease liability | $ | 20,414 |
| |
Non-current operating lease liability | 128,999 |
| |
Total operating lease liabilities | $ | 149,413 |
| |
| | |
Finance leases: | | |
Investments in real estate, net | $ | 178 |
| (1) |
| | |
Property, plant and equipment, at cost | $ | 183 |
| |
Accumulated amortization | (149 | ) | |
Property and equipment, net | $ | 34 |
| |
| | |
Current portion of notes payable and long-term debt | $ | 181 |
| |
Notes payable, long-term debt and other obligations, less current portion | 27 |
| |
Total finance lease liabilities | $ | 208 |
| |
| | |
Weighted average remaining lease term: | | |
Operating leases | 8.51 |
| |
Finance leases | 1.10 |
| |
| | |
Weighted average discount rate: | | |
Operating leases | 11.21 | % | |
Finance leases | 4.97 | % | |
| |
(1) | Included in Investments in real estate, net on the condensed consolidated balance sheet are financing lease equipment, at cost of $729 and accumulated amortization of $551 as of March 31, 2019. |
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
As of March 31, 2019, maturities of lease liabilities were as follows:
|
| | | | | | | |
| Operating Leases | | Finance Leases |
Year Ending December 31: | |
| | |
|
Remainder of 2019 | $ | 27,019 |
| | $ | 158 |
|
2020 | 30,852 |
| | 54 |
|
2021 | 28,260 |
| | 1 |
|
2022 | 25,390 |
| | — |
|
2023 | 23,753 |
| | — |
|
2024 | 18,674 |
| | |
Thereafter | 85,807 |
| | — |
|
Total lease payments | 239,755 |
| | 213 |
|
Less imputed interest | (90,342 | ) | | (5 | ) |
Total | $ | 149,413 |
| | $ | 208 |
|
Under ASC 840, Leases, future minimum lease payments under noncancelable operating leases as of December 31, 2018 were as follows:
|
| | | | | | | | | | | |
| Lease Commitments | | Sublease Rentals | | Net |
Year Ending December 31: | |
| | |
| | |
|
2019 | $ | 35,973 |
| | $ | 69 |
| | $ | 35,904 |
|
2020 | 29,917 |
| | — |
| | 29,917 |
|
2021 | 27,592 |
| | — |
| | 27,592 |
|
2022 | 25,185 |
| | — |
| | 25,185 |
|
2023 | 23,589 |
| | — |
| | 23,589 |
|
Thereafter | 104,126 |
| | — |
| | 104,126 |
|
Total | $ | 246,382 |
| | $ | 69 |
| | $ | 246,313 |
|
The Company has one lease for office space wherein the lessor is an affiliate of a significant shareholder of the Company. This lease represents $1,521 of the ROU asset balances and $1,577 of lease liability balances as of March 31, 2019. The rent expense for this lease was approximated $115 for the three months ended March 31, 2019.
As of March 31, 2019, the Company had an additional operating lease for office space, that has not yet commenced, of $657 in undiscounted lease payments. The operating lease will commence in the second quarter of 2019 with lease terms of 10 years.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Inventories consisted of:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Leaf tobacco | $ | 50,266 |
| | $ | 42,917 |
|
Other raw materials | 3,119 |
| | 3,750 |
|
Work-in-process | 2,266 |
| | 1,931 |
|
Finished goods | 67,864 |
| | 63,937 |
|
Inventories at current cost | 123,515 |
| | 112,535 |
|
LIFO adjustments | (21,538 | ) | | (21,538 | ) |
| $ | 101,977 |
| | $ | 90,997 |
|
All of the Company’s inventories at March 31, 2019 and December 31, 2018 are reported under the LIFO method. The $21,538 LIFO adjustment as of March 31, 2019 decreases the current cost of inventories by $14,932 for Leaf tobacco, $219 for Other raw materials, $25 for Work-in-process and $6,362 for Finished goods. The $21,538 LIFO adjustment as of December 31, 2018 decreased the current cost of inventories by $14,932 for Leaf tobacco, $219 for Other raw materials, $25 for Work-in-process and $6,362 for Finished goods.
Liggett enters into purchase commitments with third-party providers for leaf tobacco. The future quantities of leaf tobacco and prices are established at the date of the commitments. At March 31, 2019, Liggett had tobacco purchase commitments of approximately $3,858. Liggett has a single source supply agreement for reduced ignition propensity cigarette paper through 2019.
Each period, the Company capitalizes in inventory the portion of its MSA liability that relates to cigarettes shipped to public warehouses but not sold. The amount of capitalized MSA cost in “Finished goods” inventory was $16,892 and $16,001 at March 31, 2019 and December 31, 2018, respectively. Federal excise tax in inventory was $26,555 and $26,419 at March 31, 2019 and December 31, 2018, respectively.
| |
5. | INVESTMENT SECURITIES AT FAIR VALUE |
Investment securities at fair value consisted of the following:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Debt securities available for sale | $ | 88,605 |
| | $ | 84,367 |
|
Equity securities at fair value | 46,047 |
| | 47,202 |
|
Total investment securities at fair value | $ | 134,652 |
| | $ | 131,569 |
|
Net gains (losses) recognized on investment securities were as follows:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Net gains (losses) recognized on equity securities | $ | 4,740 |
| | $ | (2,745 | ) |
Net gains (losses) recognized on debt securities available for sale | 36 |
| | (9 | ) |
Impairments on debt securities available for sale | (3 | ) | | (586 | ) |
Net gains (losses) recognized on investment securities | $ | 4,773 |
| | $ | (3,340 | ) |
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Sales of investment securities totaled $7,759 and $2,357 and proceeds from early redemptions by issuers totaled $11,566 and $8,558 for the three months ended March 31, 2019 and 2018, respectively, mainly from the sales and redemptions of Corporate securities and U.S. Government securities.
(a) Debt Securities Available for Sale
The components of debt securities available for sale at March 31, 2019 were as follows:
|
| | | | | | | | | | | | | | | |
| Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value |
Marketable debt securities | $ | 88,093 |
| | $ | 512 |
| | $ | — |
| | $ | 88,605 |
|
Total debt securities available for sale | $ | 88,093 |
| | $ | 512 |
| | $ | — |
| | $ | 88,605 |
|
The table below summarizes the maturity dates of debt securities available for sale at March 31, 2019.
|
| | | | | | | | | | | | | | | |
Investment Type: | Fair Value | | Under 1 Year | | 1 Year up to 5 Years | | More than 5 Years |
U.S. Government securities | $ | 24,275 |
| | $ | 12,662 |
| | $ | 11,613 |
| | $ | — |
|
Corporate securities | 43,110 |
| | 10,694 |
| | 32,416 |
| | — |
|
U.S. mortgage-backed securities | 4,132 |
| | 489 |
| | 3,643 |
| | — |
|
Commercial mortgage-backed securities | 397 |
| | 33 |
| | 364 |
| | — |
|
Commercial paper | 13,180 |
| | 13,180 |
| | — |
| | — |
|
Index-linked U.S. bonds | 2,354 |
| | 2,354 |
| | — |
| | — |
|
Foreign fixed-income securities | 1,157 |
| | 652 |
| | 505 |
| | — |
|
Total debt securities available for sale by maturity dates | $ | 88,605 |
| | $ | 40,064 |
| | $ | 48,541 |
| | $ | — |
|
The components of debt securities available for sale at December 31, 2018 were as follows:
|
| | | | | | | | | | | | | | | |
| Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value |
Marketable debt securities | $ | 84,199 |
| | $ | 168 |
| | $ | — |
| | $ | 84,367 |
|
Total debt securities available for sale | $ | 84,199 |
| | $ | 168 |
| | $ | — |
| | $ | 84,367 |
|
There were no available-for-sale debt securities with continuous unrealized losses for less than 12 months and 12 months or greater at March 31, 2019 and December 31, 2018, respectively.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Gross realized gains and losses on debt securities available for sale were as follows:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Gross realized gains on sales | $ | 38 |
| | $ | — |
|
Gross realized losses on sales | (2 | ) | | (9 | ) |
Net gains (losses) recognized on debt securities available for sale | $ | 36 |
| | $ | (9 | ) |
| | | |
Gross realized losses on other-than-temporary impairments | $ | (3 | ) | | $ | (586 | ) |
|
| |
|
Although management generally does not have the intent to sell any specific securities at the end of the period, in the ordinary course of managing the Company’s investment securities portfolio, management may sell securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield and liquidity requirements.
(b) Equity Securities at Fair Value
Equity securities at fair value consisted of the following:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Marketable equity securities | $ | 24,387 |
| | $ | 26,010 |
|
Mutual funds invested in fixed income securities | 21,660 |
| | 21,192 |
|
Total equity securities at fair value | $ | 46,047 |
| | $ | 47,202 |
|
The following is a summary of unrealized and realized net gains and losses recognized in net income on equity securities at fair value during the three months ended March 31, 2019 and 2018, respectively:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Net gains (losses) recognized on equity securities (1) | $ | 4,740 |
| | $ | (2,745 | ) |
Less: Net gains recognized on equity securities sold (2) | 132 |
| | 130 |
|
Net unrealized gains (losses) recognized on equity securities still held at the reporting date | $ | 4,608 |
| | $ | (2,875 | ) |
| | | |
| |
(1) | Includes $3,559 and $1,731 of net gains recognized on equity securities at fair value that qualify for the net asset value (“NAV”) practical expedient during the three months ended March 31, 2019 and 2018, respectively. These equity securities are included in the “Long-term investments” line item on the condensed consolidated balance sheet and are further discussed in Note 6. |
| |
(2) | Includes $434 of gains recognized on sales of equity securities at fair value that qualify for the NAV practical expedient during the three months ended March 31, 2019. These equity securities are included in the “Long-term investments” line item on the condensed consolidated balance sheet and are further discussed in Note 6. |
The Company’s marketable equity securities and mutual funds invested in fixed-income securities are classified as Level 1 under the fair value hierarchy disclosed in Note 12. Their fair values are based on quoted prices for identical assets in active markets or inputs that are based upon quoted prices for similar instruments in active markets.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
(c) Equity Securities Without Readily Determinable Fair Values That Do Not Qualify for the NAV Practical Expedient
Equity securities without readily determinable fair values that do not qualify for the NAV practical expedient consisted of an investment in the common stock of a reinsurance company at March 31, 2019 and December 31, 2018, respectively. The total carrying value of this investment was $5,000 and was included in “Other assets” on the condensed consolidated balance sheet at March 31, 2019 and December 31, 2018, respectively. No impairment or other adjustments related to observable price changes in orderly transactions for identical or similar investments were identified for the three months ended March 31, 2019 and 2018, respectively.
Long-term investments consisted of the following:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Equity securities at fair value that qualify for the NAV practical expedient | $ | 54,202 |
| | $ | 54,628 |
|
Equity-method investments | 12,566 |
| | 11,631 |
|
| $ | 66,768 |
| | $ | 66,259 |
|
(a) Equity Securities at Fair Value That Qualify for the NAV Practical Expedient
The estimated fair value of the Company’s equity securities at fair value that qualify for the NAV practical expedient was provided by the partnerships based on the indicated market values of the underlying assets or investment portfolio. The investments in these investment partnerships are illiquid and the ultimate realization of these investments is subject to the performance of the underlying partnership and its management by the general partners. In accordance with Subtopic 820-10, these investments are not classified under the fair value hierarchy disclosed in Note 12 because they are investments measured at fair value using the NAV practical expedient.
The Company redeemed 25% of one of its investments that qualify for the NAV practical expedient during March 2019. The Company recorded $3,984 of in-transit redemptions from the proceeds at March 31, 2019.
(b) Equity-Method Investments:
Equity-method investments consisted of the following:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Indian Creek Investors LP (“Indian Creek”) | $ | 1,353 |
| | $ | 1,167 |
|
Boyar Value Fund (“Boyar”) | 9,041 |
| | 8,384 |
|
Ladenburg Thalmann Financial Services Inc. (“LTS”) | 2,172 |
| | 2,080 |
|
Castle Brands, Inc. (“Castle”) | — |
| | — |
|
| $ | 12,566 |
| | $ | 11,631 |
|
At March 31, 2019, the Company’s ownership percentages in Indian Creek, Boyar, LTS and Castle were 12.58%, 34.38%, 10.20% and 7.64%, respectively. The Company accounted for its Indian Creek and Boyar interests as equity-method investments because the Company’s ownership percentage meets the threshold for equity-method accounting. The Company accounted for its LTS and Castle interests as equity-method investments because the Company has the ability to exercise significant influence over their operating and financial policies.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
The fair value of the investment in Boyar, based on the quoted market price as of March 31, 2019, was $9,041, equal to its carrying value. At March 31, 2019, the aggregate fair values of the LTS and Castle investments, based on the quoted market price, were $42,991 and $9,027, respectively.
The Company received cash distributions of $427 and $414 from the Company’s equity-method investments for the three months ended March 31, 2019 and 2018, respectively. The Company recognized equity in earnings from equity-method investments of $1,362 and $1,162 for the three months ended March 31, 2019 and 2018, respectively. The Company has suspended its recognition of equity in losses from Castle to the extent such losses exceed its basis.
If it is determined that an other-than-temporary decline in fair value exists in equity-method investments, the Company records an impairment charge with respect to such investment in its condensed consolidated statements of operations. The Company will continue to perform additional assessments to determine the impact, if any, on the Company’s condensed consolidated financial statements. Thus, future impairment charges may occur.
The equity-method investments are carried on the condensed consolidated balance sheet at cost under the equity method of accounting. The fair values disclosed above for Boyar, LTS and Castle would be classified as Level 1 under the fair value hierarchy disclosed in Note 12 if such assets were recorded on the condensed consolidated balance sheet at fair value. The fair values are based on quoted prices for identical assets in active markets or inputs that are based upon quoted prices for similar instruments in active markets.
The estimated fair value of the Company’s investment in Indian Creek represents the NAV per share and was provided by the partnership based on the indicated market value of the underlying assets or investment portfolio. The investment is illiquid and its ultimate realization is subject to the performance of the underlying partnership and its management by the general partners. In accordance with Subtopic 820-10, this investment would not be classified under the fair value hierarchy disclosed in Note 12 if the asset was recorded on the condensed consolidated balance sheet at fair value because it is measured at fair value using the NAV practical expedient.
Investments in real estate ventures:
New Valley holds equity investments in various real estate projects domestically and internationally. The majority of New Valley’s investment in real estate ventures were located in the New York City Standard Metropolitan Statistical Area (“SMSA”). New Valley aggregates the disclosure of its investments in real estate ventures by property type and operating characteristics.
The components of “Investments in real estate ventures” were as follows:
|
| | | | | | | | | |
| Range of Ownership (1) | | March 31, 2019 | | December 31, 2018 |
Condominium and Mixed Use Development: | | | | | |
New York City SMSA | 3.1% - 49.5% | | $ | 63,570 |
| | $ | 65,007 |
|
All other U.S. areas | 15.0% - 48.5% | | 31,858 |
| | 31,392 |
|
| | | 95,428 |
| | 96,399 |
|
Hotels: | | | | | |
New York City SMSA | 5.2% - 18.4% | | 14,462 |
| | 15,782 |
|
International | 49.0% | | 1,848 |
| | 2,334 |
|
| | | 16,310 |
| | 18,116 |
|
Commercial: | | | | | |
New York City SMSA | 49.0% | | 1,739 |
| | 1,867 |
|
All other U.S. areas | 1.6% | | 7,345 |
| | 7,053 |
|
| | | 9,084 |
| | 8,920 |
|
| | | | | |
Other: | 15.0% - 50.0% | | 17,571 |
| | 17,670 |
|
Investments in real estate ventures | | | $ | 138,393 |
| | $ | 141,105 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
______________________
(1) The Range of Ownership reflects New Valley’s estimated current ownership percentage. New Valley’s actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners.
Contributions:
The components of New Valley’s contributions to its investments in real estate ventures were as follows:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Condominium and Mixed Use Development: | | | |
New York City SMSA | $ | 500 |
| | $ | 533 |
|
| 500 |
| | 533 |
|
Hotels: | | | |
New York City SMSA | 172 |
| | — |
|
| 172 |
| | — |
|
| | | |
Other: | 199 |
| | — |
|
Total contributions | $ | 871 |
| | $ | 533 |
|
New Valley contributed its proportionate share of additional capital along with contributions by the other investment partners during the three months ended March 31, 2019 and March 31, 2018. New Valley’s direct investment percentage for these ventures did not significantly change.
Distributions:
The components of distributions received by New Valley from its investments in real estate ventures were as follows:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Condominium and Mixed Use Development: | | | |
New York City SMSA | $ | 571 |
| | $ | 2,868 |
|
| 571 |
| | 2,868 |
|
Apartment Buildings: | | | |
All other U.S. areas | — |
| | 201 |
|
| — |
| | 201 |
|
Hotels: | | | |
New York City SMSA | 784 |
| | — |
|
| 784 |
| | — |
|
Commercial: | | | |
New York City SMSA | 6 |
| | — |
|
All other U.S. areas | 58 |
| | 215 |
|
| 64 |
| | 215 |
|
| | | |
Other | 1,098 |
| | 18 |
|
Total distributions | $ | 2,517 |
| | $ | 3,302 |
|
Of the distributions received by New Valley from its investment in real estate ventures, $1,383 and $3,083 were from distributions of earnings for the three months ended March 31, 2019 and March 31, 2018, respectively, and $1,134 and $219 were a return of capital for the three months ended March 31, 2019 and March 31, 2018, respectively. Distributions from earnings are
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
included in cash from operations in the Condensed Consolidating Statements of Cash Flows, while distributions that are returns of capital are included in cash flows from investing activities in the Condensed Consolidating Statements of Cash Flows.
Equity in Earnings (Losses) from Real Estate Ventures:
New Valley recognized equity in earnings (losses) from real estate ventures as follows:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Condominium and Mixed Use Development: | | | |
New York City SMSA | $ | (2,106 | ) | | $ | (3,462 | ) |
All other U.S. areas | (108 | ) | | (505 | ) |
| (2,214 | ) | | (3,967 | ) |
Apartment Buildings: | | | |
All other U.S. areas | — |
| | (1,580 | ) |
| — |
| | (1,580 | ) |
Hotels: | | | |
New York City SMSA | (708 | ) | | (814 | ) |
International | (486 | ) | | (425 | ) |
| (1,194 | ) | | (1,239 | ) |
Commercial: | | | |
New York City SMSA | (121 | ) | | (267 | ) |
All other U.S. areas | 292 |
| | 230 |
|
| 171 |
| | (37 | ) |
| | | |
Other: | 798 |
| | 263 |
|
Equity in losses from real estate ventures | $ | (2,439 | ) | | $ | (6,560 | ) |
As part of the Company’s ongoing assessment of the carrying values of its investments in real estate ventures, the Company determined that the fair value of a New York City SMSA Condominium and Mixed Use Development venture was less than its carrying value as of March 31, 2018. The Company determined that the impairment was other than temporary. The Company recorded an impairment charge as a component of equity in losses from real estate ventures of $7,474 of which $6,354 was attributed to the Company for the three months ended March 31, 2018.
Investment in Real Estate Ventures Entered into during 2019:
In February 2019, New Valley invested $500 for an approximate 37% interest in 352 6th, LLC. The joint venture plans to develop a condominium complex. The venture is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley's maximum exposure to loss as a result of its investment in 352 6th, LLC was $506 at March 31, 2019.
VIE Consideration:
The Company has determined that New Valley is the primary beneficiary of two real estate ventures because it controls the activities that most significantly impact economic performance of each of the two real estate ventures. Consequently, New Valley consolidates these variable interest entities (“VIEs”).
The carrying amount of the consolidated assets of the VIEs was $976 and $1,387 as of March 31, 2019 and December 31, 2018, respectively. Those assets are owned by the VIEs, not the Company. Neither of the two consolidated VIEs had recourse liabilities as of March 31, 2019 and December 31, 2018. A VIE’s assets can only be used to settle obligations of that VIE. The VIEs are not guarantors of the Company’s senior notes and other debts payable.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
For the remaining investments in real estate ventures, New Valley determined that the entities were variable interest entities but New Valley was not the primary beneficiary. Therefore, New Valley’s investment in such real estate ventures has been accounted for under the equity method of accounting.
Maximum Exposure to Loss:
New Valley’s maximum exposure to loss from its investments in real estate ventures consisted of the net carrying value of the venture adjusted for any future capital commitments and/or guarantee arrangements. The maximum exposure to loss was as follows:
|
| | | |
| March 31, 2019 |
Condominium and Mixed Use Development: | |
New York City SMSA | $ | 68,492 |
|
All other U.S. areas | 44,358 |
|
| 112,850 |
|
Hotels: | |
New York City SMSA | 14,462 |
|
International | 1,848 |
|
| 16,310 |
|
Commercial: | |
New York City SMSA | 1,739 |
|
All other U.S. areas | 7,345 |
|
| 9,084 |
|
| |
Other: | 32,350 |
|
Total maximum exposure to loss | $ | 170,594 |
|
New Valley capitalized $1,315 of interest costs into the carrying value of its ventures whose projects were currently under development for the three months ended March 31, 2019. New Valley capitalized $2,209 of interest costs into the carrying value of its venture whose projects were currently under development for the three months ended March 31, 2018.
Douglas Elliman has been engaged by the developers as the sole broker or the co-broker for several of the real estate ventures that New Valley owns an interest. Douglas Elliman earned gross commissions of approximately $3,118 and $3,759 from these projects for the three months ended March 31, 2019 and March 31, 2018, respectively.
Combined Financial Statements for Unconsolidated Subsidiaries:
The following summarized financial data for certain unconsolidated subsidiaries that meet certain thresholds pursuant to SEC Regulation S-X Rule 210.10-01(b) includes information for the 215 Chrystie Street investment. New Valley has elected a one-month lag reporting period for the investment.
Hotels:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Income Statement | | | |
Revenue | $ | 13,421 |
| | $ | 82,947 |
|
Cost of sales | — |
| | 53,851 |
|
Other expenses | 19,395 |
| | 20,692 |
|
(Loss) income from continuing operations | $ | (5,974 | ) | | $ | 8,404 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Investments in Real Estate, net:
The components of “Investments in real estate, net” were as follows:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Escena, net | $ | 10,086 |
| | $ | 10,170 |
|
Sagaponack | 16,691 |
| | 16,050 |
|
Investments in real estate, net | $ | 26,777 |
| | $ | 26,220 |
|
Escena. The assets of “Escena, net” were as follows:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Land and land improvements | $ | 8,910 |
| | $ | 8,910 |
|
Building and building improvements | 1,900 |
| | 1,900 |
|
Other | 2,197 |
| | 2,162 |
|
| 13,007 |
| | 12,972 |
|
Less accumulated depreciation | (2,921 | ) | | (2,802 | ) |
| $ | 10,086 |
| | $ | 10,170 |
|
New Valley recorded operating income of $686 and $800 for the three months ended March 31, 2019 and 2018, respectively, from Escena.
Investment in Sagaponack. In April 2015, New Valley invested $12,502 in a residential real estate project located in Sagaponack, NY. The project is wholly owned and the balances of the project are included in the condensed consolidated financial statements of the Company. As of March 31, 2019, the assets of Sagaponack consisted of land and land improvements of $16,691.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
| |
8. | NOTES PAYABLE, LONG-TERM DEBT AND OTHER OBLIGATIONS |
Notes payable, long-term debt and other obligations consisted of:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
Vector: | | | |
6.125% Senior Secured Notes due 2025 | $ | 850,000 |
| | $ | 850,000 |
|
10.5% Senior Notes due 2026 | 325,000 |
| | 325,000 |
|
7.5% Variable Interest Senior Convertible Notes due 2019, net of unamortized discount of $0 and $3,359* | — |
| | 226,641 |
|
5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $24,300 and $29,465* | 207,700 |
| | 202,535 |
|
Liggett: | | | |
Revolving credit facility | 35,435 |
| | 28,381 |
|
Term loan under credit facility | 2,335 |
| | 2,409 |
|
Equipment loans | 667 |
| | 1,039 |
|
Other | 30,346 |
| | 30,440 |
|
Notes payable, long-term debt and other obligations | 1,451,483 |
| | 1,666,445 |
|
Less: | | | |
Debt issuance costs | (22,458 | ) | | (23,614 | ) |
Total notes payable, long-term debt and other obligations | 1,429,025 |
| | 1,642,831 |
|
Less: | | | |
Current maturities | (41,080 | ) | | (256,134 | ) |
Amount due after one year | $ | 1,387,945 |
| | $ | 1,386,697 |
|
______________________
* The fair value of the derivatives embedded within the 7.5% Variable Interest Senior Convertible Notes ($0 at March 31, 2019 and $6,635 at December 31, 2018, respectively) and the 5.5% Variable Interest Senior Convertible Debentures ($21,075 at March 31, 2019 and $24,789 at December 31, 2018, respectively), is separately classified as a derivative liability in the condensed consolidated balance sheets.
6.125% Senior Secured Notes due 2025 — Vector:
As of March 31, 2019, the Company was in compliance with all debt covenants related to its 6.125% Senior Secured Notes due 2025.
10.5% Senior Notes due 2026 — Vector:
On November 2, 2018, the Company completed the sale of $325,000 of its 10.5% Senior Notes due 2026 (“10.5% Senior Notes”) in a private offering that is exempt from registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), to qualified institutional buyers in accordance with Rule 144A of the Securities Act. There are no registration rights associated with the notes, and the Company does not intend to offer notes registered under the Securities Act in exchange for the 10.5% Senior Notes or file a registration statement with respect to the 10.5% Senior Notes. The aggregate net proceeds from the sale of the 10.5% Senior Notes were approximately $315,000 after deducting underwriting discounts, commissions, fees and offering expenses.
The Company will pay cash interest at a rate of 10.5% per year, payable semi-annually on May 1 and November 1 of each year, beginning on May 1, 2019. Interest will accrue from November 2, 2018. The 10.5% Senior Notes mature on November 1, 2026. Interest on overdue principal and interest, if any, will accrue at a rate that is 1% higher than the then applicable interest rate on the 10.5% Senior Notes. The Company will make each interest payment to the holders of record on the immediately preceding April 15 and October 15. The Company may redeem some or all of the 10.5% Senior Notes at any time prior to November 1, 2021 at a make-whole redemption price. On or after November 1, 2021, the Company may redeem some or all of the 10.5% Senior Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to the redemption date. In addition, any time prior to November 1, 2021, the Company may redeem up to 40% of the aggregate outstanding amount of the 10.5% Senior Notes with the net proceeds of certain equity offerings at 110.5% of the aggregate principal amount of the 10.5% Senior
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Notes, plus accrued and unpaid interest, if any, to the redemption date, if at least 60% of the aggregate principal amount of the 10.5% Senior Notes originally issued remains outstanding after such redemption, and the redemption occurs within 90 of the closing of such equity offering. In the event of a change of control, as defined in the indenture, each holder of the 10.5% Senior Notes will have the right to require the Company to make an offer to repurchase some or all of its 10.5% Senior Notes at a repurchase price equal to 101% of the aggregate principal amount of the 10.5% Senior Notes plus accrued and unpaid interest to the date of purchase. If the Company sells certain assets and does not apply the proceeds as required pursuant to the indenture, it must offer to repurchase the 10.5% Senior Notes at the prices listed in the indenture.
The 10.5% Senior Notes are guaranteed subject to certain customary automatic release provisions on a joint and several basis by all of the wholly owned domestic subsidiaries of the Company that are engaged in the conduct of the Company’s cigarette businesses, and by DER Holdings LLC, through which the Company indirectly owns a 100.00% interest in Douglas Elliman. The 10.5% Senior Notes are the Company’s general senior unsecured obligations, and are pari passu in right of payment with all of the Company’s existing and future senior indebtedness and senior in right of payment to all of our future subordinated indebtedness. The 10.5% Senior Notes are effectively subordinated in right of payment to all of our existing and future indebtedness that is secured by assets of the Company or assets of the Guarantors, to the extent of the value of the assets securing such indebtedness. The 10.5% Senior Notes are structurally subordinated to all of the liabilities and preferred stock of any of our subsidiaries that do not guarantee the notes. Each guarantee of the 10.5% Senior Notes are the general obligation of the Guarantor and are pari passu in right of payment with all other senior indebtedness of such Guarantor, including the indebtedness of Liggett Group and Maple under their Credit Agreement with Wells Fargo. Each guarantee of the 10.5% Senior Notes are senior in right of payment to all future subordinated indebtedness of the Guarantor, if any.
The indenture contains covenants that limit the Company and each Guarantor’s ability to, among other things: (i) incur additional indebtedness; (ii) pay dividends or make other distributions, including dividends, repurchases or redemptions of its equity interests; (iii) prepay, redeem or repurchase its subordinated indebtedness; (iv) make investments; (v) sell assets; (vi) incur certain liens; (vii) enter into agreements restricting its subsidiaries’ ability to pay dividends; (viii) enter into transactions with affiliates; and (ix) consolidate, merge or sell all or substantially all of its assets. These covenants are subject to a number of important exceptions and qualifications, as described in the indenture.
As of March 31, 2019, the Company was in compliance with all debt covenants related to its 10.5% Senior Notes due 2026.
7.5% Variable Interest Senior Convertible Notes due 2019 — Vector:
In January 2019, the Company paid $230,000 of principal and $8,102 of accrued interest as full payment of its 7.5% Convertible Notes that matured on January 15, 2019.
Revolving Credit Facility and Term Loan Under Credit Facility — Liggett:
As of March 31, 2019, a total of $37,770 was outstanding under the revolving and term loan portions of the credit facility. The total outstanding balance under the revolving and term loan portions of the credit facility was classified as current debt as of March 31, 2019. Availability, as determined under the facility, was approximately $20,500 based on eligible collateral at March 31, 2019. As of March 31, 2019, the Company’s applicable subsidiaries were in compliance with all debt covenants under this revolving and term loan facility.
Non-Cash Interest Expense — Vector:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Amortization of debt discount, net | $ | 8,528 |
| | $ | 18,193 |
|
Amortization of debt issuance costs | 1,185 |
| | 2,681 |
|
| $ | 9,713 |
| | $ | 20,874 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Fair Value of Notes Payable and Long-Term Debt:
|
| | | | | | | | | | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| Carrying | | Fair | | Carrying | | Fair |
| Value | | Value | | Value | | Value |
Senior Notes | $ | 1,175,000 |
| | $ | 1,060,943 |
| | $ | 1,175,000 |
| | $ | 1,034,500 |
|
Variable Interest Senior Convertible Debt | 207,700 |
| | 235,190 |
| | 429,176 |
| | 468,704 |
|
Liggett and other | 68,783 |
| | 68,773 |
| | 62,269 |
| | 62,255 |
|
Notes payable and long-term debt | $ | 1,451,483 |
| (1) | $ | 1,364,906 |
| | $ | 1,666,445 |
| (1) | $ | 1,565,459 |
|
______________________
(1) The carrying value does not include the carrying value of the embedded derivative. See Note 12.
Notes payable and long-term debt are carried on the condensed consolidated balance sheet at amortized cost. The fair value determinations disclosed above are classified as Level 2 under the fair value hierarchy disclosed in Note 12 if such liabilities were recorded on the condensed consolidated balance sheet at fair value. The estimated fair value of the Company’s notes payable and long-term debt has been determined by the Company using available market information and appropriate valuation methodologies including the evaluation of the Company’s credit risk as described in the Company’s Form 10-K. The Company used a derived price based upon quoted market prices and trade activity as of March 31, 2019 to determine the fair value of its publicly-traded notes and debentures. The carrying value of the revolving credit facility and term loan is equal to the fair value. The fair value of the equipment loans and other obligations was determined by calculating the present value of the required future cash flows. However, considerable judgment is required to develop the estimates of fair value and, accordingly, the estimate presented herein is not necessarily indicative of the amount that could be realized in a current market exchange.
Tobacco-Related Litigation:
Overview. Since 1954, Liggett and other United States cigarette manufacturers have been named as defendants in numerous direct, third-party and purported class actions predicated on the theory that cigarette manufacturers should be liable for damages alleged to have been caused by cigarette smoking or by exposure to secondary smoke from cigarettes. The cases have generally fallen into the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs (“Individual Actions”); (ii) lawsuits by individuals requesting the benefit of the Engle ruling (“Engle progeny cases”); (iii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring, as well as cases alleging that use of the terms “lights” and/or “ultra lights” constitutes a deceptive and unfair trade practice, common law fraud or violation of federal law, purporting to be brought on behalf of a class of individual plaintiffs (“Class Actions”); and (iv) health care cost recovery actions brought by various foreign and domestic governmental plaintiffs and non-governmental plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits (“Health Care Cost Recovery Actions”). The future financial impact of the risks and expenses of litigation are not quantifiable. For the three months ended March 31, 2019 and 2018, Liggett incurred tobacco product liability legal expenses and costs totaling $1,463 and $1,508, respectively. The tobacco product liability legal expenses and costs are included in the operating, selling, administrative and general expenses and litigation settlement and judgment expense line items in the Condensed Consolidated Statements of Operations. Legal defense costs are expensed as incurred.
Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending cases. With the commencement of new cases, the defense costs and the risks relating to the unpredictability of litigation increase. Management reviews on a quarterly basis with counsel all pending litigation and evaluates the probability of a loss being incurred and whether an estimate can be made of the possible loss or range of loss that could result from an unfavorable outcome. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation. Damages awarded in tobacco-related litigation can be significant.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Bonds. Although Liggett has been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts are on appeal, there remains a risk that such relief may not be obtainable in all cases. This risk has been reduced given that a majority of states now limit the dollar amount of bonds or require no bond at all. As of March 31, 2019, to obtain a stay of the judgment pending the appeal of the Santoro case, Liggett had secured $535 in bonds.
In June 2009, Florida amended its existing bond cap statute by adding a $200,000 bond cap that applies to all Engle progeny cases in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. The maximum amount of any such bond for an appeal in the Florida state courts will be no greater than $5,000. In several cases, plaintiffs challenged the constitutionality of the bond cap statute, but to date the courts have upheld the constitutionality of the statute. It is possible that the Company’s consolidated financial position, results of operations, and cash flows could be materially adversely affected by an unfavorable outcome of such challenges.
Accounting Policy. The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except as discussed in this Note 9: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to reasonably estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any.
Although Liggett has generally been successful in managing the litigation filed against it, litigation is subject to uncertainty and significant challenges remain, including with respect to the remaining Engle progeny cases. There can be no assurances that Liggett’s past litigation experience will be representative of future results. Judgments have been entered against Liggett in the past, in Individual Actions and Engle progeny cases, and several of those judgments were affirmed on appeal and satisfied by Liggett. It is possible that the consolidated financial position, results of operations and cash flows of the Company could be materially adversely affected by an unfavorable outcome or settlement of any of the remaining smoking-related litigation. Liggett believes, and has been so advised by counsel, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. All such cases are and will continue to be vigorously defended. Liggett has entered into settlement discussions in individual cases or groups of cases where Liggett has determined it was in its best interest to do so, and it may continue to do so in the future. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.
Individual Actions
As of March 31, 2019, there were 33 Individual Actions pending against Liggett, where one or more individual plaintiffs allege injury resulting from cigarette smoking, addiction to cigarette smoking or exposure to secondary smoke and seek compensatory and, in some cases, punitive damages. These cases do not include the remaining Engle progeny cases or the individual cases pending in West Virginia state court as part of a consolidated action. The following table lists the number of Individual Actions by state:
|
| | |
State | | Number of Cases |
Florida | | 22 |
Illinois | | 4 |
New York | | 2 |
Louisiana | | 2 |
West Virginia | | 2 |
Ohio | | 1 |
The plaintiffs’ allegations of liability in cases in which individuals seek recovery for injuries allegedly caused by cigarette smoking are based on various theories of recovery, including negligence, gross negligence, breach of special duty, strict liability, fraud, concealment, misrepresentation, design defect, failure to warn, breach of express and implied warranties, conspiracy, aiding and abetting, concert of action, unjust enrichment, common law public nuisance, property damage, invasion of privacy, mental anguish, emotional distress, disability, shock, indemnity, violations of deceptive trade practice laws, the federal Racketeer Influenced and Corrupt Organizations Act (“RICO”), state RICO statutes and antitrust statutes. In many of these cases, in addition
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
to compensatory damages, plaintiffs also seek other forms of relief including treble/multiple damages, medical monitoring, disgorgement of profits and punitive damages. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.
Defenses raised in Individual Actions include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, lack of design defect, statute of limitations, equitable defenses such as “unclean hands” and lack of benefit, failure to state a claim and federal preemption.
Engle Progeny Cases
In May 1994, the Engle case was filed as a class action against Liggett and others in Miami-Dade County, Florida. The class consisted of all Florida residents who, by November 21, 1996, “have suffered, presently suffer or have died from diseases and medical conditions caused by their addiction to cigarette smoking.” A trial was held and the jury returned a verdict adverse to the defendants (approximately $145,000,000 in punitive damages, including $790,000 against Liggett). Following an appeal to the Third District Court of Appeal, the Florida Supreme Court in July 2006 decertified the class on a prospective basis and affirmed the appellate court’s reversal of the punitive damages award. Former class members had until January 2008 to file individual lawsuits. As a result, Liggett and the Company, and other cigarette manufacturers, were sued in thousands of Engle progeny cases in both federal and state courts in Florida. Although the Company was not named as a defendant in the Engle case, it was named as a defendant in substantially all of the Engle progeny cases where Liggett was named as a defendant.
Cautionary Statement About Engle Progeny Cases. Since 2009, judgments have been entered against Liggett and other cigarette manufacturers in Engle progeny cases. A number of the judgments have been affirmed on appeal and satisfied by the defendants. Many have been overturned on appeal. As of March 31, 2019, 25 Engle progeny cases where Liggett was a defendant at trial resulted in verdicts.
There have been 16 verdicts returned in favor of the plaintiffs and nine in favor of Liggett. In five of the cases, punitive damages were awarded against Liggett. In certain cases, the judgments were entered jointly and severally with other defendants and Liggett may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, under certain circumstances, Liggett may have to pay more than its proportionate share of any bonding or judgment related amounts. Except as discussed in this Note 9, management is unable to estimate the possible loss or range of loss from the remaining Engle progeny cases as there are currently multiple defendants in each case and, in most cases, discovery has not occurred or is limited. As a result, the Company lacks information about whether plaintiffs are in fact Engle class members, the relevant smoking history, the nature of the alleged injury and the availability of various defenses, among other things. Further, plaintiffs typically do not specify the amount of their demand for damages. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.
Engle Progeny Settlements.
In October 2013, the Company and Liggett entered into a settlement with approximately 4,900 Engle progeny plaintiffs and their counsel. Pursuant to the terms of the settlement, Liggett agreed to pay a total of approximately $110,000, with $61,600 paid in an initial lump sum and the balance of $48,000 to be paid in installments over 14 years starting in February 2015. In exchange, the claims of these plaintiffs were dismissed with prejudice against the Company and Liggett. The Company’s future payments will be approximately $3,400 per annum through 2028, with a cost of living increase beginning in 2021.
In December 2016, the Company and Liggett entered into an agreement with 124 Engle progeny plaintiffs and their counsel. Pursuant to the terms of this settlement, Liggett agreed to pay $17,650, $14,000 of which was paid in December 2016 with the balance paid in December 2017. As a result of this settlement, the Company recorded a charge of $17,650 in the fourth quarter of 2016.
In June 2017, Liggett entered into an agreement to settle nine cases (eight Engle progeny cases and one Individual Action) for $1,400 and in September 2017 Liggett entered into an agreement to settle 20 Engle progeny cases for $4,100. As of March 31, 2019, Liggett (and in certain cases the Company) had, on an individual basis, settled an additional 185 Engle progeny cases for approximately $7,600 in the aggregate.
Notwithstanding the comprehensive nature of the Engle Progeny Settlements, approximately 70 plaintiffs’ claims remain pending in state court. Therefore, the Company and Liggett may still be subject to periodic adverse judgments which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Judgments Paid in Engle Progeny Cases.
As of March 31, 2019, Liggett had paid in the aggregate $39,773, including interest and attorneys’ fees, to satisfy the judgments in the following Engle progeny cases: Lukacs, Campbell, Douglas, Clay, Tullo, Ward, Rizzuto, Lambert and Buchanan. An adverse verdict against Liggett for $160 in Santoro is currently on appeal.
Maryland Cases
Liggett was a defendant in 16 multi-defendant personal injury cases in Maryland alleging claims arising from asbestos and tobacco exposure (“synergy cases”). In July 2016, the Court of Appeals (Maryland’s highest court) ruled that joinder of tobacco and asbestos cases may be possible in certain circumstances, but plaintiffs must demonstrate at the trial court level how such cases may be joined while providing appropriate safeguards to prevent embarrassment, delay, expense or prejudice to defendants and “the extent to which, if at all, the special procedures applicable to asbestos cases should extend to tobacco companies.” The Court of Appeals remanded these issues to be determined at the trial court level. In June 2017, the trial court issued an order dismissing all synergy cases against the tobacco defendants, including Liggett, without prejudice. Plaintiffs may seek appellate review or file new cases against the tobacco companies.
Liggett Only Cases
There is currently one case pending where Liggett is the sole defendant: Cowart, a Florida Individual Action where there has been no recent activity. It is possible that cases where Liggett is the only defendant could increase as a result of the remaining Engle progeny cases and newly filed Individual Cases.
Class Actions
As of March 31, 2019, three actions were pending for which either a class had been certified or plaintiffs were seeking class certification where Liggett is a named defendant. Other cigarette manufacturers are also named in these actions.
Plaintiffs’ allegations of liability in class action cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violation of deceptive trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes. Plaintiffs in the class actions seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.
Defenses raised in these cases include, among others, lack of proximate cause, individual issues predominate, assumption of the risk, comparative fault and/or contributory negligence, statute of limitations and federal preemption.
In November 1997, in Young v. American Tobacco Co., a purported personal injury class action was commenced on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, allege they were exposed to secondhand smoke from cigarettes that were manufactured by the defendants, including Liggett, and suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. No class certification hearing has been held. The stay order entered on March 16, 2016 stays the case pending completion of the smoking cessation program ordered by the court in Scott v. The American Tobacco Co.
In February 1998, in Parsons v. AC & S Inc., a purported class action was commenced on behalf of all West Virginia residents who allegedly have claims arising from their exposure to cigarette smoke and asbestos fibers. The operative complaint seeks to recover unspecified compensatory and punitive damages on behalf of the putative class. The case is stayed as a result of the December 2000 bankruptcy of three of the defendants.
Although not technically a class action, in In Re: Tobacco Litigation (Personal Injury Cases), a West Virginia state court consolidated approximately 750 individual smoker actions that were pending prior to 2001 for trial of certain “common” issues. Liggett was severed from trial of the consolidated action. In May 2013, the jury rejected all but one of the plaintiffs’ claims against the non-Liggett defendants, finding in favor of plaintiffs on the claim that ventilated filter cigarettes between 1964 and July 1, 1969 should have included instructions on how to use them. The court entered judgment in October 2013, dismissing all claims against the non-Liggett defendants except the ventilated filter claim on behalf of 30 plaintiffs. Subsequently, these claims were settled by the non-Liggett defendants.
In May 2016, the trial court ruled that the case could proceed against Liggett, notwithstanding the outcome of the first phase of the trial against the non-Liggett defendants. In December 2017, the court ordered plaintiffs’ counsel to confirm all
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
remaining plaintiffs with claims against Liggett. The court further agreed that it would entertain a renewed motion by Liggett regarding the impact of the final judgment in favor of co-defendants on the claims against Liggett and whether those claims are barred by the doctrine of collateral estoppel. In 2017 Liggett moved to dismiss a number of plaintiffs’ claims on various grounds. The court granted the motions as to approximately 25 plaintiffs and reserved ruling as to other claims until additional discovery is provided by plaintiffs. The Phase I Common Issues trial is set starting August 12, 2019. It is currently estimated that Liggett could be a defendant in approximately 55 individual cases.
Health Care Cost Recovery Actions
As of March 31, 2019, one Health Care Cost Recovery Action was pending against Liggett, Crow Creek Sioux Tribe v. American Tobacco Company, a South Dakota case filed in 1997, where the plaintiff seeks to recover damages from Liggett and other cigarette manufacturers based on various theories of recovery as a result of alleged sales of tobacco products to minors. The case is dormant.
The claims asserted in health care cost recovery actions vary, but can include the equitable claim of indemnity, common law claims of negligence, strict liability, breach of express and implied warranty, breach of special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, claims under state and federal statutes governing consumer fraud, antitrust, deceptive trade practices and false advertising, and claims under RICO. Although no specific damage amounts are typically pleaded, it is possible that requested damages might be in the billions of dollars. In these cases, plaintiffs typically assert equitable claims that the tobacco industry was “unjustly enriched” by their payment of health care costs allegedly attributable to smoking and seek reimbursement of those costs. Relief sought by some, but not all, plaintiffs include punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.
Department of Justice Lawsuit
In September 1999, the United States government commenced litigation against Liggett and other cigarette manufacturers in the United States District Court for the District of Columbia. The action sought to recover, among other things, an unspecified amount of health care costs paid and to be paid by the federal government for smoking-related illnesses allegedly caused by the fraudulent and tortious conduct of defendants. In August 2006, the trial court entered a Final Judgment against each of the cigarette manufacturing defendants, except Liggett. The judgment was affirmed on appeal. As a result, the cigarette manufacturing defendants, other than Liggett, are now subject to the trial court’s Final Judgment which ordered, among other things, the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “lights” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to environmental tobacco smoke.
Upcoming Trials
As of March 31, 2019, there were three Individual Actions and two Engle Progeny cases scheduled for trial through March 31, 2020, where Liggett (and/or the Company) is a named defendant. Trial dates are subject to change and additional cases could be set for trial during this time.
MSA and Other State Settlement Agreements
In March 1996, March 1997 and March 1998, Liggett entered into settlements of smoking-related litigation with 45 states and territories. The settlements released Liggett from all smoking-related claims made by those states and territories, including claims for health care cost reimbursement and claims concerning sales of cigarettes to minors.
In November 1998, Philip Morris, R.J. Reynolds and two other companies (the “Original Participating Manufacturers” or “OPMs”) and Liggett and Vector Tobacco (together with any other tobacco product manufacturer that becomes a signatory, the “Subsequent Participating Manufacturers” or “SPMs”) (the OPMs and SPMs are hereinafter referred to jointly as “PMs”) entered into the Master Settlement Agreement (the “MSA”) with 46 states, the District of Columbia, Puerto Rico, Guam, the United States Virgin Islands, American Samoa and the Northern Mariana Islands (collectively, the “Settling States”) to settle the asserted and unasserted health care cost recovery and certain other claims of the Settling States. The MSA received final judicial approval in each Settling State.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
As a result of the MSA, the Settling States released Liggett and Vector Tobacco from:
| |
• | all claims of the Settling States and their respective political subdivisions and other recipients of state health care funds, relating to: (i) past conduct arising out of the use, sale, distribution, manufacture, development, advertising and marketing of tobacco products; (ii) the health effects of, the exposure to, or research, statements or warnings about, tobacco products; and |
| |
• | all monetary claims of the Settling States and their respective subdivisions and other recipients of state health care funds relating to future conduct arising out of the use of, or exposure to, tobacco products that have been manufactured in the ordinary course of business. |
The MSA restricts tobacco product advertising and marketing within the Settling States and otherwise restricts the activities of PMs. Among other things, the MSA prohibits the targeting of youth in the advertising, promotion or marketing of tobacco products; bans the use of cartoon characters in all tobacco advertising and promotion; limits each PM to one tobacco brand name sponsorship during any 12-month period; bans all outdoor advertising, with certain limited exceptions; prohibits payments for tobacco product placement in various media; bans gift offers based on the purchase of tobacco products without sufficient proof that the intended recipient is an adult; prohibits PMs from licensing third parties to advertise tobacco brand names in any manner prohibited under the MSA; and prohibits PMs from using as a tobacco product brand name any nationally recognized non-tobacco brand or trade name or the names of sports teams, entertainment groups or individual celebrities.
The MSA also requires PMs to affirm corporate principles to comply with the MSA and to reduce underage use of tobacco products and imposes restrictions on lobbying activities conducted on behalf of PMs. In addition, the MSA provides for the appointment of an independent auditor to calculate and determine the amounts of payments owed pursuant to the MSA.
Under the payment provisions of the MSA, PMs are required to make annual payments of $9,000,000 (subject to applicable adjustments, offsets and reductions including a “Non-Participating Manufacturers Adjustment” or “NPM Adjustment”). These annual payments are allocated based on unit volume of domestic cigarette shipments. The payment obligations under the MSA are the several, and not joint, obligation of each PM and are not the responsibility of any parent or affiliate of a PM.
Liggett has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 1.65% of total cigarettes sold in the United States. Vector Tobacco has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 0.28% of total cigarettes sold in the United States. Liggett and Vector Tobacco’s domestic shipments accounted for 4.0% of the total cigarettes sold in the United States in 2018. If Liggett’s or Vector Tobacco’s market share exceeds their respective market share exemption in a given year, then on April 15 of the following year, Liggett and/or Vector Tobacco, as the case may be, must pay on each excess unit an amount equal (on a per-unit basis) to that due from the OPMs for that year. On December 28, 2018, Liggett and Vector Tobacco pre-paid $132,500 of their approximate $166,000 2018 MSA obligation, the balance of which was paid in April 2019, subject to applicable disputes or adjustments.
Certain MSA Disputes
NPM Adjustment. Liggett and Vector Tobacco contend that they are entitled to an NPM Adjustment for each year from 2003 - 2018. The NPM Adjustment is a potential adjustment to annual MSA payments, available when PMs suffer a market share loss to NPMs for a particular year and an economic consulting firm selected pursuant to the MSA determines (or the parties agree) that the MSA was a “significant factor contributing to” that loss. A Settling State that has “diligently enforced” its qualifying escrow statute in the year in question may be able to avoid its allocable share of the NPM Adjustment. For 2003 - 2018, Liggett and Vector Tobacco, as applicable, disputed that they owed the Settling States the NPM Adjustments as calculated by the independent auditor. As permitted by the MSA, Liggett and Vector Tobacco either paid subject to dispute, withheld payment, or paid into a disputed payment account, the amounts associated with these NPM Adjustments.
In June 2010, after the PMs prevailed in 48 of 49 motions to compel arbitration, the parties commenced the arbitration for the 2003 NPM Adjustment. That arbitration concluded in September 2013. It was followed by various challenges filed in state courts by states that did not prevail in the arbitration. Those challenges resulted in reductions, but not elimination of, the amounts awarded. The arbitration for the 2004 NPM Adjustment started in 2016, and hearings in that arbitration are underway. A separate proceeding in state court is underway for one state that appealed an order compelling arbitration (New Mexico).
The PMs have now settled most of the disputed NPM Adjustment years with 37 states representing approximately 75% of the MSA share. In January 2019, Montana sent a demand letter to the PMs seeking the return of amounts withheld or paid into the disputed payments escrow account (plus interest) for the NPM Adjustment years 2005 - 2016. Any amounts purportedly due
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
from Liggett to Montana are immaterial. The 2004 arbitration and separate court proceedings continue for states with which the PMs have not settled.
As a result of the settlements and arbitration award described above, Liggett and Vector Tobacco reduced cost of sales in the aggregate by $32,840 for years 2013 - 2018. Liggett and Vector Tobacco may be entitled to further adjustments. As of March 31, 2019, Liggett and Vector Tobacco had accrued approximately $13,400 related to the disputed amounts withheld from the non-settling states for 2004 - 2010, which may be subject to payment, with interest, if Liggett and Vector Tobacco lose the disputes for those years. As of March 31, 2019, there remains approximately $27,300 in the disputed payments account relating to Liggett and Vector Tobacco’s 2011 - 2017 NPM Adjustment disputes with the non-settling states.
Other State Settlements. The MSA replaced Liggett’s prior settlements with all states and territories except for Florida, Mississippi, Texas and Minnesota. Each of these four states, prior to the effective date of the MSA, negotiated and executed settlement agreements with each of the other major tobacco companies, separate from those settlements reached previously with Liggett. Except as described below, Liggett’s agreements with these states remain in full force and effect. These states’ settlement agreements with Liggett contained most favored nation provisions which could reduce Liggett’s payment obligations based on subsequent settlements or resolutions by those states with certain other tobacco companies. Beginning in 1999, Liggett determined that, based on settlements or resolutions with United States Tobacco Company, Liggett’s payment obligations to those four states were eliminated. With respect to all non-economic obligations under the previous settlements, Liggett believes it is entitled to the most favorable provisions as between the MSA and each state’s respective settlement with the other major tobacco companies. Therefore, Liggett’s non-economic obligations to all states and territories are now defined by the MSA.
In 2003, as a result of a dispute with Minnesota regarding its settlement agreement, Liggett agreed to pay $100 a year in any year cigarettes manufactured by Liggett are sold in that state. Further, the Attorneys General for Florida, Mississippi and Texas advised Liggett that they believed Liggett had failed to make payments under the respective settlement agreements with those states. In 2010, Liggett settled with Florida and agreed to pay $1,200 and to make further annual payments of $250 for a period of 21 years, starting in March 2011, with the payments from year 12 forward being subject to an inflation adjustment.
In January 2016, the Attorney General for Mississippi filed a motion in Chancery Court in Jackson County, Mississippi to enforce the March 1996 settlement agreement alleging that Liggett owes Mississippi at least $27,000 in damages (including interest), and $20,000 in punitive damages and attorneys’ fees. In April 2017, the Chancery Court ruled that the settlement agreement should be enforced and referred the matter to a Special Master for further proceedings to determine the amount of damages, if any, to be awarded. In May 2017, Liggett filed a Petition for Interlocutory Appeal to the Mississippi Supreme Court, which was denied. Liggett filed a demand for arbitration regarding two specific issues and moved in Chancery Court to compel arbitration and stay the proceedings pending before the Special Master. In June 2018, the Chancery Court granted Liggett’s motion to compel arbitration and stayed the proceedings before the Special Master pending completion of the arbitration. On March 21, 2019, the arbitration panel issued its decision on the two specific issues before it: (i) the panel ruled in favor of Liggett, finding that the $294,000 of proceeds from Eve Holdings’ 1999 brand sale should not be included in Liggett’s pre-tax income, which would reduce the amount of compensatory damages, if any, that would be due to Mississippi; and (ii) ruled in favor of Mississippi on the remaining issue, finding that compensatory damages to Mississippi, if any, would be based on 0.5% of Liggett’s annual pre-tax income for the term of the settlement agreement. The matter will now proceed to the next phase of the proceeding before the designated Special Master to address damages, if any. Liggett continues to believe that the April 2017 Chancery Court order is in error because the most favored nations provision in the settlement agreement eliminated all of Liggett’s payment obligations to Mississippi, and Liggett intends to appeal that order, as may be necessary, after the Special Master phase of the case concludes.
Liggett may be required to make additional payments to Mississippi and Texas which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.
Cautionary Statement
Management is not able to reasonably predict the outcome of the litigation pending or threatened against Liggett or the Company. Litigation is subject to many uncertainties. Liggett has been found liable in multiple Engle progeny cases and Individual Actions, several of which were affirmed on appeal and satisfied by Liggett. It is possible that other cases could be decided unfavorably against Liggett and that Liggett will be unsuccessful on appeal. Liggett may attempt to settle particular cases if it believes it is in its best interest to do so.
Management cannot predict the cash requirements related to any future defense costs, settlements or judgments, including cash required to bond any appeals, and there is a risk that those requirements will not be able to be met. An unfavorable outcome of a pending smoking-related case could encourage the commencement of additional litigation. Except as discussed in this Note
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
9, management is unable to estimate the loss or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases and as a result has not provided any amounts in its consolidated financial statements for unfavorable outcomes.
The tobacco industry is subject to a wide range of laws and regulations regarding the marketing, sale, taxation and use of tobacco products imposed by local, state and federal governments. There have been a number of restrictive regulatory actions, adverse legislative and political decisions and other unfavorable developments concerning cigarette smoking and the tobacco industry. These developments may negatively affect the perception of potential triers of fact with respect to the tobacco industry, possibly to the detriment of certain pending litigation, and may prompt the commencement of additional litigation or legislation.
It is possible that the Company’s consolidated financial position, results of operations and cash flows could be materially adversely affected by an unfavorable outcome in any of the smoking-related litigation.
The activity in the Company’s accruals for the MSA and tobacco litigation for the three months ended March 31, 2019 was as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Current Liabilities | | Non-Current Liabilities |
| Payments due under Master Settlement Agreement | | Litigation Accruals | | Total | | Payments due under Master Settlement Agreement | | Litigation Accruals | | Total |
| | | | | | | | | | | |
Balance as of January 1, 2019 | $ | 36,561 |
| | $ | 310 |
| | $ | 36,871 |
| | $ | 16,383 |
| | $ | 21,794 |
| | $ | 38,177 |
|
Expenses | 36,358 |
| | — |
| | 36,358 |
| | — |
| | — |
| | — |
|
Change in MSA obligations capitalized as inventory | 890 |
| | — |
| | 890 |
| | — |
| | — |
| | — |
|
Payments | — |
| | (250 | ) | | (250 | ) | | — |
| | — |
| | — |
|
Reclassification to/(from) non-current liabilities | — |
| | 3,338 |
| | 3,338 |
| | — |
| | (3,338 | ) | | (3,338 | ) |
Interest on withholding | — |
| | 6 |
| | 6 |
| | — |
| | 571 |
| | 571 |
|
Balance as of March 31, 2019 | $ | 73,809 |
| | $ | 3,404 |
| | $ | 77,213 |
| | $ | 16,383 |
| | $ | 19,027 |
| | $ | 35,410 |
|
The activity in the Company’s accruals for the MSA and tobacco litigation for the three months ended March 31, 2018 were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Current Liabilities | | Non-Current Liabilities |
| Payments due under Master Settlement Agreement | | Litigation Accruals | | Total | | Payments due under Master Settlement Agreement | | Litigation Accruals | | Total |
| | | | | | | | | | | |
Balance as of January 1, 2018 | $ | 12,385 |
| | $ | 260 |
| | $ | 12,645 |
| | $ | 21,479 |
| | $ | 19,840 |
| | $ | 41,319 |
|
Expenses | 38,142 |
| | — |
| | 38,142 |
| | — |
| | — |
| | — |
|
NPM Settlement adjustment | (595 | ) | | — |
| | (595 | ) | | (2,895 | ) | | — |
| | (2,895 | ) |
Change in MSA obligations capitalized as inventory | 147 |
| | — |
| | 147 |
| | — |
| | — |
| | — |
|
Payments | — |
| | (250 | ) | | (250 | ) | | — |
| | — |
| | — |
|
Reclassification to/(from) non-current liabilities | 32 |
| | 218 |
| | 250 |
| | (32 | ) | | (218 | ) | | (250 | ) |
Interest on withholding | — |
| | 12 |
| | 12 |
| | — |
| | 514 |
| | 514 |
|
Balance as of March 31, 2018 | $ | 50,111 |
| | $ | 240 |
| | $ | 50,351 |
| | $ | 18,552 |
| | $ | 20,136 |
| | $ | 38,688 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Other Matters:
Liggett’s and Vector Tobacco’s management are unaware of any material environmental conditions affecting their existing facilities. Liggett’s and Vector Tobacco’s management believe that current operations are conducted in material compliance with all environmental laws and regulations and other laws and regulations governing cigarette manufacturers. Compliance with federal, state and local provisions regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material effect on the capital expenditures, results of operations or competitive position of Liggett or Vector Tobacco.
Liggett and the Company have received three separate demands for indemnification from Altria Client Services, on behalf of Philip Morris, relating to lawsuits alleging smokers’ use of L&M cigarettes. The indemnification demands are purportedly issued in connection with Eve Holdings’ 1999 sale of certain brands to Philip Morris.
Liggett Vector Brands entered into an agreement with a subsidiary of the Convenience Distribution Association to support a program to permit certain tobacco distributors to secure, on reasonable terms, tax stamp bonds required by state and local governments for the distribution of cigarettes. Under the agreement, Liggett Vector Brands has agreed to pay a portion of losses incurred by the surety under the bond program, with a maximum loss exposure of $500. The Company believes the fair value of Liggett Vector Brands’ obligation under the agreement was immaterial at March 31, 2019.
In addition to the foregoing, Douglas Elliman and certain of its subsidiaries are subject to numerous proceedings, lawsuits and claims in connection with their ordinary business activities. Many of these matters are covered by insurance or, in some cases, the company is indemnified by third parties.
Management is of the opinion that the liabilities, if any, resulting from other proceedings, lawsuits and claims pending against the Company and its consolidated subsidiaries, unrelated to tobacco product liability, should not materially affect the Company’s consolidated financial position, results of operations or cash flows.
| |
10. | EMPLOYEE BENEFIT PLANS |
The following table summarizes key information related to the Company’s pension plans and other postretirement benefits:
|
| | | | | | | | | | | | | | | |
| Pension Benefits | | Other Postretirement Benefits |
| Three Months Ended | | Three Months Ended |
| March 31, | | March 31, |
| 2019 | | 2018 | | 2019 | | 2018 |
Service cost — benefits earned during the period | $ | 133 |
| | $ | 147 |
| | $ | — |
| | $ | 1 |
|
Interest cost on projected benefit obligation | 1,215 |
| | 1,122 |
| | 87 |
| | 82 |
|
Expected return on assets | (1,219 | ) | | (1,393 | ) | | — |
| | — |
|
Amortization of prior service cost | — |
| | — |
| | 1 |
| | — |
|
Amortization of net loss (gain) | 501 |
| | 452 |
| | (44 | ) | | (10 | ) |
Net expense | $ | 630 |
| | $ | 328 |
| | $ | 44 |
| | $ | 73 |
|
The service cost component of net periodic benefit expense (income) is recorded in Operating, selling, administrative and general expenses in the condensed consolidated statements of income while the other components are recorded in Other, net.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
The Company’s effective income tax rate is based on expected income, statutory rates, valuation allowances against deferred tax assets, and any tax planning opportunities available to the Company. For interim financial reporting, the Company estimates the annual effective income tax rate based on full year projections and applies the annual effective income tax rate against year-to-date pretax income (loss) to record income tax expense, adjusted for discrete items, if any. The Company refines annual estimates as new information becomes available. The Company’s tax rate does not bear a relationship to statutory tax rates due to permanent differences, a valuation allowance being established for interest expense that is not deductible, and state taxes.
The Company’s income tax expense consisted of the following:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Income before provision for income taxes | $ | 21,782 |
| | $ | 5,612 |
|
Income tax expense using estimated annual effective income tax rate | 6,863 |
| | 2,056 |
|
Impact of discrete items, net | (114 | ) | | (108 | ) |
Income tax expense | $ | 6,749 |
| | $ | 1,948 |
|
The discrete items for the three months ended March 31, 2019 and 2018 is related to an income tax deduction for stock-based compensation.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
| |
12. | INVESTMENTS AND FAIR VALUE MEASUREMENTS |
The Company’s financial assets and liabilities subject to fair value measurements were as follows:
|
| | | | | | | | | | | | | | | | | | |
| | Fair Value Measurements as of March 31, 2019 | | |
Description | | Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2)
| |
Significant Unobservable Inputs (Level 3)
| | Total Gains (Losses) |
Assets: | | | | | | | | | | |
Money market funds (1) | | $ | 222,559 |
| | $ | 222,559 |
| | $ | — |
| | $ | — |
| | |
| | | | | | | | | | |
Commercial paper (1) | | 39,100 |
| | — |
| | 39,100 |
| | — |
| | |
| | | | | | | | | | |
Certificates of deposit (2) | | 2,171 |
| | — |
| | 2,171 |
| | — |
| | |
| | | | | | | | | | |
Money market funds securing legal bonds (2) | | 535 |
| | 535 |
| | — |
| | — |
| | |
| | | | | | | | | | |
Investment securities at fair value | | | | | | | | | | |
Equity securities at fair value | | | | | | | | | | |
Marketable equity securities | | 24,387 |
| | 24,387 |
| | — |
| | — |
| | |
Mutual funds invested in fixed-income securities | | 21,660 |
| | 21,660 |
| | — |
| | — |
| | |
Total equity securities at fair value | | 46,047 |
| | 46,047 |
| | — |
| | — |
| | |
Debt securities available for sale | | | | | | | | | | |
U.S. government securities | | 24,275 |
| | — |
| | 24,275 |
| | — |
| | |
Corporate securities | | 43,110 |
| | — |
| | 43,110 |
| | — |
| | |
U.S. government and federal agency | | 4,132 |
| | — |
| | 4,132 |
| | — |
| | |
Commercial mortgage-backed securities | | 397 |
| | — |
| | 397 |
| | — |
| | |
Commercial paper | | 13,180 |
| | — |
| | 13,180 |
| | — |
| | |
Index-linked U.S. bonds | | 2,354 |
| | — |
| | 2,354 |
| | — |
| | |
Foreign fixed-income securities | | 1,157 |
| | — |
| | 1,157 |
| | — |
| | |
Total debt securities available for sale | | 88,605 |
| | — |
| | 88,605 |
| | — |
| | |
| | | | | | | | | | |
Total investment securities at fair value | | 134,652 |
| | 46,047 |
| | 88,605 |
| | — |
| | |
| | | | | | | | | | |
Long-term investments | | | | | | | | | | |
Equity securities at fair value that qualify for the NAV practical expedient (3) | | 54,202 |
| | — |
| | — |
| | — |
| | |
Total | | $ | 453,219 |
| | $ | 269,141 |
| | $ | 129,876 |
| | $ | — |
| | |
| | | | | | | | | | |
Liabilities: | | | | | | | | | | |
Fair value of contingent liability | | $ | 6,258 |
| | $ | — |
| | $ | — |
| | $ | 6,258 |
| | |
Fair value of derivatives embedded within convertible debt | | 21,075 |
| | — |
| | — |
| | 21,075 |
| | |
Total | | $ | 27,333 |
| | $ | — |
| | $ | — |
| | $ | 27,333 |
| | |
| |
(1) | Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $3,719 that is included in current restricted assets and $3,910 that is included in non-current restricted assets. |
| |
(2) | Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheet. |
| |
(3) | In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy. |
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
|
| | | | | | | | | | | | | | | | | | |
| | Fair Value Measurements as of December 31, 2018 | | |
Description | | Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2)
| |
Significant Unobservable Inputs (Level 3)
| | Total Gains (Losses) |
Assets: | | | | | | | | | | |
Money market funds (1) | | $ | 448,560 |
| | $ | 448,560 |
| | $ | — |
| | $ | — |
| | |
| | | | | | | | | | |
Commercial paper (1) | | 46,062 |
| | — |
| | 46,062 |
| | — |
| | |
| | | | | | | | | | |
Certificates of deposit (2) | | 2,251 |
| | — |
| | 2,251 |
| | — |
| | |
| | | | | | | | | | |
Money market funds securing legal bonds (2) | | 535 |
| | 535 |
| | — |
| | — |
| | |
| | | | | | | | | | |
Investment securities at fair value | | | | | | | | | | |
Equity securities at fair value | | | | | | | | | | |
Marketable equity securities | | 26,010 |
| | 26,010 |
| | — |
| | — |
| | |
Mutual funds invested in fixed-income securities | | 21,192 |
| | 21,192 |
| | — |
| | — |
| | |
Total equity securities at fair value | | 47,202 |
| | 47,202 |
| | — |
| | — |
| | |
Debt securities available for sale | | | | | | | | | | |
U.S. government securities | | 28,514 |
| | — |
| | 28,514 |
| | — |
| | |
Corporate securities | | 41,733 |
| | — |
| | 41,733 |
| | — |
| | |
U.S. government and federal agency | | 4,369 |
| | — |
| | 4,369 |
| | — |
| | |
Commercial mortgage-backed securities | | 401 |
| | — |
| | 401 |
| | — |
| | |
Commercial paper | | 5,870 |
| | — |
| | 5,870 |
| | — |
| | |
Index-linked U.S. bonds | | 2,330 |
| | — |
| | 2,330 |
| | — |
| | |
Foreign fixed-income securities | | 1,150 |
| | — |
| | 1,150 |
| | — |
| | |
Total debt securities available for sale | | 84,367 |
| | — |
| | 84,367 |
| | — |
| | |
| | | | | | | | | | |
Total investment securities at fair value | | 131,569 |
| | 47,202 |
| | 84,367 |
| | — |
| | |
| | | | | | | | | | |
Long-term investments | | | | | | | | | | |
Equity securities at fair value that qualify for the NAV practical expedient (3) | | 54,628 |
| | — |
| | — |
| | — |
| | |
Total | | $ | 683,605 |
| | $ | 496,297 |
| | $ | 132,680 |
| | $ | — |
| | |
| | | | | | | | | | |
Liabilities: | | | | | | | | | | |
Fair value of contingent liability | | $ | 6,304 |
| | $ | — |
| | $ | — |
| | $ | 6,304 |
| | |
Fair value of derivatives embedded within convertible debt | | 31,424 |
| | — |
| | — |
| | 31,424 |
| | |
Total | | $ | 37,728 |
| | $ | — |
| | $ | — |
| | $ | 37,728 |
| | |
| |
(1) | Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $2,570 that is included in current restricted assets and $3,910 that is included in non-current restricted assets. |
| |
(2) | Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheet. |
| |
(3) | In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy. |
The fair value of the Level 2 certificates of deposit is based on the discounted value of contractual cash flows. The discount rate is the rate offered by the financial institution. The fair value of investment securities at fair value included in Level 1 is based on quoted market prices from various stock exchanges. The Level 2 investment securities at fair value are based on quoted market
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
prices of securities that are thinly traded, quoted prices for identical or similar assets in markets that are not active or inputs other than quoted prices such as interest rates and yield curves.
The long-term investments are based on NAV per share provided by the partnerships based on the indicated market value of the underlying assets or investment portfolio. In accordance with Subtopic 820-10, these investments are not classified under the fair value hierarchy disclosed above because they are measured at fair value using the NAV practical expedient.
The fair value of derivatives embedded within convertible debt was derived using a valuation model. These derivatives have been classified as Level 3. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads based upon the implied credit spread of the 5.5% Convertible Notes due 2020 to determine the fair value of the derivatives embedded within the convertible debt. The changes in fair value of derivatives embedded within convertible debt are presented on the condensed consolidated statements of operations.
The fair value of the Level 3 contingent liability was derived using a Monte Carlo valuation model. As part of the acquisition of the 29.41% non-controlling interest in Douglas Elliman, New Valley entered into a four-year payout agreement that requires it to pay the sellers a portion of the fair value in excess of the purchase price of Douglas Elliman should a sale of a controlling interest in Douglas Elliman occur.
The contingent liability is recorded within “Other liabilities” in the condensed consolidated balance sheet, and any change in fair value will be recorded in “Other, net” within the condensed consolidated statements of operations. The value of the contingent liability is calculated using the outstanding payable owed to the sellers and the estimated fair value of Douglas Elliman. The liability is contingent upon the sale of a controlling interest in Douglas Elliman by the Company prior to October 1, 2022.
The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at March 31, 2019: |
| | | | | | | | | | | | |
| | Quantitative Information about Level 3 Fair Value Measurements |
| | Fair Value at | | | | | | |
| | March 31, 2019 | | Valuation Technique | | Unobservable Input | | Range (Actual) |
| | | | | | | | |
Fair value of derivatives embedded within convertible debt | | $ | 21,075 |
| | Discounted cash flow | | Assumed annual stock dividend | | 5 | % |
| | | | | | Assumed annual cash dividend | | $ | 1.60 |
|
| | | | | | Stock price | | $ | 10.79 |
|
| | | | | | Convertible trading price (as a percentage of par value) | | 101.38 | % |
| | | | | | Volatility | | 25.48 | % |
| | | | | | Risk-free rate | | Term structure of US Treasury Securities |
| | | | | | Implied credit spread | | 7.5% - 8.5% (8.0%) |
|
| | | | | | | | |
Fair value of contingent liability | | $ | 6,258 |
| | Monte Carlo simulation model | | Estimated fair value of the Douglas Elliman reporting unit | | $ | 320,000 |
|
| | | | | | Risk-free rate for a 4-year term | | 2.19 | % |
| | | | | | Leverage-adjusted equity volatility of peer firms | | 30.42 | % |
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at December 31, 2018:
|
| | | | | | | | | | | | |
| | Quantitative Information about Level 3 Fair Value Measurements |
| | Fair Value at | | | | | | |
| | December 31, 2018 | | Valuation Technique | | Unobservable Input | | Range (Actual) |
| | | | | | | | |
Fair value of derivatives embedded within convertible debt | | $ | 31,424 |
| | Discounted cash flow | | Assumed annual stock dividend | | 5 | % |
| | | | | | Assumed annual cash dividend | | $ | 1.60 |
|
| | | | | | Stock price | | $ | 9.73 |
|
| | | | | | Convertible trading price (as a percentage of par value) | | 100.31 | % |
| | | | | | Volatility | | 20.39 | % |
| | | | | | Risk-free rate | | Term structure of US Treasury Securities |
| | | | | | Implied credit spread | | 8.0% - 9.0% (8.5%) |
|
| | | | | | | | |
Fair value of contingent liability | | $ | 6,304 |
| | Monte Carlo simulation model | | Estimated fair value of the Douglas Elliman reporting unit | | $ | 320,000 |
|
| | | | | | Risk-free rate for a 4-year term | | 2.45 | % |
| | | | | | Leverage-adjusted equity volatility of peer firms | | 30.22 | % |
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company is required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets and liabilities are recorded at fair value on a nonrecurring basis as a result of impairment charges. The Company had no nonrecurring nonfinancial assets subject to fair value measurements as of March 31, 2019 and 2018, respectively.
The Company’s business segments for the three months ended March 31, 2019 and 2018 were Tobacco and Real Estate. The Tobacco segment consisted of the manufacture and sale of conventional cigarettes. The Real Estate segment included the Company’s investment in New Valley LLC, which includes Douglas Elliman, Escena, Sagaponack and investments in real estate ventures. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Financial information for the Company’s operations before taxes and non-controlling interests for the three months ended March 31, 2019 and 2018 were as follows:
|
| | | | | | | | | | | | | | | |
| | | Real | | Corporate | | |
| Tobacco | | Estate | | and Other | | Total |
Three months ended March 31, 2019 | | | | | | | |
Revenues | $ | 256,756 |
| | $ | 164,168 |
| | $ | — |
| | $ | 420,924 |
|
Operating income (loss) | 60,144 |
| | (10,409 | ) | | (7,145 | ) | | 42,590 |
|
Equity in losses from real estate ventures | — |
| | (2,439 | ) | | — |
| | (2,439 | ) |
Depreciation and amortization | 1,957 |
| | 2,501 |
| | 250 |
| | 4,708 |
|
Capital expenditures | 1,638 |
| | 2,187 |
| | — |
| | 3,825 |
|
|
|
| | | | | | |
Three months ended March 31, 2018 | | | | | | | |
Revenues | $ | 267,116 |
| | $ | 161,850 |
| | $ | — |
| | $ | 428,966 |
|
Operating income (loss) | 63,411 |
| (1) | (8,760 | ) | (2) | (6,567 | ) | | 48,084 |
|
Equity in losses from real estate ventures | — |
| | (6,560 | ) | | — |
| | (6,560 | ) |
Depreciation and amortization | 2,037 |
| | 2,289 |
| | 261 |
| | 4,587 |
|
Capital expenditures | 911 |
| | 3,071 |
| | 5 |
| | 3,987 |
|
| |
(1) | Operating income includes $3,490 of income from a settlement of a long-standing dispute related to the Master Settlement Agreement. |
| |
(2) | Operating income includes $2,469 of litigation settlement and judgment income. |
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
14. CONDENSED CONSOLIDATING FINANCIAL INFORMATION
The condensed consolidating financial information is based upon the following subsidiaries being subsidiary guarantors of unsecured debt securities that may be issued by the Company: VGR Holding LLC; Liggett Group LLC; Liggett Vector Brands LLC; Vector Research LLC; Vector Tobacco Inc.; Liggett & Myers Holdings Inc.; 100 Maple LLC; V.T. Aviation LLC; VGR Aviation LLC; Eve Holdings LLC; Zoom E-Cigs LLC; and DER Holdings LLC. Each of the subsidiary guarantors is 100% owned, directly or indirectly, by the Company, and all guarantees are full and unconditional and joint and several. The Company’s investments in its consolidated subsidiaries are presented under the equity method of accounting.
The Company and the guarantors have filed a shelf registration statement for the offering of debt securities on a delayed or continuous basis and the Company is including this condensed consolidating financial information in connection therewith. Any such debt securities may be issued by the Company and guaranteed by the guarantors, but any such debt securities would not be guaranteed by any of the Company’s other subsidiaries, including those subsidiaries other than DER Holdings LLC that are engaged in the real estate businesses conducted through its subsidiary New Valley.
Presented herein are Condensed Consolidating Balance Sheets as of March 31, 2019 and 2018, the related Condensed Consolidating Statements of Operations for the three months ended March 31, 2019 and 2018, and the related Condensed Consolidating Statements of Cash Flows for the three months ended March 31, 2019 and 2018 of Vector Group Ltd. (Parent/Issuer), the guarantor subsidiaries (Subsidiary Guarantors) and the subsidiaries that are not guarantors (Subsidiary Non-Guarantors).
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
CONDENSED CONSOLIDATING BALANCE SHEETS
|
| | | | | | | | | | | | | | | | | | | |
| | | March 31, 2019 | | |
| | | | | Subsidiary | | | | Consolidated |
| Parent/ | | Subsidiary | | Non- | | Consolidating | | Vector Group |
| Issuer | | Guarantors | | Guarantors | | Adjustments | | Ltd. |
ASSETS: | | | | | | | | | |
Current assets: | | | | | | | | | |
Cash and cash equivalents | $ | 203,828 |
| | $ | 47,903 |
| | $ | 60,907 |
| | $ | — |
| | $ | 312,638 |
|
Investment securities at fair value | 134,652 |
| | — |
| | — |
| | — |
| | 134,652 |
|
Accounts receivable - trade, net | — |
| | 15,034 |
| | 21,406 |
| | — |
| | 36,440 |
|
Intercompany receivables | 39,561 |
| | — |
| | — |
| | (39,561 | ) | | — |
|
Inventories | — |
| | 101,977 |
| | — |
| | — |
| | 101,977 |
|
Income taxes receivable, net | — |
| | — |
| | 5,036 |
| | (5,036 | ) | | — |
|
Restricted assets | — |
| | 1,124 |
| | 4,288 |
| | — |
| | 5,412 |
|
Other current assets | 4,923 |
| | 7,400 |
| | 23,919 |
| | — |
| | 36,242 |
|
Total current assets | 382,964 |
| | 173,438 |
| | 115,556 |
| | (44,597 | ) | | 627,361 |
|
Property, plant and equipment, net | 453 |
| | 37,695 |
| | 47,493 |
| | — |
| | 85,641 |
|
Investments in real estate, net | — |
| | — |
| | 26,777 |
| | — |
| | 26,777 |
|
Long-term investments (of which $54,202 were carried at fair value) | 66,768 |
| | — |
| | — |
| | — |
| | 66,768 |
|
Investments in real estate ventures | — |
| | — |
| | 138,393 |
| | — |
| | 138,393 |
|
Operating lease right of use assets | 7,882 |
| | 5,684 |
| | 111,157 |
| | — |
| | 124,723 |
|
Investments in consolidated subsidiaries | 412,964 |
| | 230,191 |
| | — |
| | (643,155 | ) | | — |
|
Restricted assets | 1,502 |
| | 904 |
| | 3,910 |
| | — |
| | 6,316 |
|
Goodwill and other intangible assets, net | — |
| | 107,511 |
| | 158,554 |
| | — |
| | 266,065 |
|
Prepaid pension costs | — |
| | 24,179 |
| | — |
| | — |
| | 24,179 |
|
Other assets | 13,083 |
| | 13,624 |
| | 36,226 |
| | — |
| | 62,933 |
|
Total assets | $ | 885,616 |
| | $ | 593,226 |
| | $ | 638,066 |
| | $ | (687,752 | ) | | $ | 1,429,156 |
|
LIABILITIES AND STOCKHOLDERS' DEFICIENCY: | | | | | | | | | |
Current liabilities: | | | | | | | | | |
Current portion of notes payable and long-term debt | $ | — |
| | $ | 40,798 |
| | $ | 2,782 |
| | $ | (2,500 | ) | | $ | 41,080 |
|
Current portion of employee benefits | — |
| | 875 |
| | — |
| | — |
| | 875 |
|
Intercompany payables | — |
| | 84 |
| | 39,477 |
| | (39,561 | ) | | — |
|
Income taxes payable, net | 11,524 |
| | 3,213 |
| | — |
| | (5,036 | ) | | 9,701 |
|
Litigation accruals and current payments due under the Master Settlement Agreement | — |
| | 77,213 |
| | — |
| | — |
| | 77,213 |
|
Current operating lease liability | 991 |
| | 1,817 |
| | 17,606 |
| | — |
| | 20,414 |
|
Other current liabilities | 39,649 |
| | 58,995 |
| | 54,914 |
| | (224 | ) | | 153,334 |
|
Total current liabilities | 52,164 |
| | 182,995 |
| | 114,779 |
| | (47,321 | ) | | 302,617 |
|
Notes payable, long-term debt and other obligations, less current portion | 1,360,242 |
| | 27,639 |
| | 27,564 |
| | (27,500 | ) | | 1,387,945 |
|
Fair value of derivatives embedded within convertible debt | 21,075 |
| | — |
| | — |
| | — |
| | 21,075 |
|
Non-current employee benefits | 46,118 |
| | 15,566 |
| | — |
| | — |
| | 61,684 |
|
Deferred income taxes, net | (11,596 | ) | | 18,307 |
| | 33,112 |
| | — |
| | 39,823 |
|
Non-current operating lease liability | 7,808 |
| | 4,346 |
| | 116,845 |
| | — |
| | 128,999 |
|
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement | 394 |
| | 35,413 |
| | 41,307 |
| | — |
| | 77,114 |
|
Total liabilities | 1,476,205 |
| | 284,266 |
| | 333,607 |
| | (74,821 | ) | | 2,019,257 |
|
Commitments and contingencies |
|
| |
|
| |
|
| |
|
| |
|
|
Stockholders' (deficiency) equity attributed to Vector Group Ltd. | (590,589 | ) | | 308,960 |
| | 303,971 |
| | (612,931 | ) | | (590,589 | ) |
Non-controlling interest | — |
| | — |
| | 488 |
| | — |
| | 488 |
|
Total stockholders' (deficiency) equity | (590,589 | ) | | 308,960 |
| | 304,459 |
| | (612,931 | ) | | (590,101 | ) |
Total liabilities and stockholders' deficiency | $ | 885,616 |
| | $ | 593,226 |
| | $ | 638,066 |
| | $ | (687,752 | ) | | $ | 1,429,156 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
CONDENSED CONSOLIDATING BALANCE SHEETS |
| | | | | | | | | | | | | | | | | | | |
| | | December 31, 2018 | | |
| | | | | Subsidiary | | | | Consolidated |
| Parent/ | | Subsidiary | | Non- | | Consolidating | | Vector Group |
| Issuer | | Guarantors | | Guarantors | | Adjustments | | Ltd. |
ASSETS: | | | | | | | | | |
Current assets: | | | | | | | | | |
Cash and cash equivalents | $ | 474,880 |
| | $ | 23,308 |
| | $ | 86,393 |
| | $ | — |
| | $ | 584,581 |
|
Investment securities at fair value | 131,569 |
| | — |
| | — |
| | — |
| | 131,569 |
|
Accounts receivable - trade, net | — |
| | 15,440 |
| | 18,806 |
| | — |
| | 34,246 |
|
Intercompany receivables | 38,391 |
| | — |
| | — |
| | (38,391 | ) | | — |
|
Inventories | — |
| | 90,997 |
| | — |
| | — |
| | 90,997 |
|
Income taxes receivable, net | — |
| | — |
| | 1,268 |
| | (1,268 | ) | | — |
|
Restricted assets | — |
| | 1,124 |
| | 3,353 |
| | — |
| | 4,477 |
|
Other current assets | 1,500 |
| | 6,475 |
| | 18,376 |
| | — |
| | 26,351 |
|
Total current assets | 646,340 |
| | 137,344 |
| | 128,196 |
| | (39,659 | ) | | 872,221 |
|
Property, plant and equipment, net | 506 |
| | 38,562 |
| | 47,668 |
| | — |
| | 86,736 |
|
Investments in real estate, net | — |
| | — |
| | 26,220 |
| | — |
| | 26,220 |
|
Long-term investments (of which $54,628 were carried at fair value) | 66,259 |
| | — |
| | — |
| | — |
| | 66,259 |
|
Investments in real estate ventures | — |
| | — |
| | 141,105 |
| | — |
| | 141,105 |
|
Investments in consolidated subsidiaries | 431,288 |
| | 252,113 |
| | — |
| | (683,401 | ) | | — |
|
Restricted assets | 1,495 |
| | 901 |
| | 3,910 |
| | — |
| | 6,306 |
|
Goodwill and other intangible assets, net | — |
| | 107,511 |
| | 159,100 |
| | — |
| | 266,611 |
|
Prepaid pension costs | — |
| | 23,869 |
| | — |
| | — |
| | 23,869 |
|
Other assets | 13,121 |
| | 13,384 |
| | 33,672 |
| | — |
| | 60,177 |
|
Total assets | $ | 1,159,009 |
| | $ | 573,684 |
| | $ | 539,871 |
| | $ | (723,060 | ) | | $ | 1,549,504 |
|
LIABILITIES AND STOCKHOLDERS' DEFICIENCY: | | | | | | | | | |
Current liabilities: | | | | | | | | | |
Current portion of notes payable and long-term debt | $ | 226,343 |
| | $ | 29,480 |
| | $ | 311 |
| | $ | — |
| | $ | 256,134 |
|
Current portion of fair value of derivatives embedded within convertible debt | 6,635 |
| | — |
| | — |
| | — |
| | 6,635 |
|
Current portion of employee benefits | — |
| | 875 |
| | — |
| | — |
| | 875 |
|
Intercompany payables | — |
| | 479 |
| | 37,912 |
| | (38,391 | ) | | — |
|
Income taxes payable, net | 5,257 |
| | 1,263 |
| | — |
| | (1,268 | ) | | 5,252 |
|
Litigation accruals and current payments due under the Master Settlement Agreement | — |
| | 36,871 |
| | — |
| | — |
| | 36,871 |
|
Other current liabilities | 55,915 |
| | 72,094 |
| | 51,144 |
| | — |
| | 179,153 |
|
Total current liabilities | 294,150 |
| | 141,062 |
| | 89,367 |
| | (39,659 | ) | | 484,920 |
|
Notes payable, long-term debt and other obligations, less current portion | 1,354,219 |
| | 2,349 |
| | 30,129 |
| | — |
| | 1,386,697 |
|
Fair value of derivatives embedded within convertible debt | 24,789 |
| | — |
| | — |
| | — |
| | 24,789 |
|
Non-current employee benefits | 45,615 |
| | 15,673 |
| | — |
| | — |
| | 61,288 |
|
Deferred income taxes, net | (13,084 | ) | | 17,732 |
| | 32,763 |
| | — |
| | 37,411 |
|
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement | 1,379 |
| | 38,179 |
| | 62,207 |
| | — |
| | 101,765 |
|
Total liabilities | 1,707,068 |
| | 214,995 |
| | 214,466 |
| | (39,659 | ) | | 2,096,870 |
|
Commitments and contingencies |
|
| |
|
| |
|
| |
|
| |
|
|
Stockholders' (deficiency) equity attributed to Vector Group Ltd. | (548,059 | ) | | 358,689 |
| | 324,712 |
| | (683,401 | ) | | (548,059 | ) |
Non-controlling interest | — |
| | — |
| | 693 |
| | — |
| | 693 |
|
Total stockholders' (deficiency) equity | (548,059 | ) | | 358,689 |
| | 325,405 |
| | (683,401 | ) | | (547,366 | ) |
Total liabilities and stockholders' deficiency | $ | 1,159,009 |
| | $ | 573,684 |
| | $ | 539,871 |
| | $ | (723,060 | ) | | $ | 1,549,504 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
|
| | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, 2019 | | |
| | | | | Subsidiary | | | | Consolidated |
| Parent/ | | Subsidiary | | Non- | | Consolidating | | Vector Group |
| Issuer | | Guarantors | | Guarantors | | Adjustments | | Ltd. |
Revenues | $ | — |
| | $ | 256,875 |
| | $ | 164,168 |
| | $ | (119 | ) | | $ | 420,924 |
|
Expenses: | | | | | | | | | |
Cost of sales | — |
| | 177,303 |
| | 108,717 |
| | — |
| | 286,020 |
|
Operating, selling, administrative and general expenses | 9,831 |
| | 16,691 |
| | 65,911 |
| | (119 | ) | | 92,314 |
|
Management fee expense | — |
| | 2,993 |
| | — |
| | (2,993 | ) | | — |
|
Operating (loss) income | (9,831 | ) | | 59,888 |
| | (10,460 | ) | | 2,993 |
| | 42,590 |
|
Other income (expenses): | | | | | | | | | |
Interest expense | (36,548 | ) | | (967 | ) | | (229 | ) | | 224 |
| | (37,520 | ) |
Change in fair value of derivatives embedded within convertible debt | 10,349 |
| | — |
| | — |
| | — |
| | 10,349 |
|
Equity in losses from real estate ventures | — |
| | — |
| | (2,439 | ) | | — |
| | (2,439 | ) |
Equity in earnings from investments | 1,362 |
| | — |
| | — |
| | — |
| | 1,362 |
|
Equity in earnings in consolidated subsidiaries | 35,265 |
| | (10,414 | ) | | — |
| | (24,851 | ) | | — |
|
Net gain recognized on investment securities | 4,773 |
| | — |
| | — |
| | — |
| | 4,773 |
|
Management fee income | 2,993 |
| | — |
| | — |
| | (2,993 | ) | | — |
|
Other, net | 1,810 |
| | 153 |
| | 704 |
| | — |
| | 2,667 |
|
Income (loss) before provision for income taxes | 10,173 |
| | 48,660 |
| | (12,424 | ) | | (24,627 | ) | | 21,782 |
|
Income tax benefit (expense) | 4,780 |
| | (14,948 | ) | | 3,419 |
| | — |
| | (6,749 | ) |
Net income (loss) | 14,953 |
| | 33,712 |
| | (9,005 | ) | | (24,627 | ) | | 15,033 |
|
Net income attributed to non-controlling interest | — |
| | — |
| | (80 | ) | | — |
| | (80 | ) |
Net income (loss) attributed to Vector Group Ltd. | $ | 14,953 |
| | $ | 33,712 |
| | $ | (9,085 | ) | | $ | (24,627 | ) | | $ | 14,953 |
|
Comprehensive income attributed to non-controlling interest | $ | — |
| | $ | — |
| | $ | (80 | ) | | $ | — |
| | $ | (80 | ) |
Comprehensive income (loss) attributed to Vector Group Ltd. | $ | 15,534 |
| | $ | 33,947 |
| | $ | (9,085 | ) | | $ | (24,862 | ) | | $ | 15,534 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
|
| | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, 2018 | | |
| | | | | Subsidiary | | | | Consolidated |
| Parent/ | | Subsidiary | | Non- | | Consolidating | | Vector Group |
| Issuer | | Guarantors | | Guarantors | | Adjustments | | Ltd. |
Revenues | $ | — |
| | $ | 267,235 |
| | $ | 161,850 |
| | $ | (119 | ) | | $ | 428,966 |
|
Expenses: | | | | | | | | | |
Cost of sales | — |
| | 184,962 |
| | 109,313 |
| | — |
| | 294,275 |
|
Operating, selling, administrative and general expenses | 9,096 |
| | 16,275 |
| | 63,824 |
| | (119 | ) | | 89,076 |
|
Litigation settlement and judgment income | — |
| | — |
| | (2,469 | ) | | — |
| | (2,469 | ) |
Management fee expense | — |
| | 2,877 |
| | — |
| | (2,877 | ) | | — |
|
Operating (loss) income | (9,096 | ) | | 63,121 |
| | (8,818 | ) | | 2,877 |
| | 48,084 |
|
Other income (expenses): | | | | | | | | | |
Interest expense | (45,231 | ) | | (667 | ) | | (49 | ) | | — |
| | (45,947 | ) |
Change in fair value of derivatives embedded within convertible debt | 10,567 |
| | — |
| | — |
| | — |
| | 10,567 |
|
Equity in losses from real estate ventures | — |
| | — |
| | (6,560 | ) | | — |
| | (6,560 | ) |
Net gains (losses) recognized on investment securities | 1,066 |
| | (4,406 | ) | | — |
| | — |
| | (3,340 | ) |
Equity in earnings from investments | 1,162 |
| | — |
| | — |
| | — |
| | 1,162 |
|
Equity in earnings in consolidated subsidiaries | 34,421 |
| | (5,716 | ) | | — |
| | (28,705 | ) | | — |
|
Management fee income | 2,877 |
| | — |
| | — |
| | (2,877 | ) | | — |
|
Other, net | 527 |
| | 777 |
| | 342 |
| | — |
| | 1,646 |
|
(Loss) income before provision for income taxes | (3,707 | ) | | 53,109 |
| | (15,085 | ) | | (28,705 | ) | | 5,612 |
|
Income tax benefit (expense) | 10,918 |
| | (15,860 | ) | | 2,994 |
| | — |
| | (1,948 | ) |
Net income (loss) | 7,211 |
| | 37,249 |
| | (12,091 | ) | | (28,705 | ) | | 3,664 |
|
Net loss attributed to non-controlling interest | — |
| | — |
| | 3,547 |
| | — |
| | 3,547 |
|
Net income (loss) attributed to Vector Group Ltd. | $ | 7,211 |
| | $ | 37,249 |
| | $ | (8,544 | ) | | $ | (28,705 | ) | | $ | 7,211 |
|
Comprehensive loss attributed to non-controlling interest | $ | — |
| | $ | — |
| | $ | 3,547 |
| | $ | — |
| | $ | 3,547 |
|
Comprehensive income (loss) attributed to Vector Group Ltd. | $ | 7,461 |
| | $ | 37,387 |
| | $ | (8,544 | ) | | $ | (28,843 | ) | | $ | 7,461 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
|
| | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, 2019 | | |
| | | | | Subsidiary | | | | Consolidated |
| Parent/ | | Subsidiary | | Non- | | Consolidating | | Vector Group |
| Issuer | | Guarantors | | Guarantors | | Adjustments | | Ltd. |
Net cash provided by (used in) operating activities | $ | 22,468 |
| | $ | 72,093 |
| | $ | (10,746 | ) | | $ | (64,089 | ) | | $ | 19,726 |
|
Cash flows from investing activities: | | | | | | | | | |
Sale of investment securities | 7,759 |
| | — |
| | — |
| | — |
| | 7,759 |
|
Maturities of investment securities | 11,308 |
| | — |
| | — |
| | — |
| | 11,308 |
|
Purchase of investment securities | (20,623 | ) | | — |
| | — |
| | — |
| | (20,623 | ) |
Investments in real estate ventures | — |
| | — |
| | (871 | ) | | — |
| | (871 | ) |
Purchase of subsidiaries | — |
| | — |
| | (668 | ) | | — |
| | (668 | ) |
Distributions from investments in real estate ventures | — |
| | — |
| | 1,134 |
| | — |
| | 1,134 |
|
Increase in cash surrender value of life insurance policies | 38 |
| | (276 | ) | | — |
| | — |
| | (238 | ) |
Increase in restricted assets | (7 | ) | | — |
| | — |
| | — |
| | (7 | ) |
Investments in subsidiaries | (1,794 | ) | | — |
| | — |
| | 1,794 |
| | — |
|
Capital expenditures | — |
| | (1,638 | ) | | (2,187 | ) | | — |
| | (3,825 | ) |
Pay downs of investment securities | 258 |
| | — |
| | — |
| | — |
| | 258 |
|
Investments in real estate, net | — |
| | — |
| | (641 | ) | | — |
| | (641 | ) |
Net cash used in investing activities | (3,061 | ) | | (1,914 | ) | | (3,233 | ) | | 1,794 |
| | (6,414 | ) |
Cash flows from financing activities: | | | | | | | | | |
Repayments of debt | (230,000 | ) | | (372 | ) | | (94 | ) | | — |
| | (230,466 | ) |
Borrowings under revolver | — |
| | 94,400 |
| | — |
| | — |
| | 94,400 |
|
Repayments on revolver | — |
| | (87,420 | ) | | — |
| | — |
| | (87,420 | ) |
Capital contributions received | — |
| | 400 |
| | 1,394 |
| | (1,794 | ) | | — |
|
Intercompany dividends paid | — |
| | (52,589 | ) | | (11,500 | ) | | 64,089 |
| | — |
|
Dividends and distributions on common stock | (60,459 | ) | | — |
| | — |
| | — |
| | (60,459 | ) |
Distributions to non-controlling interest | — |
| | — |
| | (285 | ) | | — |
| | (285 | ) |
Net cash used in financing activities | (290,459 | ) | | (45,581 | ) | | (10,485 | ) | | 62,295 |
| | (284,230 | ) |
Net (decrease) increase in cash, cash equivalents and restricted cash | (271,052 | ) | | 24,598 |
| | (24,464 | ) | | — |
| | (270,918 | ) |
Cash, cash equivalents and restricted cash, beginning of period | 474,880 |
| | 23,849 |
| | 93,000 |
| | — |
| | 591,729 |
|
Cash, cash equivalents and restricted cash, end of period | $ | 203,828 |
| | $ | 48,447 |
| | $ | 68,536 |
| | $ | — |
| | $ | 320,811 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
|
| | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, 2018 | | |
| | | | | Subsidiary | | | | Consolidated |
| Parent/ | | Subsidiary | | Non- | | Consolidating | | Vector Group |
| Issuer | | Guarantors | | Guarantors | | Adjustments | | Ltd. |
Net cash provided by (used in) operating activities | $ | 18,670 |
| | $ | 74,867 |
| | $ | (9,669 | ) | | $ | (43,154 | ) | | $ | 40,714 |
|
Cash flows from investing activities: | | | | | | | | | |
Sale of investment securities | 2,357 |
| | — |
| | — |
| | — |
| | 2,357 |
|
Maturities of investment securities | 8,112 |
| | — |
| | — |
| | — |
| | 8,112 |
|
Purchase of investment securities | (4,364 | ) | | — |
| | — |
| | — |
| | (4,364 | ) |
Investments in real estate ventures | — |
| | — |
| | (533 | ) | | — |
| | (533 | ) |
Investments in real estate, net | — |
| | — |
| | (355 | ) | | — |
| | (355 | ) |
Distributions from investments in real estate ventures | — |
| | — |
| | 219 |
| | — |
| | 219 |
|
Increase in cash surrender value of life insurance policies | 11 |
| | (47 | ) | | — |
| | — |
| | (36 | ) |
Increase in restricted assets | (4 | ) | | — |
| | — |
| | — |
| | (4 | ) |
Repayments of notes receivable | 20,000 |
| | — |
| | 32 |
| | (20,000 | ) | | 32 |
|
Pay downs of investment securities | 446 |
| | — |
| | — |
| | — |
| | 446 |
|
Investments in subsidiaries | (605 | ) | | — |
| | — |
| | 605 |
| | — |
|
Capital expenditures | (5 | ) | | (911 | ) | | (3,071 | ) | | — |
| | (3,987 | ) |
Net cash provided by (used in) investing activities | 25,948 |
| | (958 | ) | | (3,708 | ) | | (19,395 | ) | | 1,887 |
|
Cash flows from financing activities: | | | | | | | | | |
Repayments of debt | — |
| | (20,422 | ) | | (68 | ) | | 20,000 |
| | (490 | ) |
Borrowings under revolver | — |
| | 55,170 |
| | — |
| | — |
| | 55,170 |
|
Repayments on revolver | — |
| | (61,728 | ) | | — |
| | — |
| | (61,728 | ) |
Capital contributions received | — |
| | 350 |
| | 255 |
| | (605 | ) | | — |
|
Intercompany dividends paid | — |
| | (40,119 | ) | | (3,035 | ) | | 43,154 |
| | — |
|
Dividends and distributions on common stock | (57,187 | ) | | — |
| | — |
| | — |
| | (57,187 | ) |
Net cash used in financing activities | (57,187 | ) | | (66,749 | ) | | (2,848 | ) | | 62,549 |
| | (64,235 | ) |
Net (decrease) increase in cash, cash equivalents and restricted cash | (12,569 | ) | | 7,160 |
| | (16,225 | ) | | — |
| | (21,634 | ) |
Cash, cash equivalents and restricted cash, beginning of period | 194,719 |
| | 20,175 |
| | 96,043 |
| | — |
| | 310,937 |
|
Cash, cash equivalents and restricted cash, end of period | $ | 182,150 |
| | $ | 27,335 |
| | $ | 79,818 |
| | $ | — |
| | $ | 289,303 |
|
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(Dollars in Thousands, Except Per Share Amounts)
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of Vector Group Ltd.’s financial statements with a narrative from our management’s perspective. Our MD&A is divided into the following sections:
•Overview and Recent Developments
•Results of Operations
•Summary of Real Estate Investments
•Liquidity and Capital Resources
Please read this discussion along with our MD&A and audited financial statements as of and for the year ended December 31, 2018 and Notes thereto, included in our 2018 Annual Report on Form 10-K, and our Condensed Consolidated Financial Statements and related Notes as of and for the quarterly period ended March 31, 2019 and 2018.
Overview
We are a holding company and are engaged principally in two business segments:
| |
• | Tobacco: the manufacture and sale of cigarettes in the United States through our Liggett Group LLC (“Liggett”) and Vector Tobacco Inc. (“Vector Tobacco”) subsidiaries, and |
| |
• | Real Estate: the real estate business through our New Valley LLC (“New Valley”) subsidiary, which owns Douglas Elliman Realty, LLC (“Douglas Elliman”) and is seeking to acquire or invest in additional real estate properties or projects. Douglas Elliman operates the largest residential brokerage company in the New York metropolitan area and also conducts residential real estate brokerage operations in South Florida, Southern California, Connecticut, Massachusetts and Aspen, Colorado. On December 31, 2018, New Valley increased its ownership of Douglas Elliman from 70.59% to 100%. |
Recent Developments
Maturity of 7.5% Variable Interest Senior Convertible Notes due 2019. In January 2019, we paid $230,000 of principal and $8,102 of accrued interest as full payment of our 7.5% Convertible Notes that matured on January 15, 2019.
Recent Developments in Litigation
Mississippi Dispute. In January 2016, the Attorney General for Mississippi filed a motion in state Chancery Court in Jackson County, Mississippi to enforce the March 1996 settlement agreement alleging that Liggett owes Mississippi at least $27,000 in damages (including interest), and $20,000 in punitive damages and attorneys’ fees. In April 2017, the Chancery Court ruled that the settlement agreement should be enforced and referred the matter to a Special Master for further proceedings to determine the amount of damages, if any, to be awarded. In May 2017, Liggett filed a Petition for Interlocutory Appeal to the Mississippi Supreme Court, which was denied. Liggett filed a demand for arbitration regarding two specific issues and moved in Chancery Court to compel arbitration and stay the proceedings pending before the Special Master. In June 2018, the Chancery Court granted Liggett’s motion to compel arbitration and stayed the proceedings before the Special Master pending completion of the arbitration. On March 21, 2019, the arbitration panel issued its decision as to the two specific issues before it: (i) the panel ruled in favor of Liggett on the first issue, finding that $294,000 of proceeds from Eve Holdings’ 1999 brand sale should not be included in Liggett’s pre-tax income, which would reduce the amount of compensatory damages, if any, that would be due to Mississippi; and (ii) ruled in favor of Mississippi on the second issue, finding that compensatory damages to Mississippi, if any, would be based on 0.5% of Liggett’s annual pre-tax income for the term of the settlement agreement. The matter will now proceed to the next phase of the proceeding before the designated Special Master to address damages, if any. Liggett continues to assert that the April 2017 Chancery Court order is in error because the most favored nations provision in the settlement agreement eliminated all of Liggett’s
payment obligations to Mississippi, and Liggett intends to appeal that order, as may be necessary, after the Special Master phase of the case concluded.
Critical Accounting Policies
There are no material changes except for the item listed below from the critical accounting policies set forth in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K, for the year ended December 31, 2018. Please refer to that section and the information below for disclosures regarding the critical accounting policies related to our business.
Leasing Standard. On January 1, 2019, we adopted ASU No. 2016-02- Leases (Topic 842), therefore, our lease accounting policy has been modified as discussed in Note 3 to our condensed consolidated financial statements.
Results of Operations
The following discussion provides an assessment of our results of operations, capital resources and liquidity and should be read in conjunction with our condensed consolidated financial statements included elsewhere in this report. The condensed consolidated financial statements include the accounts of Liggett, Vector Tobacco, Liggett Vector Brands, New Valley and other less significant subsidiaries.
For purposes of this discussion and other consolidated financial reporting, our business segments for the three months ended March 31, 2019 and 2018 were Tobacco and Real Estate. The Tobacco segment consisted of the manufacture and sale of cigarettes. The Real Estate segment included our investment in New Valley, which includes Douglas Elliman, Escena, Sagaponack and investments in real estate ventures.
|
| | | | | | | | |
| Three Months Ended | |
| March 31, | |
| 2019 | | 2018 | |
Revenues: | | | | |
Tobacco | $ | 256,756 |
| | $ | 267,116 |
| |
Real estate | 164,168 |
| | 161,850 |
| |
Total revenues | $ | 420,924 |
| | $ | 428,966 |
| |
Operating income (loss): | | | | |
Tobacco | $ | 60,144 |
| | $ | 63,411 |
| (1) |
Real estate | (10,409 | ) | | (8,760 | ) | (2) |
Corporate and Other | (7,145 | ) | | (6,567 | ) | |
Total operating income | $ | 42,590 |
| | $ | 48,084 |
| |
____________________
| |
(1) | Operating income includes $3,490 of income from a settlement of a long-standing dispute related to the Master Settlement Agreement. |
| |
(2) | Operating income includes $2,469 of litigation settlement and judgment income. |
Three Months Ended March 31, 2019 Compared to Three Months Ended March 31, 2018
Revenues. Total revenues were $420,924 for the three months ended March 31, 2019 compared to $428,966 for the three months ended March 31, 2018. The $8,042 (1.9%) decline in revenues was primarily due to a $10,360 decline in Tobacco revenues, which was primarily related to decreased unit sales volume offset by $2,318 increase in Real Estate revenues, which was primarily related to an increase in Douglas Elliman’s brokerage revenues.
Cost of sales. Total cost of sales was $286,020 for the three months ended March 31, 2019 compared to $294,275 for the three months ended March 31, 2018. The $8,255 (2.8%) decline in cost of sales was primarily due to a $7,659 decline in Tobacco cost of sales primarily related to lower sales volume. This was offset by a $596 decline in Real Estate cost of sales, which was primarily related to Douglas Elliman’s agent commissions.
Expenses. Operating, selling, general and administrative expenses were $92,314 for the three months ended March 31, 2019 compared to $89,076 for the same period last year. The $3,238 (3.6%) increase was due to a $2,094 increase in Real Estate operating, selling, general and administrative expenses primarily at Douglas Elliman, a $566 increase in Tobacco operating, selling, general and administrative expenses and a $578 increase in Corporate and Other expense.
Operating income. Operating income was $42,590 for the three months ended March 31, 2019 compared to $48,084 for the same period last year, a decline of $5,494 (11.4%). Real Estate operating income declined by $1,649 primarily related to Douglas Elliman’s operations, while Tobacco operating income declined by $3,267 and Corporate and Other operating loss increased by $578.
Other income (expenses). Other expenses were $20,808 and $42,472 for the three months ended March 31, 2019 and 2018, respectively. For the three months ended March 31, 2019, other expenses primarily consisted of interest expense of $37,520, equity in losses from real estate ventures of $2,439. This was offset by income of $10,349 from changes in fair value of derivatives embedded within convertible debt, equity in earnings from investments of $1,362, net gains recognized on investment securities of $4,773, and other income of $2,667. For the three months ended March 31, 2018, other expenses primarily consisted of interest expense of $45,947, net losses recognized on investment securities of $3,340, and equity in losses from real estate ventures of $6,560. This was offset by income of $10,567 from changes in fair value of derivatives embedded within convertible debt, equity in earnings from investments of $1,162, and other income of $1,646.
The value of the embedded derivatives is contingent on changes in interest rates of debt instruments maturing over the duration of the convertible debt, our stock price as well as projections of future cash and stock dividends over the term of the debt. The interest rate component of the value of the embedded derivative is computed by calculating an equivalent non-convertible, unsecured and subordinated borrowing cost. This rate is determined by calculating the implied rate on each of the two series of our Convertible Notes after removing the embedded option value within the convertible security. This rate is based upon market observable inputs and influenced by our stock price, convertible bond trading price, risk-free interest rates and stock volatility. We recognized benefits from reductions in the value of embedded derivatives of $10,349 and $10,567 for the years ended March 31, 2019 and 2018, respectively.
Income before provision for income taxes. Income before income taxes was $21,782 and $5,612 for the three months ended March 31, 2019 and 2018, respectively.
Income tax expense. Income tax expense was $6,749 for the three months ended March 31, 2019 compared to income tax expense of $1,948 for the three months ended March 31, 2018. Our provision for income taxes in interim periods is based on expected income, statutory rates, permanent differences, valuation allowances against deferred tax assets, and any tax planning opportunities available to us. For interim financial reporting, we estimate the annual effective income tax rate based on full year projections and apply the annual effective income tax rate against year-to-date pretax income (loss) to record income tax expense, adjusted for discrete items, if any. We refine annual estimates as new information becomes available. Our effective tax rates for the three months ended March 31, 2019 and 2018 were impacted by non-deductibility of interest expense and non-deductible compensation. Our income tax expense for the three months ended March 31, 2019 is lower than the income tax expense for the three months ended March 31, 2018 due to tax planning opportunities available within the Tax Cuts and Jobs Act (“The Tax Act”). The tax planning opportunities relate to our conclusion from guidance issued in the fourth quarter of 2018 that we will be able to allocate some of our interest expense to our real estate business and the deduction of this interest expense will not be limited. (The Tax Act generally limits a corporation’s interest expense deduction to 30% of taxable income before interest, depreciation and amortization from 2018 to 2021 and then taxable income before interest thereafter for non-excepted trade or businesses. However, one such excepted trade or business is any electing real property trade or business, which portions of our real estate segment may qualify. Interest expense allocable to an excepted trade or business is not subject to limitation.) The Tax Act also permits us to carry forward disallowed interest expense indefinitely. Even after the allocation of some of our interest expense to the real estate segment, we expect a portion of our interest expense in 2019 and future years to be disallowed as a tax deduction and, based on current projections, we do not expect any of this disallowed interest expense to be tax deductible in the future. Consequently, as part of our annual effective tax rate, we have established an interest expense carryforward deferred tax asset and corresponding valuation allowance for any disallowed interest expense in 2019. Additionally, for the three months ended March 31, 2019 our annual effective tax rate includes nondeductible executive compensation due to guidance issued in August 2018. We continue to analyze the impact of the nondeductible items on our operations and capital structure. For the three months ended March 31, 2019, our income tax expense was also lower than our estimated annual effective rate by $114 primarily due to an income tax deduction for stock-based compensation.
Tobacco.
Tobacco revenues. Liggett increased the list price of EAGLE 20’s by $1.10 per carton in February 2019 and $1.00 per carton in September 2018. Liggett also increased the list price of PYRAMID, LIGGETT SELECT, EVE and GRAND PRIX by $1.10 per carton in February 2019, $1.00 per carton in September 2018, and $0.90 per carton in March 2018.
All of our Tobacco sales were in the discount category in 2019 and 2018. For the three months ended March 31, 2019, Tobacco revenues were $256,756 compared to $267,116 for the three months ended March 31, 2018. Revenues declined by $10,360 (3.9%) due primarily to a 7.1% (158.6 million units) decline in unit sales volume. We believe our unit volume for the three months ended March 31, 2018 was increased as a result of wholesalers purchasing product in anticipation of the March 2018 price increase. Because the 2019 price increase occurred in February 2019 instead of March 2019, we believe such incremental wholesaler purchasing activity was lower in the three months ended March 31, 2019 compared to the three months ended March 31, 2018. We believe the absence of this incremental buying by wholesalers was a significant contributor to the decline from the 2018 first quarter to the comparable 2019 period.
Tobacco cost of sales. The major components of our Tobacco cost of sales were as follows:
|
| | | | | | | | | | | |
| | | | Three Months Ended | |
| | | | March 31, | |
| | | | 2019 | | 2018 | |
| | | | | |
Manufacturing overhead, raw materials and labor | | $ | 28,475 |
| | $ | 30,552 |
| |
Customer shipping and handling | | | 1,492 |
| | 1,352 |
| |
Federal Excise Taxes, net | | | 104,633 |
| | 112,801 |
| |
FDA expense | | | 6,345 |
| | 5,605 |
| |
MSA expense, net of market share exemption | | | 36,358 |
| | 34,652 |
| (1) |
| Total cost of sales | | | $ | 177,303 |
| | $ | 184,962 |
| |
(1) Includes $3,490 reduction in expense from a settlement of a long-standing dispute related to the Master Settlement Agreement.
The Tobacco segment’s MSA expense is included in cost of sales. Under the terms of the MSA, we have no payment obligations except to the extent that our tobacco subsidiaries’ market share of the U.S. Cigarette market exceeds 1.92%. The calculation of our benefit from the MSA is an estimate based on U.S. domestic taxable cigarette shipments. As of March 31, 2019, we estimate taxable shipments in the U.S. will decline by 5% in 2019. Our annual MSA liability changes by approximately $1,700 for each percentage change in estimated shipment volumes in the U.S. market. For the three months ended March 31, 2019, the estimated decline in taxable shipments in excess of the annual MSA inflation adjustment resulted in an increase in cost of sales of $1,100 because the value of Liggett’s market share exemption declined compared to the three months ended March 31, 2018.
Tobacco gross profit was $79,453 for the three months ended March 31, 2019 compared to $82,154 for the three months ended March 31, 2018, a decline of $2,701. Tobacco gross profit for the three months ended March 31, 2018 included a $3,490 reduction in cost of sales from a settlement of a long-standing dispute related to the Master Settlement Agreement. This was offset by an increase in gross profit for the three months ended March 31, 2019 of $789, primarily attributable to increased pricing associated with the EAGLE 20’s brand. After careful market analysis and based on our successful results, in September 2018, we began the process of shifting focus from volume to income growth by increasing pricing on EAGLE 20’s and PYRAMID, as well as other brands, in connection with industry-wide price increases. As a percentage of revenue (excluding Federal Excise Taxes), Tobacco gross profit decreased from 53.2% in the 2018 period to 52.2% in the 2019 period. The decrease is the result of the impact of the 2018 MSA settlement offset by increased EAGLE 20’s pricing as discussed above.
The unfavorable sales volume growth was primarily due to a decline in unit volumes of all brands except EAGLE 20’s. Despite the price increases on EAGLE 20’s in September 2018 and March 2019, EAGLE 20’s unit sales volumes increased by 6.8% for the three months ended March 31, 2019 compared to the three months ended March 31, 2018 as a result of momentum from Liggett’s strategy to invest promotional expenses in the brand, which are included as a reduction of revenues. EAGLE 20’s percentage of Liggett’s total unit sales increased from approximately 50% in the three months ended March 31, 2018 to approximately 57% for the three months ended March 31, 2019.
Tobacco expenses. Tobacco operating, selling, general and administrative expenses, excluding settlements and judgments, were $19,309 for the three months ended March 31, 2019 compared to $18,743 for the three months ended March 31, 2018. Tobacco product liability legal expenses, including settlements and judgments, were $1,463 and $1,508 for the three months ended March 31, 2019 and 2018, respectively.
Tobacco operating income. Tobacco operating income was $60,144 for the three months ended March 31, 2019 compared to $63,411 for the same period last year. Tobacco operating income for the three months ended March 31, 2018 included a $3,490 reduction in cost of sales from a settlement of a long-standing dispute related to the Master Settlement Agreement. This was offset by an increase in operating income for the three months ended March 31, 2019 of $223 primarily attributable to increased EAGLE 20’s pricing, as discussed above, partially offset by increased operating, selling, general and administrative expenses.
Real Estate.
Real Estate revenues. Real Estate revenues were $164,168 and $161,850 for the three months ended March 31, 2019 and 2018, respectively. Real Estate revenues increased by $2,318 (1.4%), which was primarily related to an increase of $2,197 in Douglas Elliman’s commission and other brokerage income. The increase in commission and other brokerage income was primarily related to increased commission and other brokerage income from Douglas Elliman’s developing marketing and existing-home sales in New York City. This amount was partially offset by declines in existing-home sales in Douglas Elliman’s West market (Los Angeles and Aspen), Northeast market and in its Southeast market, which consists entirely of South Florida.
Real Estate revenues and cost of sales for the three months ended March 31, 2019 and 2018, respectively, were as follows:
|
| | | | | | | |
| Three Months Ended |
| March 31, |
| 2019 | | 2018 |
Real Estate Revenues: | | | |
Commission and other brokerage income | $ | 152,313 |
| | $ | 150,116 |
|
Property management revenue | 8,351 |
| | 8,338 |
|
Title fees | 1,233 |
| | 989 |
|
Sales on facilities primarily from Escena | 2,271 |
| | 2,407 |
|
Total real estate revenues | $ | 164,168 |
| | $ | 161,850 |
|
| | | |
Real Estate Cost of Sales: | | | |
Real estate agent commissions | $ | 107,350 |
| | $ | 108,026 |
|
Cost of sales on facilities primarily from Escena | 1,087 |
| | 1,092 |
|
Title fees | 280 |
| | 195 |
|
Total real estate cost of sales | $ | 108,717 |
| | $ | 109,313 |
|
Brokerage cost of sales. Douglas Elliman real estate agent commissions declined by $676 as a result of changes in the sales mix between markets with varying agent commission percentages.
Douglas Elliman’s gross margin on real estate brokerage income increased from 28.0% for the three months ended March 31, 2018 to 29.5% for the three months ended March 31, 2019 primarily as a result of an increase in commission income generated from its development marketing division and existing-home sales in New City market, which traditionally earn higher gross margins.
Real Estate expenses. Real Estate operating, selling, general and administrative expenses, excluding settlements and judgments, were $65,860 and $63,766 for the three months ended March 31, 2019 and 2018, respectively. The increased expenses were associated with increased expenses in Douglas Elliman’s brokerage administrative expenses.
Real Estate operating (loss) income. The Real Estate segment had operating loss of $10,409 for the three months ended March 31, 2019 and operating loss of $8,760 for the three months ended March 31, 2018, an increase of $1,649. Real Estate operating loss for the three months ended March 31, 2018 included $2,469 litigation settlement and judgment income. The remaining difference of $820 was the result of the increase in Douglas Elliman’s gross profit offset by the increase in operating, selling, general and administrative expenses.
Corporate and Other.
Corporate and Other loss. The operating loss at the Corporate and Other segment was $7,145 for the three months ended March 31, 2019 compared to $6,567 for the same period in 2018.
Summary of Real Estate Investments
We own and seek to acquire investment interests in various domestic and international real estate projects through debt and equity investments. Our real estate investments primarily include the following projects as of March 31, 2019:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (Dollars in Thousands. Area and Unit Information in Ones) |
| Location | Date of Initial Investment | Percentage Owned (1) | Net Cash Invested (Returned) | Cumulative Earnings (Losses) | Carrying Value as of March 31, 2019 | Future Capital Commit- ments from New Valley (2) | Projected Residential and/or Hotel Area | Projected Commercial Space | Projected Number of Residential Lots, Units and/or Hotel Rooms | Actual/Projected Construction Start Date | Projected Construction End Date |
| | | | | | | | | | | | | | | |
Sagaponack | Sagaponack, NY | April 2015 | 100 | % | $ | 16,691 |
| $ | — |
| $ | 16,691 |
| $ | — |
| TBD |
| | N/A |
| | 1 |
| R | N/A | N/A |
Escena, net | Master planned community, golf course, restaurant and shop in Palm Springs, CA | March 2008 | 100 | % | 2,450 |
| 7,636 |
| 10,086 |
| — |
| 450 |
| Acres | — |
| | 667 450 |
| R Lots H | N/A | N/A |
Investments in real estate, net | | | | $ | 19,141 |
| $ | 7,636 |
| $ | 26,777 |
| $ | — |
| | | | | | | | |
| | | | | | | | | | | | | | | |
Investments in real estate ventures: | | | | | | | | | | | | | | | |
10 Madison Square West (1107 Broadway) | Flatiron District/NoMad neighborhood, Manhattan, NY | October 2011 | 5.0 | % | $ | (43,671 | ) | $ | 43,671 |
| $ | — |
| $ | — |
| 260,000 |
| SF | 20,000 |
| SF | 124 |
| R | August 2012 | Completed |
The Marquand (11 East 68th Street) | Upper East Side, Manhattan, NY | December 2011 | 18.0 | % | (2,355 | ) | 3,007 |
| 652 |
| — |
| 90,000 |
| SF | — |
| | 29 |
| R | June 2012 | Completed |
11 Beach Street | TriBeCa, Manhattan, NY | June 2012 | 49.5 | % | 4,790 |
| 9,043 |
| 13,833 |
| — |
| 97,000 |
| SF | — |
| | 27 |
| R | May 2014 | Completed |
20 Times Square (701 Seventh Avenue) | Times Square, Manhattan, NY | August 2012 | 7.9 | % | (7,827 | ) | 8,484 |
| 657 |
| — |
| 252,000 |
| SF | 80,000 |
| SF | 452 |
| H | September 2013 | Completed |
111 Murray Street | TriBeCa, Manhattan, NY | May 2013 | 9.5 | % | 4,448 |
| (701 | ) | 3,747 |
| — |
| 330,000 |
| SF | 1,700 |
| SF | 157 |
| R | September 2014 | June 2019 |
160 Leroy Street (3) | West Greenwich Village, Manhattan, NY | March 2013 | 3.1 | % | (626 | ) | 1,602 |
| 976 |
| — |
| 130,000 |
| SF | — |
| | 57 |
| R | Fall 2015 | Completed |
The Dutch (25-19 43rd Avenue) | Long Island City, NY | May 2014 | 9.9 | % | (799 | ) | 1,399 |
| 600 |
| | 65,000 |
| SF | — |
| | 86 |
| R | September 2014 | Completed |
87 Park (8701 Collins Avenue) | Miami Beach, FL | December 2013 | 15.0 | % | 19,630 |
| 4,337 |
| 23,967 |
| — |
| 160,000 |
| SF | TBD |
| | 70 |
| R | October 2015 | December 2019 |
125 Greenwich Street (3) | Financial District, Manhattan, NY | August 2014 | 13.4 | % | 7,992 |
| (7,992 | ) | — |
| — |
| 306,000 |
| SF | 16,000 |
| SF | 273 |
| R | March 2015 | February 2020 |
West Hollywood Edition (9040 Sunset Boulevard) | West Hollywood, CA | October 2014 | 48.5 | % | (1,552 | ) | (197 | ) | (1,749 | ) | — |
| 210,000 |
| SF | — |
| | 20 190 |
| R H | May 2015 | June 2019 |
The XI (76 Eleventh Avenue) | West Chelsea, Manhattan, NY | May 2015 | 5.1 | % | 17,000 |
| 6,935 |
| 23,935 |
| — |
| 630,000 |
| SF | 85,000 |
| SF | 236 137 |
| R H | September 2016 | June 2020 |
Monad Terrace | Miami Beach, FL | May 2015 | 18.2 | % | 7,635 |
| 2,005 |
| 9,640 |
| — |
| 160,000 |
| SF | — |
| | 59 |
| R | May 2016 | December 2020 |
Takanasee (805 Ocean Ave) | Long Branch, NJ | December 2015 | 22.8 | % | 5,921 |
| 2,109 |
| 8,030 |
| — |
| 63,000 |
| SF | — |
| | 13 |
| R | June 2017 | TBD |
15 East 19th St | Brooklyn, NY | April 2017 | 9.8 | % | 402 |
| 92 |
| 494 |
| — |
| 24,000 |
| SF | — |
| | 33 |
| R | August 2017 | July 2019 |
Dime (209 Havemeyer St) | Brooklyn, NY | November 2017 | 19.8 | % | 8,650 |
| 1,490 |
| 10,140 |
| — |
| 100,000 |
| SF | 150,000 |
| SF | 177 |
| R | May 2017 | December 2019 |
352 6th Avenue | Brooklyn, NY | February 2019 | 37.0 | % | 500 |
| 6 |
| 506 |
| — |
| 5,200 |
| SF | — |
| | 4 |
| R | September 2019 | September 2020 |
Condominium and Mixed Use Development | | | | $ | 20,138 |
| $ | 75,290 |
| $ | 95,428 |
| $ | — |
| | | | | | | | |
| | | | | | | | | | | | | | | |
Maryland Portfolio | Primarily Baltimore County, MD | July 2012 | 7.6 | % | $ | 774 |
| $ | (774 | ) | $ | — |
| $ | — |
| N/A |
| | N/A |
| | 5,517 |
| R | N/A | N/A |
ST Portfolio |
| November 2013 | 16.3 | % | (1,669 | ) | 1,669 |
| — |
| — |
| N/A |
|
| N/A |
|
| N/A |
|
| N/A | N/A |
Apartment Buildings | | | | $ | (895 | ) | $ | 895 |
| $ | — |
| $ | — |
| | | | | | | | |
| | | | | | | | | | | | | | | |
Park Lane Hotel (36 Central Park South) | Central Park South, Manhattan, NY | November 2013 | 5.2 | % | $ | 29,470 |
| $ | (15,008 | ) | $ | 14,462 |
| $ | — |
| 446,000 |
| SF | — |
| | 628 |
| H | N/A | N/A |
215 Chrystie Street | Lower East Side, Manhattan, NY | December 2012 | 18.4 | % | (4,551 | ) | 4,551 |
| — |
| — |
| 246,000 |
| SF | — |
| | 367 |
| H | June 2014 | Completed |
Coral Beach and Tennis Club | Coral Beach, Bermuda | December 2013 | 49.0 | % | 6,048 |
| (4,200 | ) | 1,848 |
| — |
| 52 |
| Acres | — |
| | 101 |
| H | N/A | N/A |
Hotels | | | | $ | 30,967 |
| $ | (14,657 | ) | $ | 16,310 |
| $ | — |
| | | | | | | | |
| | | | | | | | | | | | | | | |
The Plaza at Harmon Meadow (700 Plaza Drive) | Secaucus, NJ | March 2015 | 49.0 | % | $ | 4,810 |
| $ | (3,071 | ) | $ | 1,739 |
| $ | — |
| — |
| — | 219,000 |
| SF | — |
| — | N/A | N /A |
Wynn Las Vegas Retail (3131 Las Vegas Blvd South) | Las Vegas, NV | December 2016 | 1.6 | % | 5,042 |
| 2,303 |
| 7,345 |
| — |
| — |
| — | 160,000 |
| SF | — |
| — | N/A | N/A |
Commercial | | | | $ | 9,852 |
| $ | (768 | ) | $ | 9,084 |
| $ | — |
| | | | | | | | |
| | | | | | | | | | | | | | | |
Witkoff GP Partners (4) | Multiple | March 2017 | 15.0 | % | $ | 14,142 |
| $ | (784 | ) | $ | 13,358 |
| $ | 5,768 |
| N/A |
| | N/A |
| | N/A |
| | N/A | N/A |
1 QPS Tower (23-10 Queens Plaza South) | Long Island City, NY | December 2012 | 45.4 | % | (11,882 | ) | 13,666 |
| 1,784 |
| — |
| N/A |
| | N/A |
| | N/A |
| | March 2014 | Completed |
Witkoff EB-5 Capital Partners | Multiple | September 2018 | 49 | % | (387 | ) | 758 |
| 371 |
| 9,010 |
| N/A |
| | N/A |
| | N/A |
| | N/A | N/A |
Diverse Real Estate Portfolio | | | | $ | 1,873 |
| $ | 13,640 |
| $ | 15,513 |
| $ | 14,778 |
| | | | | | | | |
| | | | | | | | | | | | | | | |
Investments in real estate ventures | | | | $ | 61,935 |
| $ | 74,400 |
| $ | 136,335 |
| $ | 14,778 |
|
|
| | | | | | | |
| | | | | | | | | | | | | | | |
Total Carrying Value | | | | $ | 81,076 |
| $ | 82,036 |
| $ | 163,112 |
| | | | | | | | | |
(1) The Percentage Owned reflects our estimated current ownership percentage. Our actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners. |
(2) This column only represents capital commitments required under the various joint venture agreements. However, many of the operating agreements provide for the operating partner to call capital. If a joint venture partner, such as New Valley, declines to fund the capital call, then the partner’s ownership percentage could either be diluted or, in some situations, the character of a funding member’s contribution would be converted from a capital contribution to a member loan. |
(3) Carrying value as of March 31, 2019, includes non-controlling interest of $488 and $0 respectively. |
(4) The Witkoff GP Partners venture consisted of a $1,859 investment in 500 Broadway, a $7,308 investment in Fontainebleau Las Vegas, $466 investment in 1568 Broadway debt, and a $3,725 investment in 701 7th debt. |
N/A - Not applicable | SF - Square feet | H - Hotel rooms | | | | | | | | | | | |
TBD -To be determined | R - Residential Units | R Lots - Residential lots | | | | | | | | | | | |
Other investments in real estate ventures relate to an investment in an insurance consulting company by Douglas Elliman with a carrying value of $2,058 as of March 31, 2019. New Valley capitalizes net interest expense into the carrying value of its ventures whose projects were under development. Net capitalized interest costs included in Carrying Value as of March 31, 2019 were $24,716. This amount is included in the “Cumulative Earnings (Losses)” column in the table above. During the three months ended March 31, 2019, New Valley capitalized $1,315 of interest costs and utilized (reversed) $930 of previously capitalized interest in connection with the recognition of equity in earnings, gains and liquidations from various ventures.
Liquidity and Capital Resources
Cash, cash equivalents and restricted cash decreased by $270,918 and $21,634 for the three months ended March 31, 2019 and 2018, respectively.
Cash provided from operations was $19,726 and $40,714 for the three months ended March 31, 2019 and 2018, respectively. The decline primarily related to increases in inventory and accounts receivable balances in the tobacco segment in the 2019 period compared to the 2018 period, lower distributions from real estate ventures in the 2019 period as well as a decline in operating income in the real estate segment in the 2019 period.
Cash used in investing activities was $6,414 for the three months ended March 31, 2019 and cash provided by investing activities was $1,887 for the three months ended March 31, 2018. In the first three months of 2019, cash used in investing activities was for the purchase of investment securities of $20,623, investments in real estate ventures of $871, capital expenditures of $3,825, investments in real estate, net of $641, an increase in cash surrender value of corporate-owned life insurance policies of $238, acquisition of a business of $668, and increase in restricted assets of $7. This was offset by the sale of investment securities of $7,759, pay downs of investment securities of $258, maturities of investment securities of $11,308, and distributions from investments in real estate ventures of $1,134. In the first three months of 2018, cash provided by investing activities was from the sale of investment securities of $2,357, pay downs of investment securities of $446, the maturities of investment securities of $8,112, distributions from investments in real estate ventures of $219, and repayments of notes receivable of $32. This was offset by the purchase of investment securities of $4,364, investments in real estate ventures of $533, capital expenditures of $3,987, investments in real estate, net of $355, an increase in cash surrender value of corporate-owned life insurance policies of $36, and an increase in restricted assets of $4.
Cash used in financing activities was $284,230 and $64,235 for the three months ended March 31, 2019 and 2018, respectively. In the first three months of 2019, cash was used for the dividends and distributions on common stock of $60,459, repayments of debt of $230,466, distributions to non-controlling interest of $285, offset by net borrowings of debt under the revolver of $6,980. In the first three months of 2018, cash was used for the dividends and distributions on common stock of $57,187, repayments of debt of $490, and net repayments of debt under the revolver of $6,558.
For the years ended December 31, 2018, 2017 and 2016, cash payments of dividends and distributions on common stock exceeded cash from operations by $43,533, $79,902 and $101,311, respectively. The terms of our 10.5% Senior Notes due 2026 contain covenants that place significant limitations on our ability to pay dividends and distributions in the future. See “10.5% Senior Notes due 2026” below. For the next twelve months beginning March 31, 2019, we have significant liquidity commitments at the corporate level (not including our tobacco and real estate operations) that require the use of existing cash resources. These include repayment of the $232,000 of principal outstanding on our convertible notes due April 2020 (assuming they do not convert into shares of our common stock) and cash interest expense of approximately $110,400, which includes $34,125 from our 10.5% Senior Notes due 2026 that were issued in November 2018, dividends on our outstanding common shares of approximately $241,100, which is based on a historical quarterly cash dividend of $0.40 per share, and other corporate expenses and taxes.
In order to meet these liquidity requirements as well as other liquidity needs in the normal course of business, we have in the past used cash flows from operations as well as existing cash and cash equivalents, which have, in the past, been generated from operations, monetization of investments and proceeds from debt issuances. Should these resources be insufficient to meet upcoming liquidity needs, we may also liquidate investment securities and other long-term investments, or, if available, draw on Liggett’s credit facility. While there are actions we can take to reduce our liquidity needs, there can be no assurance that such measures will be successful. As of March 31, 2019, we had cash and cash equivalents of $312,638 (including $59,445 of cash at Douglas Elliman and $47,667 of cash at Liggett), investment securities, which were carried at $134,652 (see Note 5 to condensed consolidated financial statements), and long-term investments, which were carried at $66,768 (and, based on market prices as of March 31, 2019, had a fair value of $120,598, including in-transit redemptions (see Note 6 to condensed consolidated financial statements)). As of March 31, 2019, our investments in real estate ventures were carried at $138,393 and our investments in real estate, net were carried at $26,777.
Corporate Impact of the Tax Act. The Tax Act limits our interest expense deduction to 30% of taxable income before interest, depreciation and amortization from 2018 to 2021 and then taxable income before interest thereafter for non-excepted trade or businesses. One such excepted trade or business is any electing real property trade or business, which portions of our real estate segment may qualify. Interest expense allocable to an excepted trade or business is not subject to limitation. The Tax Act permits us to carry forward disallowed interest expense indefinitely. Due to our high degree of leverage, a portion of our interest expense in future years may not be deductible, which would increase the after-tax cost of any new debt financings as well as the refinancing of our existing debt. We expect a portion of our interest expense in 2019 and future years to be disallowed as a tax deduction and, based on current projections, we do not expect any of this disallowed interest expense to be tax deductible in the future. Consequently, as part of our annual effective tax rate, we have established an interest expense carryforward deferred tax asset and corresponding valuation allowance for any disallowed interest expense in 2019. We continue to analyze the impact of the nondeductible interest on our operations and capital structure.
Tobacco Litigation. As of March 31, 2019, verdicts have been entered in 16 Engle progeny cases against Liggett. Liggett has paid $39,773, including interest and attorney’s fees, to satisfy the judgments entered against it. It is possible that additional cases could be decided unfavorably.
Notwithstanding the comprehensive nature of the Engle Progeny Settlements, approximately 70 plaintiffs’ claims remain outstanding. Therefore, we and Liggett may still be subject to periodic adverse judgments which could have a material adverse effect on our consolidated financial position, results of operations and cash flows.
Management cannot predict the cash requirements related to any future settlements or judgments, including cash required to bond any appeals, and there is a risk that those requirements will not be able to be met. Management is unable to make a reasonable estimate of the amount or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases. It is possible that our consolidated financial position, results of operations or cash flows could be materially adversely affected by an unfavorable outcome in any such tobacco-related litigation.
Vector.
6.125% Senior Secured Notes due 2025. In January 2017, we issued $850,000 of our 6.125% Senior Secured Notes due 2025 (“6.125% Senior Secured Notes”). The indenture governing our 6.125% Senior Secured Notes (the “2025 Indenture”) contains covenants that restrict the payment of dividends if our consolidated earnings before interest, taxes, depreciation and amortization (“Consolidated EBITDA”), as defined in the 2025 Indenture, for the most recently ended four full quarters is less than $75,000. The 2025 Indenture also restricts the incurrence of debt if our Leverage Ratio and our Secured Leverage Ratio, as defined in the 2025 Indenture, exceed 3.0 and 1.5, respectively. Our Leverage Ratio is defined in the 2025 Indenture as the ratio of our guaranteeing subsidiaries’ total debt less the fair market value of our cash, investment securities and long-term investments to Consolidated EBITDA, as defined in the 2025 Indenture. Our Secured Leverage Ratio is defined in the 2025 Indenture in the same manner as the Leverage Ratio, except that secured indebtedness is substituted for indebtedness. The following table summarizes the requirements of these financial covenants and the results of the calculation, as defined in the 2025 Indenture.
|
| | | | |
| | Indenture | | March 31, 2019 |
Covenant | | Requirement | |
Consolidated EBITDA, as defined | | $75,000 | | $325,651 |
Leverage ratio, as defined | | <3.0 to 1 | | 2.72 to 1 |
Secured leverage ratio, as defined | | <1.5 to 1 | | 1.12 to 1 |
As of March 31, 2019 and December 31, 2018, we were in compliance with all debt covenants related to the 2025 Indenture.
10.5% Senior Notes due 2026. On November 2, 2018, we issued $325,000 of our 10.5% Senior Notes due 2026. The aggregate net proceeds from the sale of the 10.5% Senior Notes were approximately $315,000 after deducting underwriting discounts, commissions, fees and offering expenses. We used some of the net cash proceeds from the issuance of our 10.5% Senior Notes to retire, the principal amount, plus accrued and unpaid interest on our outstanding 7.5% Variable Interest Senior Convertible Notes in January 2019, and may use the remaining proceeds for general corporate purposes (including to redeem, repurchase, repay or otherwise retire the principal amount, plus accrued and unpaid interest on our outstanding 5.5% Variable Interest Senior Convertible Notes due 2020, at, or prior to, their maturity).
The 10.5% Senior Notes bear interest at a rate of 10.5% per year, payable semi-annually on May 1 and November 1 of each year, beginning on May 1, 2019, and mature on November 1, 2026. Interest will accrue from November 2, 2018. We may redeem some or all of the 10.5% Senior Notes at any time prior to November 1, 2021 at a make-whole redemption price. On or after November 1, 2021, we may redeem some or all of the 10.5% Senior Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to the redemption date. In addition, any time prior to November 1, 2021, we may redeem up to 40% of the aggregate outstanding amount of the 10.5% Senior Notes with the net proceeds of certain equity offerings at 110.5%
of the aggregate principal amount of the 10.5% Senior Notes, plus accrued and unpaid interest, if any, to the redemption date, if at least 60% of the aggregate principal amount of the 10.5% Senior Notes originally issued remains outstanding after such redemption, and the redemption occurs within 90 days of the closing of such equity offering. In the event of a change of control, as defined in the indenture, each holder of the 10.5% Senior Notes will have the right to require us to make an offer to repurchase some or all of our 10.5% Senior Notes at a repurchase price equal to 101% of the aggregate principal amount of the 10.5% Senior Notes plus accrued and unpaid interest to the date of purchase. If we sell certain assets and does not apply the proceeds as required pursuant to the indenture, we must offer to repurchase the 10.5% Senior Notes at the prices listed in the indenture.
The 10.5% Senior Notes are guaranteed subject to certain customary automatic release provisions on a joint and several basis by all of our wholly-owned domestic subsidiaries that are engaged in the conduct of our cigarette businesses, and by DER Holdings LLC, through which we indirectly own a 100% interest in Douglas Elliman as of December 31, 2018. DER Holdings LLC does not guarantee our 6.125% Senior Secured Notes.
The indenture governing our 10.5% Senior Notes due 2026 (the “2026 Indenture”) restricts our ability to pay dividends and make certain other distributions subject to certain exceptions, including exceptions for (1) dividends and other distributions in an amount up to 50% of our consolidated net income, plus certain specified proceeds received us, if no event of default has occurred, and we are in compliance with a Fixed Charge Coverage Ratio (as defined in the 2026 Indenture) of at least 2.0x, and (2) dividends and other distributions in an unlimited amount, if no event of default has occurred and we are in compliance with a Net Leverage Ratio (as defined in the 2026 Indenture) no greater than 4.0x. As a result, absent an event of default, we can pay dividends if the Net Leverage ratio is below 4.0x, regardless of the value of the Fixed Charge Coverage Ratio at the time. The 2026 Indenture also restricts our ability to incur debt if our Fixed Charge Coverage Ratio is less than 2.0x, and restricts our ability to secure debt other than secured debt incurred pursuant to a Secured Leverage Ratio no greater than 3.75x, unless the 10.5% Senior Notes are secured on an equal and ratable basis. In addition, the 2026 Indenture restricts our ability to spin-off or transfer New Valley and its subsidiaries as a whole, or DER Holdings LLC and its subsidiaries (including Douglas Elliman) as a whole, unless (1) such spin-off or transfer complies with the covenants restricting mergers and asset sales, or (2) our Net Leverage Ratio is no greater than 4.0x. Our Fixed Charge Coverage Ratio is defined in the 2026 Indenture as the ratio of our Consolidated EBITDA to our Fixed Charges (each as defined in the 2026 Indenture). Our Net Leverage Ratio is defined in the 2026 Indenture as the ratio of our and our guaranteeing subsidiaries’ total debt less our cash, cash equivalents, and the fair market value of our investment securities, long-term investments, investments in real estate, net, and investments in real estate ventures, to Consolidated EBITDA, as defined in the 2026 Indenture. Our Secured Leverage Ratio is defined in the 2026 Indenture as the ratio of our and our guaranteeing subsidiaries’ total secured debt, to Consolidated EBITDA, as defined in the 2026 Indenture.
|
| | | | |
Covenant | | Indenture Requirement | | March 31, 2019 |
Consolidated EBITDA, as defined | | N/A | | $249,578 |
Fixed charge coverage ratio, as defined | | >2.0 to 1 | | 2.56 to 1 |
Net leverage ratio, as defined | | <4.0 to 1 | | 2.77 to 1 |
Secured leverage ratio, as defined | | <3.75 to 1 | | 0.56 to 1 |
As of March 31, 2019 and December 31, 2018, we were in compliance with all of the debt covenants governing our 10.5% Senior Notes.
Liggett Credit Facility and Liggett Term Loan Under Credit Facility. As of March 31, 2019, $37,770 was outstanding under the revolving and term loan portions of the credit facility, all of which was classified as current liabilities. Availability as determined under the Credit Facility was $20,488 based on eligible collateral at March 31, 2019. At March 31, 2019, management believed that Liggett was in compliance with all covenants under the credit facility; Liggett’s EBITDA, as defined, were $247,842 for the last twelve months ended March 31, 2019.
Anticipated Liquidity Obligations. We and our subsidiaries have significant indebtedness and debt service obligations. As of March 31, 2019, we and our subsidiaries had total outstanding indebtedness of $1,475,800, of which $232,000 of our 5.5% variable interest senior convertible notes mature in 2020, $850,000 of our 6.125% Senior Secured Notes mature in 2025, and $325,000 of our 10.5% Senior Notes mature in 2026. There is a risk that we will not be able to generate sufficient funds to repay our debt. If we cannot service our fixed charges, it would have a material adverse effect on our business and results of operations.
Our 7.5% convertible notes matured on January 15, 2019 and we used the proceeds of the offering of our 10.5% Senior Notes to pay $230,000 of principal and $8,102 of accrued interest on the maturity date. We may utilize the remaining proceeds from the offering of our 10.5% Senior Notes that were not applied to the repayment of our 7.5% convertible notes to repay, repurchase, retire or redeem our 5.5% variable interest senior convertible notes due April 2020 at or prior to the maturity of these convertible notes or for general corporate purposes, including to pursue business opportunities. We will otherwise need to use our liquidity resources to repay the $232,000 of principal outstanding on these notes when they mature in April 2020, either through use of current liquidity on hand or through external financings.
We believe that our cigarette and real estate operations are positive cash-flow-generating units and will continue to be able to sustain their operations without any significant liquidity concerns.
In order to meet the above liquidity requirements as well as other anticipated liquidity needs in the normal course of business, we had cash and cash equivalents of approximately $312,600, investment securities at fair value of approximately $134,700, long-term investments with an estimated value of approximately $120,600, including $3,984 of in-transit redemptions, and availability under Liggett’s credit facility of approximately $20,500 at March 31, 2019. Management currently anticipates that these amounts, as well as expected cash flows from our operations, proceeds from public and/or private debt and equity financing, management fees and other payments from subsidiaries should be sufficient to meet our liquidity needs over the next 12 months. We may acquire or seek to acquire additional operating businesses through merger, purchase of assets, stock acquisition or other means, or to make other investments, which may limit our liquidity otherwise available.
On a quarterly basis, we evaluate our debt securities available for sale and equity securities without readily determinable fair values that do not qualify for the NAV practical expedient to determine whether an impairment has occurred. If so, we also make a determination if such impairment is considered temporary or other-than-temporary. We believe that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven. The impairment indicators that are taken into consideration as part of our analysis include (a) a significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee, (b) a significant adverse change in the regulatory, economic, or technological environment of the investee, (c) a significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates, and (d) factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants.
Market Risk
We are exposed to market risks principally from fluctuations in interest rates, foreign currency exchange rates and equity prices. We seek to minimize these risks through our regular operating and financing activities and our long-term investment strategy. Our market risk management procedures cover all market risk sensitive financial instruments.
As of March 31, 2019, approximately $37,800 of our outstanding debt at face value had variable interest rates determined by various interest rate indices, which increases the risk of fluctuating interest rates. Our exposure to market risk includes interest rate fluctuations in connection with our variable rate borrowings, which could adversely affect our cash flows. As of March 31, 2019, we had no interest rate caps or swaps. Based on a hypothetical 100 basis point increase or decrease in interest rates (1%), our annual interest expense could increase or decrease by approximately $378.
In addition, as of March 31, 2019, $207,700 ($232,000 principal amount) of outstanding debt had a variable interest rate determined by the amount of the dividends on our common stock. The difference between the stated value of the debt and carrying value is due principally to certain embedded derivatives, which were separately valued and recorded upon issuance, and debt issuance costs. Changes to the estimated fair value of these embedded derivatives are reflected within our statements of operations as “Change in fair value of derivatives embedded within convertible debt.” The value of the embedded derivative is contingent on changes in interest rates of debt instruments maturing over the duration of the convertible debt as well as projections of future cash and stock dividends over the term of the debt and changes in the closing stock price at the end of each quarterly period. Based on a hypothetical 100 basis point increase or decrease in interest rates (1%), our annual “Change in fair value of derivatives embedded within convertible debt” could increase or decrease by approximately $103 resulting from the embedded derivative associated with our 5.5% variable interest senior convertible debentures due 2020. An increase in our quarterly dividend rate by $0.10 per share would increase interest expense by approximately $5,000 per year.
We have estimated the fair market value of the embedded derivatives based principally on the results of a valuation model. The value of the embedded derivatives is contingent on changes in interest rates of debt instruments maturing over the duration of the convertible debt, our stock price as well as projections of future cash and stock dividends over the term of the debt. The interest rate component of the value of the embedded derivative is computed by calculating an equivalent non-convertible, unsecured and subordinated borrowing cost. This rate is determined by calculating the implied rate on our 5.5% Convertible Notes when removing the embedded option value within the convertible security. This rate is based upon market observable inputs and influenced by our stock price, convertible bond trading price, risk-free interest rates and stock volatility. The range of estimated fair market values of our embedded derivatives was between $21,125 and $21,022. We recorded the fair market value of our embedded
derivatives at the approximate midpoint of the range at $21,075 as of March 31, 2019. The estimated fair market value of our embedded derivatives could change significantly based on future market conditions.
We held debt securities available for sale totaling $88,605 as of March 31, 2019. See Note 5 to our condensed consolidated financial statements. Adverse market conditions could have a significant effect on the value of these investments.
Equity Security Price Risk
As of March 31, 2019, we held various investments in equity securities with a total fair value of $100,249, of which $46,047 represents equity securities at fair value and $54,202 represents equity securities that qualify for the NAV practical expedient. The latter securities represent long-term investments in various investment partnerships. These investments are illiquid and their ultimate realization is subject to the performance of the underlying entities. See Note 5 and 6 to our condensed consolidated financial statements, respectively, for more details on equity securities at fair value and equity securities that qualify for the NAV practical expedient. The impact to our condensed consolidated statement of operations related to equity securities fluctuates based on changes in their fair value.
We record changes in the fair value of equity securities in net income. To the extent that we continue to hold equity securities, our operating results may fluctuate significantly. Based on our equity securities held as of March 31, 2019, a hypothetical decrease of 10% in the price of these equity securities would reduce the fair value of the investments and, accordingly, our net income by approximately $10,025.
New Accounting Pronouncements
Refer to Note 1, Summary of Significant Accounting Policies, to our financial statements for further information on New Accounting Pronouncements.
Legislation and Regulation
There are no material changes from the Legislation and Regulation section set forth in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K for the year ended December 31, 2018, except as follows. The following paragraph of “Item. 1. Business--Legislation and Regulation-Advertising and Warnings on Packaging” from our Annual Report on Form 10-K, which is referenced therein, is amended and restated in its entirety:
In June 2011, FDA issued a final rule that would have modified the required warnings that appear on cigarette packages and in cigarette advertisements. The rule would have required each cigarette package and advertisement to bear one of nine new textual warning statements accompanied by graphic images. The warnings would have had to appear on at least the top 50% of the front and rear panels of cigarette packages and occupy at least 20% of cigarette advertisements. In August 2011, a number of cigarette manufacturers, including Liggett, filed a federal lawsuit against FDA challenging the constitutionality of these new graphic images on First Amendment and other grounds and seeking an injunction staying implementation of the graphic images, and other related labeling requirements. In February 2012, on First Amendment grounds, the court granted the industry’s motion for summary judgment permanently enjoining implementation of FDA’s graphic warnings regulation. This decision was affirmed on appeal and FDA did not seek United States Supreme Court review. FDA instead decided to undertake research to support a new graphic warnings rule. In October 2016, the American Academy of Pediatrics and other public health groups filed a federal lawsuit claiming that the FDA had unlawfully withheld and unreasonably delayed action on the rule. In September 2018, the District Court for the District of Massachusetts issued an order granting summary judgment to the plaintiffs and ordered FDA to provide an expedited schedule for the issuance of the rule. FDA subsequently proposed a new deadline for the final rule of May 2021. The plaintiffs responded by asking the court to order FDA to publish a final rule by January 31, 2020. In March 2019, the court ordered FDA to issue a proposed rule by August 15, 2019, and a final rule by March 15, 2020. Should FDA ultimately issue new graphic warnings that are deemed constitutionally valid, the decision provides that such warnings would go into effect 15 months after they are issued (June 15, 2021 based on the court-ordered timeline). We cannot predict how the inclusion of new warnings, if ultimately required by FDA in new rulemaking, would impact product sales or whether it would have a material adverse effect on us.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
In addition to historical information, this report contains “forward-looking statements” within the meaning of the federal securities law. Forward-looking statements include information relating to our intent, belief or current expectations, primarily with respect to, but not limited to:
| |
• | legislation and regulations, |
| |
• | related industry developments (including trends affecting our business, financial condition and results of operations). |
We identify forward-looking statements in this report by using words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may be,” “objective,” “plan,” “seek,” “predict,” “project” and “will be” and similar words or phrases or their negatives.
The forward-looking information involves important risks and uncertainties that could cause our actual results, performance or achievements to differ materially from our anticipated results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, without limitation, the following:
| |
• | general economic and market conditions and any changes therein, due to acts of war and terrorism or otherwise, |
| |
• | governmental regulations and policies, |
| |
• | effects of industry competition, |
| |
• | impact of business combinations, including acquisitions and divestitures, both internally for us and externally in the tobacco industry, |
| |
• | impact of legislation on our results of operations and product costs, i.e. the impact of federal legislation providing for regulation of tobacco products by FDA, |
| |
• | impact of substantial increases in federal, state and local excise taxes, |
| |
• | uncertainty related to product liability and other tobacco-related litigations including the Engle progeny cases pending in Florida and other individual and class action cases where certain plaintiffs have alleged compensatory and punitive damage amounts ranging into the hundreds of million and even billions of dollars; and, |
| |
• | potential additional payment obligations for us under the MSA and other settlement agreements with the states. |
Further information on the risks and uncertainties to our business include the risk factors discussed above in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and under Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission.
Although we believe the expectations reflected in these forward-looking statements are based on reasonable assumptions, there is a risk that these expectations will not be attained and that any deviations will be material. The forward-looking statements speak only as of the date they are made.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Market Risk” is incorporated herein by reference.
ITEM 4. CONTROLS AND PROCEDURES
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered
by this report, and, based on their evaluation, our principal executive officer and principal financial officer have concluded that these controls and procedures are effective.
There have not been any changes in our internal control over financial reporting that occurred during the first quarter of 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We implemented internal controls to ensure we adequately evaluated our contracts and properly assessed the impact of the new accounting standard related to revenue recognition. There were no significant changes to our internal control over financial reporting due to the adoption of the new standard.
PART II
OTHER INFORMATION
Item 1. Legal Proceedings
Reference is made to Note 9, incorporated herein by reference, to our condensed consolidated financial statements included elsewhere in this report which contains a general description of certain legal proceedings to which our company, or its subsidiaries are a party and certain related matters. Reference is also made to Exhibit 99.1 for additional information regarding the pending smoking-related legal proceedings to which Liggett or us is a party. A copy of Exhibit 99.1 will be furnished without charge upon written request to us at our principal executive offices, 4400 Biscayne Boulevard, 10th Floor, Miami, Florida 33137, Attn. Investor Relations.
Item 1A. Risk Factors
There are no material changes from the risk factors set forth in Item 1A, “Risk Factors,” of our Annual Report on 10-K for the year ended December 31, 2018.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
No equity securities of ours which were not registered under a private offering of the Securities Act have been issued or sold by us during the three months ended March 31, 2019.
Issuer Purchase of Equity Securities
Our purchase of our common stock during the three months ended March 31, 2019 were as follows:
|
| | | | | | | | | | | | |
Period | Total Number of Shares Purchased | | Average Price Paid per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs |
January 1 to January 31, 2019 | — |
| | $ | — |
| | — |
| | — |
|
February 1 to February 28, 2019 | — |
| | — |
| | — |
| | — |
|
March 1 to March 31, 2019 | 15,577 |
| | 11.18 |
| (1) | — |
| | — |
|
Total | 15,577 |
| | $ | 11.18 |
| | — |
| | — |
|
(1) Delivery of shares to us in payment of tax withholding in connection with an employee’s vesting in restricted stock. The shares were immediately canceled.
Item 6. Exhibits:
|
| |
| Certification of Chief Executive Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
| Certification of Chief Financial Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
| Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
| Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
| Material Legal Proceedings |
| |
101.INS | |
| |
101.SCH | XBRL Taxonomy Extension Schema |
| |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase |
| |
101.DEF | XBRL Taxonomy Extension Definition Linkbase |
| |
101.LAB | XBRL Taxonomy Extension Label Linkbase |
| |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
* Incorporated by reference
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| | |
| | VECTOR GROUP LTD. |
| | (Registrant) |
| | |
| | By: /s/ J. Bryant Kirkland III |
| | J. Bryant Kirkland III |
| | Senior Vice President, Treasurer and |
| | Chief Financial Officer |
Date: | May 10, 2019 | |